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ABSTRACT 
 
The high long-term failure rate of synthetic vascular grafts in the 
replacement of small vessels is known to be associated with the lack of 
physiological signals to vascular cells causing adverse hemodynamic, inflammatory 
or coagulatory events. Current studies focus on developing engineered vascular 
devices with ability of directing cell activity in vitro and in vivo for tissue 
regeneration. It is also known that controlled molecule release from scaffolds can 
dramatically increase the scaffold ability of directing cell activities in vitro and in 
vivo for tissue regeneration. To address the mechanical and biological problems 
associated with graft materials, we demonstrated a degradable polyester-fibroin 
composite tubular scaffolds which shows well-integrated nanofibrous structure, 
endothelial-conducive surface and anisotropic mechanical property, suitable as 
engineered vascular constructs. 
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Tissue regeneration needs not only functional biomolecules providing 
signaling cues to cells and guide tissue remodeling, but also an adequate modality 
of molecule delivery. In fact, healthy tissue formation requires specific signals at 
well-defined place and time. To develop scaffolds with multi-modal presentation 
of biomolecules, we patterned electrospun nanofibers over the thickness of the 3-
dimensional scaffolds by programming the deposition of interpenetrating 
networks of degradable polymers poly(ε-caprolactone) and poly(lactide-co-
glycolide) acid  in tailored proportion. Fluorescent model molecules, drug and 
growth factors  were embedded in the polymeric fibers with different techniques 
and release profiles were obtained and discussed.  
Fabrication process resulted in precise gradient patterns of materials and 
functional biomolecules throughout the thickness of the scaffold. These graded 
materials showed programmable spatio-temporal control over the release. 
Molecule release profiles on each side of the scaffolds were used to determine 
the separation efficiency of molecule delivery, which achieved >90% for proteins 
in 200µm scaffolds. Gradient-patterned scaffolds were also used to program 
simultaneous release of two proteins to the opposite sides of the scaffold and 
sequential release of proteins to a defined space, which further demonstrate the 
ability of patterned nanofibers to spatially and temporally confine sustained 
release. Moreover, results showed that temporal release kinetics could be altered 
by the structural patterns. Thus, the hierarchically-structured scaffolds presented 
here may enable development of novel multifunctional scaffolds with defined 3D 
dynamic microenvironments for tissue regeneration. 
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1 INTRODUCTION 
 
1.1 Cardiovascular system and diseases 
The cardiovascular system consists of the heart and blood vessels that 
distribute blood in to the various parts of the body. The complex system of organs 
that contributes to the cardiovascular systems has a critical role in the transport 
of nutrients, biochemical signals and cellular waste product, and in the processes 
of oxygen/carbon dioxide exchange. Oxygenated blood travels from the left 
section of the heart to the peripheral capillaries in the peripheral tissues through 
the arteries, and from the capillaries to the heart through the venous system 
(systemic circulation). Deoxygenated blood leaves the right section of the heart 
through the pulmonary arteries and enters the lungs, from where it is carried by 
the pulmonary veins  to the left atrium (pulmonary system). The vascular tree 
forms a hierarchical system of branched arteries and veins that vary in size, 
mechanical properties, biochemical and cellular content, and morphological 
organization, depending on their location and specific function. Largest arteries, 
such as the aorta, that transport blood away from the heart, branch into smaller 
diameter muscular arteries and then in smaller arterioles and capillaries, which 
distribute blood within the tissues and organs. Blood is returned to the heart 
through venules, which combine to form small and large veins, which converge in 
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the superior and inferior vena cavae [1]. Blood vessels consist of three main 
layers: the tunica intima, the tunica media, and the tunica adventitia. The tunica 
intima includes the monolayered endothelial lining of the vessel and the 
underlying layer of connective tissue, the internal elastic lamina. The tunica media 
contains concentric sheets of circumferentially aligned smooth muscle cells 
embedded in a 3-D structure of loose connective tissue. The largest arteries 
(called elastic arteries), such as aorta and brachiocephalic have a considerable 
fraction of elastic tissue, alternated with layers of muscular tissue oriented both in 
longitudinal and circumferential direction. The tunica adventitia, the outermost 
layer of the vessel, contains collagen and a limited number of elastic fibers [2]. 
A number of factors, including, age, genetics, stress, food habits, smoking 
and alcohol consumption are known to contribute to diseases and disorders 
associated with this system which are known as cardiovascular diseases. 
Nowadays, heart, arteries or veins dysfunctions have become the primary cause 
of death in the USA, the leading causes of mortality in Western society [3]. 
Atherosclerosis is the major disease of blood vessels, and affects the larger and 
medium sized elastic and muscular arteries that contain an intima. It consists of 
artery wall hardening and conduit narrowing (stenosis) through accumulation of 
fats, cholesterol, calcium and other substances in the inner lumen of the blood 
vessels. The process is commonly referred as atherosclerotic plaque formation. 
The lesions of atherosclerosis takes form of coronary artery and peripheral 
vascular disease, thus leading to ischemia of the heart, brain or peripheral organs. 
World Health Organizations reports that there were at least 7,200,000 deaths due 
to stenosis around the world in 2004 [4].  
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1.2 Vascular grafts 
Patients with less severe symptoms are treated with numerous non-
invasive treatments, such as the use of anti-thrombotic drugs or cholesterol-
lowering drugs. Therapies such endovascular procedures, are considered available 
minimally invasive strategies. In the case of more severe pathologies, surgical 
bypass and vessel replacement became necessary. Vein replacements have been 
performed in the largest part with autografts, using healthy sections of patient’s 
own veins. 
In the case of highly compromise arteries, bypass surgery and artery 
stenting are the accepted treatments. Coronary artery bypass grafting or coronary 
artery stenting are the most common diseases for patients with severe artery 
blockage. Currently, bypass grafts fall in two general categories: biological and 
synthetic grafts.  
1.2.1 Biological grafts 
Biological grafts can be natural veins or minor arteries harvested from the 
patient itself (autograft), from another individual or the same species (allografts 
or homografts) or from animals (xenografts).  
Proposed autologus grafts used in vascular replacement are saphenous 
veins, internal thoracic arteries, radial artery are used. Although vascular bypass 
grafting remains the gold standard for revascularization for ischemic heart disease 
and peripheral vascular disease, many patients do not have healthy suitable 
vessels, due to previous surgery, vessel diseases or trauma. The vascular 
4 
  
 
 
 
 
substitutes have been proposed and tested are decellularized allografts, 
decellularized and cross-linked xerografts and artificial synthetic grafts. 
1.2.2 Synthetic grafts [5] 
Nowadays, polytetrafluoroethylene (PTFE), Dacron and polyurethane (PU) 
are considered standards materials for vascular replacement. Synthetic polymer 
devices for vascular replacements are the more practical alternative to autografts. 
Though impressive success of these grafts has been made in aortic and iliac 
surgery (medium and large arteries), smaller diameter (≤6mm) grafts has been a 
symbol for the limitations of modern biotechnology because their long-term 
failure rates are still high [6–8]. Thrombogenicity and graft occlusion represent 
the major limitations for currently used small diameter vascular grafts. The 
inability of the body to remodel synthetic materials is related poor long term 
patency of permanent synthetic grafts. 
Small-diameter vascular grafts are used as medical implants for a number 
of diseases, such as coronary or periphery artery bypass grafts, pediatric vascular 
shunts and vascular access grafts. The materials and structures of contemporary 
grafts provide limited capability of endothelium regeneration and tissue ingrowth. 
Lack of good tissue ingrowth and regeneration in the grafts makes grafts more 
prone to ongoing thrombogenity and intima hyperplasia [9–11].  
Exposition of a prosthesis surface to blood flow results rapidly in a 
deposition of blood proteins on the luminal surface and generates the process of 
platelet activation, leading to thrombus formation via the intrinsic coagulation 
pathway and ultimately in vessel occlusion. At the same time, activated platelets 
secrete platelet-derived growth factor (PDGF), which is responsible for the 
migration of smooth-muscle cells (SMC) from the media into the intima [2].  
5 
  
 
 
 
 
During the past few decades, many efforts have been made to improve 
the performance of vascular grafts mainly through the attempts that modify the 
structure and surface of the contemporary graft materials. These attempts 
include: (a) increasing structural porosity; (b) increasing mechanical compliance; 
(c) pre-endothelialization; and (d) incorporating anti-thrombotic molecules on the 
surface [10,12]. Impressive advancement on these synthetic vascular grafts has 
been made to improve graft patency. However, as commented by Zilla et al [8], 
these graft materials have structure-related limitations to regenerating vascular 
tissue both on the surface and in the transmural space. The non-degradable 
nature of the materials restricts the remodeling and regeneration capability of 
media and adventitia.  
The most common causes for the poor performance of small-diameter 
grafts are surface thrombogenicity and intimal hyperplasia (IH), which are mainly 
mediated by denude of endothelium and lack of sufficient tissue ingrowth [7,13]. 
Exposition of a bare graft surface to blood flow results rapidly in a deposition of 
blood proteins on the luminal surface, activating platelets and leading to 
thrombus formation via the intrinsic coagulation pathway and ultimately to vessel 
occlusion. Also, activated platelets secrete molecules such as platelet-derived 
growth factor (PDGF) which is responsible for the proliferation and migration of 
smooth muscle cells (SMC) from the media into the intima leading to IH. IH 
narrows the vessel lumen decreasing blood flow to the point that it may in turn 
promote local thrombosis. Intima hyperplasia can also be induced by flow 
turbulence at the graft-vessel junction due to the mismatch mechanical 
compliance of graft and vessel [14]. Graft modification with protein lining, heparin 
incorporation and polymer resurfacing reduced thrombosis and neo-intimal 
hyperplasia but did little to improve long-term arterial graft patency [9].  
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It is generally agreed that efforts to improve the graft should be made on 
the formation of a physiological vascular tissues including functional endothelium, 
smooth muscle and connective layers around the vascular graft ensure mimetic 
biological and mechanical functioning of the graft and allow it better integrated 
with native blood vessels [6,8,15]. Considering the important role that 
physiological tissue formation on or around the grafts plays in the long-term 
patency of small-diameter vascular grafts, a more recent research thrust is to 
develop various tissue engineering approaches which allow the tissue formation 
to spontaneously occur in vitro or in vivo and eventually replace the grafts [16,17].  
1.3 Vascular Tissue Engineering approach  
1.3.1 Tissue Engineering 
Tissue Engineering is an interdisciplinary field that applies the principles of 
engineering and life sciences toward the repair and the restoration of damaged 
tissue functions [18]. The three fundamental tools that Tissue Engineering exploits 
to achieve successful tissue regeneration are  cells, scaffolds and specific signalling 
factors [19]. An effective interplay and an synergistic cooperation between these 
three components have been proven to be a critical factors for the process of 
scaffold-tissue integration and, eventually, for tissue regeneration. Scaffolds have 
to provide adequate structural and mechanical support and to direct cell activity 
toward the regeneration of a new physiological tissue by providing chemical, 
biological and physical cues. For example, active molecules and Growth Factors 
(GFs), that have the ability to influence cell attachment, migration, proliferation 
and differentiation, can be encapsulated in the scaffolds and released in situ 
[20,21]. 
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1.3.2 Vascular Tissue Engineering 
Tissue engineering has emerged as a promising strategy for vascular tissue 
regeneration. Tissue engineering approach aims at regenerating damaged tissues 
or organs, in order to growth an integrated new tissue with the same 
characteristics of the native one. When in 1986, Weinberg and Bell claimed the 
construction of new blood vessel in vitro, with bovine aortic endothelial cells, 
smooth muscle cells and fibroblasts seeded on a collagen matrix [22] [Weinberg 
and Bell 1986], they signed the road that would address the research strategies 
for tissue regeneration until the present days. This work has been commonly 
regarded as the first engineered construct for vascular tissue engineering, though 
their work had been published seven year in advance to the Tissue Engineering 
definition [18]. 
Vascular tissue engineering offers a promising alternative approach to 
address the needs for small-diameter vascular grafts by overcoming the 
mechanical and/or biological problems associated with the current materials [1]. 
To avoid adverse hemodynamic conditions, mechanical properties of tissue 
engineering grafts must closely match those of native arteries, meanwhile the 
grafts should be sufficiently strong. Many studies have demonstrated the 
anisotropic mechanical property of natural arteries; higher stiffness in the 
longitudinal direction can avoid an excessive stimulation of anastomotic regions, 
while being compliant in the circumferential direction to match the compliance of 
native artery can avoid flow disturbance [7,8].  
In vitro tissue regeneration is regarded as the most traditional approach 
used in the studies on tissue engineered vessels. According to the scheme 
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proposed by MacNeill in 2002, autologous cells are expanded in vitro and 
organized on a suitable scaffold, cell culture is performed in specifically designed 
bioreactors to produce an engineered functional tissue similar. The new tissue 
similar to the physiological one is implanted into the patient, without any 
rejection problem [25]. 
However, expansion of harvested autologous cells in vitro and cell growth 
onto the scaffolds are the time limiting steps. These reasons make this approach 
barely unfeasible in the normal clinical situations, and completely impossible in 
the case of acute diseases or trauma. 
In the case of in vivo tissue regeneration, a scaffold is directly implanted 
either in the site of injury and the patient’s body itself produces the new tissue, by 
invading the scaffold with cells, remodelling and sometime replacing it in the 
time.  
1.4 Electrospinning as a method for preparing scaffolds 
for Tissue Engineering 
1.4.1 Electrospinning history 
Electrospinning is the most widely used method to generate nanofibers.  
Fundamental electrospinning idea took its origin from Lord Rayleigh’s 
observations on the electrospray phenomena in 1882 [26]. He found that a highly 
charged droplet was unstable and would break down into smaller droplets in 
presence of an high voltage: the so called  “Rayleigh instability’’. The electric 
Columbic repulsive forces, overcoming the surface tension, result in a rupture of 
the droplet surface. Later, Zeleny investigated the Instability of electrified of 
aqueous solutions [27]; in the late 60’s, Dole et al. studied the electrosprays of 
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dilute polymer solutions [28]. Electrospinning phenomenon is a similar to the 
electrospraying; the substantial difference between the two is that 
electrospinning produces continuous fibers instead of small droplets.  
In 1934, Formhals electrospun fine fibers from a cellulose acetate solution 
and registered a patent in U.S. on this new technology [29], [30]. Later, Simons 
signed another patent, in which he used concentrated solutions to increase the 
viscosity, having a more stable process and producing longer fibers [31]. In the 
early 80’s, Larrondo and Manley performed an electrospinning process with 
polymer melts and produced polyethylene nanofibers [32].  
The recent, rising interest in nanotechnology has renewed attention to 
this convenient, economical technology that enables engineers to produce 
nanofibers for various applications. 
1.4.2 Electrospinning process 
The electrospinning process enables to produce polymeric fibers with 
diameters in the range of a few nanometers to several microns. In 
electrospinning, a high voltage is applied to polymer solution (or a melt), 
saturating the solution with electrical unbalanced charges. The polymeric solution 
is stored in a reservoir and is forced out of a needle (or spinneret) at a constant 
rate. With increasing voltage, the surface charge on the polymer droplet 
increases, resulting in the formation of a conical shape (Taylor cone) at the tip of 
the spinnaret. As shown in Figure 1-1, once that a threshold voltage has been 
reached, the surface charge overcomes the surface tension and viscosity of the 
polymer droplet, a jet is initiated and ejected form the apex of the Taylor cone 
toward the grounded collector. 
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Figure 1-1. Schematization of the electrospinning process 
The jet travels toward a region of lower electrical potential, that, for 
convenience, is a grounded collector. After being ejected from the apex of the 
Taylor cone, the jet travels linearly in a region, called linear region, whose 
extension can vary considerably between different polymer/solvent system. After 
that the high charge density results in a instability of the jet, that enters a so 
called instability region, where it undergoes to repeating bending and whipping 
rapid movements that contributed to elongate the fiber, narrowing its diameter 
down to the nanometric range. High speed photography have been used to image 
the fiber path and behavior along the air gap between spinneret and collector 
[33,34]. In addition. several studies applied mathematical models and numerical 
simulations to rationalize the shape of fiber track and the bending instability 
phenomenon [33,35,36].  
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In the small fraction of time, in which the jet travels from the needle to 
the grounded collector, the solvent evaporates, and dry nanometric fibers are 
deposited on the metal target plate, forming a non-woven nanofibrous mat. A 
fundamental step by step description of the electrospinning principles and the 
mechanisms of fiber formation have been presented by Rutledge and Fridrikh 
[37], and Detailed reviews on the topic of electrospinning for tissue engineering 
are given by several groups [35,38–41]. The electrospinning process can be 
manipulated by a number of variables for desired morphology and property of 
nanofibers. These variables include solution characteristics, process variables, and 
environmental parameters. Polymer solution characteristics, such as polymer 
molecular weight, concentration, solution viscosity, solution charge density, 
conductivity, dielectric constant and surface tension, are often difficult to isolate 
since varying one generally affects others. Process or system variables include: 
• flow rate, 
• field voltage,  
• distance between tip and collector,  
• needle tip design and placement,  
• collector composition and geometry.  
 
Environmental parameters, such as environmental temperature, humidity 
and atmosphere, are as important but less often explored [42], [43]. A general 
understanding of these parameters, allows one to set up a process to produce 
defect-free fibers with controllable nanofiber morphology. When electrospinning 
parameters are optimized, the obtained fiber diameters should have a narrow 
distribution. Also, porosity of electrospun materials can be altered by changing 
the void spaces laying between the fibers through varying the mean fiber 
diameter, the diameter distribution and the degree of fiber packing.  
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1.4.3 Electrospinning in Tissue Engineering 
Electrospinning is a simple and widespread technique for the production 
of nano- and micro-metric polymeric fibers that are deposited on a grounded 
collector to form a nonwoven material with regular nano-structured surface [44]. 
Electrospun nanofiber matrices are characterized by ultrafine continuous fibers, 
interconnected pores, high porosity and variable pore-size distribution similar to 
the dimensions of basement membranes. Those matrices present a dynamic 
system in which the pore size and shape can change when compared to other 
rigid porous structures. 
Electrospun constructs can be produced that are particularly interesting 
as scaffolds for Tissue Engineering and as drug delivery systems [45–49]. A variety 
of degradable and resorbable materials have been processed, including 
degradable polyesters, such as poly(ε-caprolactone) (PCL), poly(lactide) (PLA), 
poly(glycolide) (PGA) and their copolymers poly(lactide-co-glycolide) (PLGA) , and 
natural polymers, such as collagen, silk fibroin, fibrinogen and other proteins [50–
54].  
Electrospun devices have been proposed for a multiplicity of applications 
where the scaffold is required to interact with different cells, tissues or even 
different organs at the same time.  In those situations, the electrospun scaffold 
acts like an interphase between environments with diverse characteristics and 
requirements. For example, electrospinning have been considered in the repair of 
the osteochondral defects, where integration with both the subchondral bone and 
the deep cartilage zone is required. The two regions are characterized by different 
cell types, different degree of vascularisation of the tissue, collagen distribution 
and porosity. Therefore, a scaffold with the ability to interact independently with 
the two tissues, in a particular selectively release different biomolecules, is 
required [Yang, engineering orthopaedic interfaces]. In the field of tissue 
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engineered vascular grafts electrospun scaffold have been used to promote 
endothelial call attachment and proliferation on one side, while supporting the 
organization of new extracellular matrix generated by smooth muscle cells and 
fibroblasts on the other side. Selective release of Growth Factors that could target 
specifically  the different types of cells has been prospected both for in vitro co-
culture tests and for in vivo integration of tissue engineered vascular grafts. 
Control- and spatial-confinement of the released biomolecules can be obtained 
with graded materials and segregation of the delivery systems in particular 
regions of the scaffold. 
1.4.3.1 Nanofibers scaffolds 
Scaffolds made from nanofibrous materials using electrospinning 
techniques have been increasingly used for various tissue constructs, including 
those for replacement of intervertebral disk, meniscus, annulus fibrosus, blood 
vessels, and cartilage [55–61]. The advantages of using nanofibrous scaffolds for 
tissue engineering include their load-bearing functionality, porous structure, and 
nano- to micro- sized fibers, similar in the length scale to native extracellular 
matrix (ECM), to guide cell adhesion and proliferation [53,54,62–65]. The versatile 
use of electrospinning with a variety of natural and synthetic degradable polymers 
offers a large repertoire for tissue engineering and drug delivery applications [66–
69]. Additionally, electrospun biomaterials provide a wide range of mechanical 
and chemical properties via fiber composition, diameter, distribution and 
porosity, through control over a panel of engineering parameters in the process 
[45,47,49,70]. Further, collection of nanofibers onto a rotating mandrel or other 
collectors with specialized surfaces, can result in structural and mechanical 
anisotropy for the applications of vascular or fibrous tissue engineering [43,71].  
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1.4.3.2 Nanofibers scaffolds for vascular Tissue Engineering 
Recent developments in nanofiber fabrication technology provide 
tremendous opportunities to improve vascular implant performances, because 
diverse fabrication methods and functionalization strategies allow one to design 
optimal material properties and environments for desired short-term and long-
term performances that meet the needs of a specific treatment [72–75]. 
Specifically, nanofiber scaffolding materials offer a number of advantages for 
vascular grafting applications:  
The nanofibers mimic the nanostructure of the extracellular matrix (ECM) 
of natural tissues. Cells live in a nano-featured ECM environment. They attach and 
organize better around fibers with diameters much smaller than cell diameter 
(>5μm). It is found that nanometric surface topography with a high surface area-
to-volume ratio attracts more endothelial cells and promote their growth, thus, 
accelerating the re-formation of an endothelium to prohibit thrombosis of the 
artery [76].  
Controllable porosity and interconnected pores together with 
biodegradable property could allow the materials to have large and ever 
increasing space for SMCs to grow, migrate and fulfill regeneration and for better 
integration of the host tissue in the long term.  
Electrospinning of synthetic fibers and protein fibers have been 
demonstrated for vascular applications. Electrospun synthetic polymers such as 
PCL and PLGA have successfully been applied to engineer vascular tissues [50–
52,77,78]. Electrospinning of natural-derived biopolymers such as collagen, 
elastin, silk fibroin, chitosan and fibrinogen have also been developed for vascular 
engineering [79–81].  
A particularly interesting and promising area of electrospinning is creating 
composite scaffolds with mixed nanofibers or with a blended composition of 
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polymers in the nanofiber. The benefit of scaffolds formed with a combination of 
different polymers is in the possibility of synergizing the favorable characteristics 
of each individual component to obtain a composite with superior mechanical 
and/or biological properties required for vascular grafts. Nanofibers with different 
physical or biological properties, such as hydrophobic/hydrophilic fibers, fibers 
with different degradation rates, and synthetic/biological fibers, can be combined 
to form hybrid fibers with desired properties. The hydrophilic/hydrophobic 
characteristic is a critical factor that affects protein adhesion thus influencing blot 
clotting formation and cell adhesion. It also affects biomolecule release and 
mechanical properties. Therefore, a composite made of hydrophobic and 
hydrophilic polymers can combine superior mechanical properties, better 
hydrolytic resistance and better thrombo-resistance that hydrophobic polymers 
provide with higher molecule incorporation potential that hydrophilic polymers 
provide [81]. Using fiber composites with a polymer that degrades faster than the 
other can increase the porosity for tissue in-growth [82].  
1.5 Drug delivering scaffolds for tissue regeneration 
In addition to structural support, mechanical property and biodegradable 
feature, an ideal scaffold for tissue regeneration should provide molecular cues to 
guide regeneration of tissue structure and function. To incorporate regenerative 
or therapeutic molecules into biomaterials that sustain the molecule release in 
vitro or in vivo, various methods such as adsorption and covalent binding [83,84], 
encapsulation [85,86], and addition during scaffold formation [87], have been 
developed. A step forward could be moving from static cues of one molecule 
toward delivery systems that reproduce more closely the dynamically evolving 
microenvironment occurring in natural ECM [88–90]. The delivery systems 
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incorporating molecules, mainly biodegradable particles, could offer distinctive 
advantages such as regulation of release rate while protecting their molecule 
cargo during all the stages of tissue re-growth [91,92]. Indeed, scaffolds that 
support tissue repair, re-growth or regeneration from cells, particularly from 
undifferentiated stem or progenitor cells, may have to partially recapitulate 
natural tissue morphogenesis, which is driven by the concomitant action of 
multiple factors working in concert. Growing evidence has shown that tissue 
morphogenesis is coordinated by the spatial arrangement and temporal duration 
of multiple molecules in the three-dimensional (3D) ECM [93,94]. For precise 
regulation, recent developments have demonstrated the benefits of using micro- 
and nano- structures [70,95–104]. The majority of newly-developed molecule-
impregnated scaffolds, however, are capable of achieving sustained or 
temporally-controlled molecule release. Few techniques are available to engineer 
3D scaffolds that define spatial organization of molecules or control release in 
both space and time scale. Control of where and when a molecule acts can 
strongly contribute to provide spatially complex arrangements of cells in length 
scales ranging from nano-/micro- meters to centimeters. The spatial control over 
release is critical to coordinate cell behaviors for tissue pattern formation 
[92,102].  
Selective release of molecules that target specific cell types or tissue 
formation without influencing the activity of other cell populations or tissue 
functions is important to establish both in vitro physiological tissue models and in 
vivo tissue regeneration [105–107]. Patterning or segregation of molecule delivery 
materials are important to spatially confine biomolecules [108–110]. To meet 
various physiological needs of different cell types during tissue regrowth, a 3D 
scaffold should present a multitude of regenerative biomolecules in a sustained 
manner at defined locations. 
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1.5.1 Nanofibers scaffolds as drug delivery systems 
Recently, strategies that use electrospun fibers to encapsulate and deliver 
molecules have been established [46,87,104]. Due to inherently high surface area 
of electrospun materials, nanofiber constructs allow high molecule loading and 
efficient release in situ. However, the developed techniques have been limited to 
tune molecule release kinetics and often the structure and property of nanofibers 
are significantly influenced to facilitate molecule encapsulation. Herein, we report 
a new strategy of designing electrospun constructs, which utilize micropatterns of 
nanofiber to spatially define or temporally control delivery of molecules. We 
previously demonstrated the development of double-electrospinning system that 
used a rotating mandrel collector to produce constructs composed of 
interpenetrating networks of nanofibers with diverse nanofibers in a tailored 
proportion to achieve anisotropic mechanical properties and engineered surfaces 
[43]. The incorporation of molecules which affect cell function and tissue 
regeneration must be designed to target at specific cell physiology process, 
dependent on cell type and cell differentiating state. Thus, an in-depth 
understanding of vascular cell biology and/or stem cell biology, particularly cell 
signalling, is important for the incorporation of the right molecular signals at the 
right location and time. Localized delivery of medicaments at a controlled rate 
over a specific period of time improves therapeutic efficacy and reduce toxicity of 
bioactive agents. In this view, a finely designed controlled-release device is 
required to spatially and temporally encounter the needs of the regenerating 
tissue [102,111,112]. 
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1.6 Objectives of the thesis 
Designing bioinspired vascular grafting materials through nanofiber 
fabrication techniques, such as electrospinning is an emerging field. To enhance 
the biomimicry of nanofibrous scaffolds, multi-functional nanofibers should be 
made by combining bioactive surface with spatiotemporal release of functional 
molecules and drugs. This is being explored by following techniques: (a) modifying 
the surface of nanofibers; (b) incorporating bioactive molecules in the nanofibers 
and achieving spatiotemporal control over the molecule release; (c) incorporating 
cells during the fiber-formation process; and (d) forming composite nanofibers 
that combine the different mechanical, bioactive and degradable properties of 
component materials. 
 
The objective of this thesis is to develop a platform for producing a novel 
and innovative scaffolds for Vascular Tissue Engineering applications. Vascular 
tissue engineering offers a promising alternative approach to address the needs 
for small-diameter vascular grafts by overcoming the mechanical and/or biological 
problems associated with the current synthetic materials. The primary 
requirement is to design and manufacture with adequate mechanical property 
and deformational behavior and superior surface biocompatibility for endothelial 
cell adhesion and proliferation. To overcome the drawbacks related to materials 
and structures used in contemporary synthetic grafts, we will combine the 
superior biological properties of a natural polymer (silk fibroin) with higher 
mechanical stability and performance of a degradable and resorbable polyester 
(PCL). In Chapter 2, we will demonstrate a robust multilayered scaffolds with 
intermixing nanofiber structure, tunable anisotropy ratio, and surface properties 
which may hold great potential in tissue engineering applications.  
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Moreover, the present study intends to address the problem of spatial 
confinement of drug delivery in a specific region of the scaffold. Therefore, we will 
design scaffolds with capability of selectively releasing molecules in spatially- and 
temporally- controlled manner. Herein, electrospun composite scaffolds used to 
form materials with compositional and biochemical gradients along the scaffold 
thickness will be presented in Chapter 3, Chapter 4 and Chapter 5. We have 
characterized compositional and morphological changes as well as degradation 
behaviours of these composite scaffolds. More importantly, we will display a 
variety of tunable nanofiber micropatterns composed of degradable polymers PCL 
and PLGA and characterized by compositional and biochemical gradients with the 
ability to control spatially and temporally the delivery of one or multiple 
molecules. 
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2 BIOHYBRID NANOFIBER COMPOSITE 
CONSTRUCTS WITH ANISOTROPIC 
MECHANICAL PROPERTIES 
 
Abstract 
 
Synthetic implant materials often lack of the anisotropic mechanical 
properties and cell-interactive surface which are shown by natural tissues. For 
example, engineered vascular grafts need to be developed to address the 
mechanical and biological problems associated with the graft materials. The 
present study has demonstrated a double-electrospinning fabrication process to 
produce a poly(ε-caprolactone)-fibroin multilayer scaffold which shows well-
integrated nanofibrous structure, endothelial-conducive surface and anisotropic 
mechanical property, suitable as engineered vascular constructs. Electrospinning 
parameters such as voltage, solution concentration, feed rate and relative 
humidity were optimized to obtain defect-free, uniform nanofibers. In order to 
mimic the different mechanical properties of natural vessels in the circumferential 
and longitudinal directions, a rotating cylinder was used as collector, resulting in 
the production of constructs with anisotropic properties. The combination of the 
collector shape and the collector rotation allows us to produce a tubular structure 
with tunable anisotropic mechanical properties. Fourier transform infrared 
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spectroscopy, differential scanning calorimetry and uniaxial tensile tests were 
used to characterize the electrospun constructs. Cell cultures with primary 
endothelial cells demonstrated that cells showed spread morphology and strong 
adhesion on fibroin richer surfaces. The platform for producing robust multilayer 
scaffolds with intermixing nanofiber structure, tunable anisotropy ratio, and 
surface with specific compositions may hold great potential in tissue engineering 
applications. 
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2.1 Introduction 
The proper design of a scaffold that supports tissue regeneration has to 
take in account for a variety of factors such as mechanical properties, surface 
properties, morphology, pore size and distribution, biocompatibility and 
biodegradability [1,2]. Mechanical properties on tissue regeneration and cell 
growth are particularly important in tissues such as bone, muscles, cartilage, 
blood vessels and tendons [115].  
Vascular grafts are currently used to replace damaged or occluded blood 
vessels for treatment of a number of vascular diseases such as coronary vascular 
diseases. Many patients that require vascular grafting do not have suitable 
autologous grafts and thus require synthetic grafts. Synthetic vascular grafting 
materials currently in clinical use are often made from stiff, bioinert materials 
such as expanded polytetrafluoroethylene (ePTFE) and dacron. When these 
synthetic grafts are used to replace small-diameter (<6 mm) vessels, low patency 
or high failure rates occur [116].
. 
Grafting pathology is often characterized by 
anastomotic intimal hyperplasia and thrombosis, which are induced by improper 
hemodynamic, inflammatory or coagulatory conditions around grafts. A leading 
cause of these adverse conditions is the mechanical and biological properties of 
the synthetic graft materials [8].  
Vascular tissue engineering offers a promising alternative approach to 
address the needs for small-diameter vascular grafts by overcoming the 
mechanical and/or biological problems associated with the current materials [1]. 
To avoid adverse hemodynamic conditions, mechanical properties of tissue 
engineering grafts must closely match those of native arteries, meanwhile the 
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grafts should be sufficiently strong. Many studies have demonstrated the 
anisotropic mechanical property of natural arteries; higher stiffness in the 
longitudinal direction can avoid an excessive stimulation of anastomotic regions, 
while being compliant in the circumferential direction to match the compliance of 
native artery can avoid flow disturbance [23,24].  
Therefore, one of the goals in the present study is to create a structure 
that reproduces anisotropic mechanical properties of natural arteries. In addition, 
to provide anti-coagulatory and anti-inflammatory environments, the graft 
surface must be inherently anti-thrombogenic or conducive to endothelial cells. 
Furthermore, the presence of non-degradable grafts always imposes long-term 
concerns about the synthetic materials. Therefore, an ideal tissue engineering 
graft scaffold should not only closely match the mechanical properties of native 
arteries and be conductive to endothelial cells, but also be degradable as it 
provides a temporary scaffold to support the growing tissue substitute until cells 
produce their own extracellular matrix. It has been shown that a single material is 
difficult to simultaneously satisfy all these requirements.   
Electrospinning is an attractive technique for fabricating tissue 
engineering scaffolds, due to the simplicity of the process and the capability of 
generating nanofibrous structures that mimic the natural extracellular matrix 
[40,45,117]. A variety of polymers have been electrospun for biomedical 
applications proposed in a wide range of areas including skin, nerve, tendon, 
cartilage, bone, and blood vessel [118–120]. Regenerated silk fibroin, one of the 
most promising biological polymers, is recently experimented in the field of tissue 
engineering because of its favorable interactions with cells and proteins [121–
123]. Zhang et al. suggested that electrospun fibroin scaffolds held potential for 
explorations of tissue-engineered vascular grafts because they sustained vascular 
cell viability, maintained cell phenotype and promoted cell reorganization [124]. 
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In a recent study, Bondar et al. [125] have shown that endothelial cells recognize 
fibroin nanofibers through integrin-dependent mechanisms and, and the 
nanometric silk fibroin scaffolds did not interfere with the formation of a 
differentiated and interconnected endothelial layer. Poly(ε-caprolactone) (PCL) is 
a semicrystalline, bioresorbable, aliphatic synthetic polyester. A number of 
implantable medical devices are made of robust PCL. Electrospun PCL materials 
have been widely demonstrated for biomedical applications [126–128].  
In the present study, we have demonstrated a novel multilayered 
biohybrid nanofiber scaffold made of silk fibroin and PCL. The scaffold is 
characterized by anisotropic mechanical properties, surface conducive to 
endothelial cells and degradation capacity. Anisotropic mechanical properties and 
surfaces with different functionalities are achieved by sequentially and 
simultaneously electrospinning fibroin and PCL on a rotational mandrel, which 
forms a robust multilayered structure with non-homogeneous compositions and 
an interpenetrating fibrous layer in the transition region. 
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2.2 Materials and Methods 
2.2.1  Materials 
Cocoons of Bombyx mori silkworm PN06 (Poli-ibrido Nazionale 2006) 
were kindly supplied by Centro Sperimentale di Gelsibachicoltura (Como, Italy). 
Poly-ε-caprolactone (PCL) with nominal average MW of 80,000 Da and 
poly(ethylene oxide) (PEO) with nominal average MW of 500,000 Da were 
purchased from Sigma Aldrich S.r.l (Milan, ITALY). Formic acid (98-100% purity) 
was also obtained from Sigma-Aldrich. N,N-dimethylformamide (DMF) minimum 
purity 99.9%, and methylene chloride (DCM)  minimum purity of 99.5% were 
purchased from BDH Italia (Milan, Italy). All other substances were of analytical or 
pharmaceutical grade and obtained from Sigma-Aldric. 
2.2.2 Preparation of regenerated Bombyx mori silk fibroin 
Bombyx mori silk-fibroin water solutions were prepared as previously 
described [129]. Briefly, to remove sericin, cocoons were degummed by treating 
silk twice with 1.1 g/l and 0.4g/l Na2CO3 (anhydrous, minimum 99%) water 
solution at 98 °C for 1 hr each time. This resulted in 1 litre of solution containing 
10 g of silk fibroin, which were then washed in de-ionized water and air-dried. The 
extracted silk fibroin was then dissolved in 9.3M LiBr (1 g fibroin in 10 ml LiBr 
solution) at 65 °C for 8-10 hr. After that, the solution was dialyzed in a Slide-A-
Lyzer Cassette of 3500 MW (Pierce, Rockford, Illinoys, USA) against distilled water 
for three days in order to remove the salt, and then filtered through a ceramic 
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filter foam (porosity <5 μm). Finally, water-soluble powders of fibroin were 
prepared with a freeze-drying process. 
2.2.3  Electrospinning 
2.2.3.1 Preparation of spinning solutions 
A series of fibroin solutions were prepared by dissolving regenerated silk-
fibroin powders in formic acid at a concentration of 8-16% (wt%). PCL was 
dissolved at a concentration of 9% (wt%) in a mixture of DCM/DMF with 3-to-1 
volumetric proportion. PEO was dissolved at a concentration of 5% (wt%) in 
water.  
2.2.3.2 Electrospinning of single-polymer materials 
In this study, single-polymer materials and composite materials were 
produced in flat sheet form or in tubular shape. The single-polymer nanofibrous 
materials were fabricated by a single electrospinning apparatus. A home-made 
electrospinning apparatus was composed of a Gamma High Voltage Research 
ES30P-10W power supply (Gamma High Voltage Research Inc., Ormond Beach, 
FL), a single syringe pump (Pump 11 Plus - Harvard Apparatus, Crisel Instrument, 
Rome, ITALY), and a flat aluminium collector to produce flat sheets or a rotating 
cylindrical collector to produce tubular-shaped materials. A cylindrical collector 
with 20 mm in diameter was rotated by a brushless rotating electric motor 
(BLF230C-A Oriental Motor Italia S.r.l., Milan, ITALY). Rotation speeds in the range 
of 50 - 2000 rpm were achieved. In addition. another collector with 4.96 mm in 
diameter rotating at 100 rpm was used to produce constructs with a smaller 
diameter. To facilitate the detachment of the scaffold materials (fibroin or PCL), 
the collector was preventively coated with a thin veil of electrospun PEO. Fibroin 
28 
  
 
 
 
 
and PCL fibers were collected with needle-collector distances of 12 cm and 22 cm, 
respectively. Syringes of 5 ml were filled with polymer solutions and fitted with a 
stainless-steel 18G blunt-ended needle which is then connected to 25 cm flexible 
PTFE tubing.  
2.2.3.3 Parametric study in the fibroin electrospinning process   
To produce good-quality silk-fibroin nanofibers, several electrospinning 
parameters were investigated and analyses were carried out on evaluating their 
effects on fiber morphology and diameter. The parameters of interest included 
applied voltage, solution concentration and feed rate, which varied in the range of 
14-30 kV, 8-12% (wt%) and 1-12 μl/min, respectively. In addition, the effect of 
environmental relative humidity on fiber diameter was investigated.  
The electrospinning processes were thus carried out in two different 
environments with a relative humidity of 45% or 70%. Parameter configurations 
that resulted in defect-free fibers were carried further for morphology, chemical 
and thermal characterizations.  
2.2.3.4 Double-electrospinning system to produce nanofibrous composite 
scaffolds 
 Multilayered composite scaffolds were produced by a new double-
electrospinning system (Figure 2-1a and Figure 2-1b) through sequentially and 
simultaneously electrospinning fibroin and PCL on a rotational mandrel collector.  
 
29 
  
 
 
 
 
 
a. 
 
b. 
 
c. 
Figure 2-1. (a) Schematic illustration of the double electrospinning system; (b) 
Actual setup of the system; (c) Illustration of the PCL_fibroin multilayered 
material. 
In sequence, a thin layer of fibroin nanofibers, an intermixed layer of 
fibroin and PCL nanofibers, and a thick layer of PCL electrospun fibers were 
deposited on the grounded cylindrical metallic collector (Figure 2-1c). Each 
solution (fibroin or PCL solution) was stored in a separate 5 ml syringe that served 
as a charged spinneret. The syringe was fitted with a blunt-ended needle and 
connected to PTFE tubing. Each spinneret were placed at the opposite side of the 
rotating mandrel, perpendicularly oriented with respect to the principal axis of 
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the collector, and connected to a separate high voltage power supply. Both 
spinnerets moved in concert over a 15 cm path with a speed of 5m/s along the 
mandrel under the control of a linear motorized stage (EZS3D025-C  Oriental 
Motor Italia S.r.l., Milan, ITALY). The feed rates of the two solutions were varied 
independently between 0 and an optimal flow rate over the deposition time via 
two different syringe pumps. 
Using single-polymer electrospinning processes, electrospinning 
parameters were optimized for regenerated fibroin and PCL (Table 2-1).  
 
Parameter Fibroin PCL 
Solvent  
Concentration 
Voltage 
Work distance 
Feed rate 
Formic acid 
10% (wt)   
22 kV 
12 cm 
7 μl/min 
DCM/DMF (3:1) 
9% (wt) 
28 kV 
22 cm 
15 μl/min 
Table 2-1. Optimized electrospinning parameters. 
These fabrication parameters were used to produce fibroin-PCL 
composite scaffolds. Using the double electrospinning system described above, 
the silk-fibroin solution stored in syringe A was first electrospun on the collector 
at a feed rate equal to the optimal value of 7μl/min, while the PCL solution stored 
in syringe B were kept static. Thus, a thin layer of fibroin nanofibers was obtained. 
After 5 minutes, the PCL solution started to be electrospun and deposited onto 
the collector with a low feed rate of 1 μl/min. This was done simultaneously with 
the electrospinning and deposition of fibroin. During the next 10 minutes, the 
feed rate of the PCL solution was gradually adjusted to the optimal value of 
31 
  
 
 
 
 
15μl/min, while the feed rate of the fibroin solution were gradually reduced to 
zero. As a result, an intermixed interlayer of fibroin and PCL nanofibers was 
deposited on the top of the thin fibroin layer (Figure 2-1c). Finally, electrospinning 
of the PCL solution was conducted for another 30-40 minutes, in order to obtain a 
thick PCL bulk layer. The obtained electrospun tubular constructs were cut along 
the longitudinal axis, resulting in a smooth flat sheet with a dimension of 6x12 cm 
and thickness approximately in the range of 90-120 μm. 
2.2.3.5 Post-treatment of scaffold materials containing fibroin 
A water/methanol mixture with 9:1 ratio was used for fibroin stabilization 
and detachment by dissolving PEO. Then, fibroin was rinsed with DI water and 
soaked overnight in DI water to eliminate solvent residuals. 
2.2.4  Characterizations of the scaffold materials 
Non-woven electrospun meshes were imaged with scanning electron 
microscopy (SEM). To investigate net morphology, samples were mounted on 
aluminium stubs and sputter coated with gold. Observations were made at 10 kV 
by using a Stereoscan 200 SEM (Cambridge Instrument Company, Cambridge 
U.K.). For nanofiber diameter analysis, three images were taken in different 
locations of each sample, and roughly 100 fiber diameters were measured and 
averaged using Image-J, an image analysis software. Results were presented as 
mean ± standard deviation. Electrospun mats were analysed by FTIR in attenuate 
total reflectance (ATR) mode with a Perkin Elmer Spectrum One 
Spectrophotometer equipped with a diamond probe. In all cases 64 scans at a 
resolution of 2 cm
-1
 were used to obtain the spectra. 
Differential scanning calorimetry (DSC) was performed on 10 mg of 
material in an open crucible. The analysis was performed with a TA2920 
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calorimeter under flushing nitrogen (100 ml /min). A sample was first cooled 
down to -100 °C at the cooling rate of 50 °C/min, and was held at this 
temperature for 5 min. Subsequently, the first scan was performed by heating the 
sample up to 100 °C with the heating rate of 10 °C/min. This was followed by 
quenching the sample to -100 °C. The second heating scan was carried out by 
heating the sample from -100 to 315 °C with the heating rate of 10 °C/min and 
obtaining the thermogram. The melting peaks of PCL and PCL/fibroin samples 
were quantified by integration. Degree of crystallinity χc of PCL was calculated 
using χc = 100*ΔHm/ΔHm°, where ΔHm° was the theoretical heat of fusion for PCL  
with 100% crystallinity equal to 135 J/g. 
2.2.5 Mechanical characterization 
Mechanical properties were evaluated with uniaxial tensile tests on 
rectangular specimens (30x5 mm and 15x3 mm) cut along the circumferential (or 
transversal) direction and the longitudinal direction. Silk-fibroin nets were tested 
in a wet condition as well as in a dry condition. The fibroin nets were stored in 
water for 3 days at 4 °C before testing. For each specimen, three thickness 
measurements were taken using an electronic digital micrometer and averaged; 
three width measurements were taken using a custom digital caliper and 
averaged. Thickness of the specimens was in the range of 40-50 μm for fibroin 
electrospun mats and 100-120 μm for PCL and composite samples. Mechanical 
tests were performed with an electromechanical Instron 4502 (Instrom, Canton, 
MA) universal tensile testing machine equipped with a 100 N load cell. Samples 
were first preloaded to 0.10 N, and the gauge length was recorded. The tensile 
test was carried to failure at a rate of 3 mm/min for fibroin samples and 10 
mm/min for PCL samples and multilayered samples. Elastic modulus was 
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calculated from the slope of the linear portion of the resultant stress-strain curve; 
maximum stress and failure deformation were also calculated from the 
measurement data. Four to five specimens were tested for each sample. The 
calculated values were averaged and reported as mean ± standard deviation. 
Students’ t-test was carried out for statistic analysis of the data. A p value less 
than 0.05 was considered statistically different; a p value less than 0.01 was 
considered statistically very different.   
2.2.6 Cell characterization   
The endothelial cells used for characterization were cells isolated from 
proximal bovine pulmonary arteries and sub-cultured. Cells between passages 
three and six were used. Cells were cultured in Dulbecco’s Modified Eagle’s 
Medium (from Sigma-Aldrich) supplemented with 10% FBS, 2% L-Glutamine, and 
1% penicillin-streptomycin at 37 ˚C and 5% CO2 in the cell culture incubator. 
Circular electrospun nets (diameter of 1.5 cm) were sterilized in 70% ethanol, 
allowed to dry and briefly exposed to UV light before seeding. Cells were cultured 
to 90% confluency in the culture flask, detached and then seeded on the fibroin 
side with 1.0 ml of cell suspension per membrane at the concentration of  200,000 
cells/ml. Culture medium was changed every other day. After 4 days of culture, 
the cell-seeded membranes were fixed with 4% formalin and stored in PBS at 4 °C. 
In order to prepare samples for SEM examination, electrospun nets were washed 
2–3 times with distilled water, exposed to different grades of ethanol for 10 min. 
Finally, they were air dried under laminar flow hood. Samples were sputter coated 
with gold and the morphology was observed under SEM (JEOL 6480LV) at an 
accelerating voltage of 10 kV. 
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2.3 Results 
2.3.1  Fibroin and PCL electrospun materials produced by a 
single-polymer electrospinning process 
We have established single-polymer electrospinning processes to 
fabricate nanofibrous materials made of fibroin and PCL, respectively. The process 
parameters for each type of material have been optimized using a flat collector in 
the electrospinning system, and results are listed in Table 1. SEM images (Figure 
2-2) demonstrate the microscopic morphology of nanofibrous fibroin nets and PCL 
nets electrospun with the optimized parameters. In both nets, the nanofibers 
appear to have a rounded cross-section and regular shape, with diameters in the 
nanometric range.  
The average diameters of fibroin and PCL nanofibers are 192±79 nm and 
421±105 nm, respectively. Because several studies have reported the 
electrospinning process of PCL structures [130], [78], the optimization of PCL 
electrospinning parameters is not detailed here. Parametric studies on the fibroin 
electrospinning process are presented below because of its unique setup. In 
addition, using a rotational cylindrical mandrel, we have developed the 
electrospinning processes for tubular structured fibroin and PCL, respectively. 
Parametric studies for these electrospinning processes, in particular, the effects of 
rotation speed on anisotropic mechanical properties of PCL nets and silk-fibroin 
nets, respectively, are presented.  
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Figure 2-2. SEM imaging graphs of silk-fibroin nanofibers (a) and PCL 
nanofibers (b) (scale bar = 10 μm). At a higher magnification, details of fiber 
morphology are shown (scale bar = 3 μm). The electrospinning processes were 
conducted on a flat aluminium collector with RH = 70% and optimized 
electrospinning parameters listed in Table 1. 
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2.3.1.1 Fibroin nets: parametric studies on nanofiber diameter 
Four electrospinning parameters, namely voltage, solution concentration, 
feed rate and relatively humidity, have been varied to investigate their influences 
on the fibroin fiber diameter. The electrospun fibers usually show diameters 
ranging from tens of nanometers to one micron. It is found that applied electric 
voltage in the tested range does not significantly influence the diameter of silk-
fibroin nanofibers (Figure 2-3a), while the solution concentration plays an 
important role in determining the fiber diameter. No continuous defect-free fibers 
have been obtained with the fibroin solution at a concentration of 8% or lower in 
formic acid. When the solution concentration is 10% or higher, the mean fiber 
diameter increase exponentially with concentration; the mean fiber diameter 
increases from 192 nm at 10% to 325 nm at 14% (Figure 2-3b).  
 
With our fabrication setup, it is not possible to obtain fibroin solutions in 
formic acid at a concentration higher than 14%. Another parameter, the feed rate 
at which the solution is forced out of the spinneret, does not significantly 
influence the mean fiber diameter when the feed rate is lower than 7 μl/min. 
Higher feed rates result in larger mean diameters (Figure 2-3c). Furthermore, 
environmental relative humidity (RH) shows a significant effect on the fiber 
diameter (Figure 2-3d). Electrospinning in a relatively humid condition (RH = 70%) 
results in much larger fibroin fibers compared to that in a less humid condition 
(RH = 45%).  
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Figure 2-3. Effects of electrospinning process parameters on the mean fiber 
diameter of electrospun silk-fibroin: (a) applied voltage; (b) solution 
concentration; (c) feed rate; and (d) environmental relative humidity (R.H.). 
Effects of R.H were studied at different electrospinning voltages: 20 kV, 24 kV, 
and 28 kV. 
Using the single-polymer electrospinning process with optimized 
parameters (Table 2-1) and a flat collector, fibroin nanofibers are characterized by 
an average diameter of 192 nm with a narrow normal-like distribution (Figure 
2-4). The resultant electrospun nets contained a uniform array of randomly 
oriented fibers with smooth rounded surface. 
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Figure 2-4. Frequency distribution of the fiber diameter of silk-fibroin nets 
electrospun with optimized parameters shown in Table 2-1. 
2.3.1.2 Fibroin nets: mechanical properties in a hydrated condition 
Fibroin nanofiber scaffolds were prepared by electrospinning fibers on a 
rotating cylindrical collector with a 20 mm diameter at varied rotation speeds 
including 100, 250, 500, 1000, 1500 and 2000 rpm. As a reference, electrospun 
samples for 0 rpm were prepared by using a rectangular collector with the same 
projected area as the cylindrical collector. Tensile tests were performed on the 
samples cut from the tubular constructs in the longitudinal direction and in the 
circumferential direction, respectively. Samples of a similar size from the 
rectangular scaffold materials were used as the reference (0 rpm). Figure 2-5 
demonstrates that the mechanical properties, elastic modulus and maximum 
strength, change as function of the rotation speed of the mandrel. The samples 
collected at a high rotation speed, such as 500 rpm and 2000 rpm, show higher 
elastic modulus and mechanical strength in the circumferential direction.  
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Figure 2-5. Elastic modulus and ultimate strength of silk-fibroin electrospun nets 
produced with a rotating collector. These properties in both longitudinal and 
circumferential directions change with the rotation speed. “ ” shows that the 
mechanical property of the sample in the longitudinal direction is significantly 
different from that in the circumferential direction (p<0.05). 
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On the contrary, the samples collected at a low rotation speed, such as 
100 rpm, and those collected from a static rectangular collector (0 rpm) show 
higher elastic modulus and mechanical strength in the longitudinal direction. 
According to the data, an inversion point for the anisotropy of mechanical 
properties is estimated to be around 200 rpm. However, at several rotation 
speeds, no statistically significant differences between the mechanical properties 
in the two directions are found. Results also show that the strengths of fibroin 
nanofiber scaffolds fabricated in various conditions were always low – no higher 
than 1.7 MPa. 
2.3.1.3 PCL anisotropic mechanical properties 
PCL nanofiber scaffolds were prepared by electrospinning fibers on a 
rotating cylindrical collector with a diameter of 20 mm at varied rotation speeds, 
including 100, 250, 500, 1000, 1500 and 2000 rpm. Similar as fibroin, electrospun 
PCL samples for 0 rpm were prepared by using a static rectangular collector with 
the same projected area as the cylindrical collector. Samples for mechanical 
testing were also collected in both longitudinal and circumferential directions. It is 
found that the mechanical properties of PCL samples show more anisotropic 
behaviors than fibroin samples. The anisotropy is also dependent on the rotation 
speed of the mandrel collector (Figure 2-6). The samples collected at a low 
rotation speed, such as 0, 100, 250, 500 and 1000 rpm, show higher elastic 
modulus and ultimate strength in the longitudinal direction. The samples 
collected at a high rotation speed, such as 1500 and 2000 rpm, show higher elastic 
modulus and ultimate strength in the circumferential direction. The estimated 
inversion point for the anisotropy is between 1000 and 1500 rpm.  
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Figure 2-6. Elastic modulus and ultimate strength of PCL electrospun nets 
produced with a rotating collector. These properties in both longitudinal and 
circumferential directions change with the rotation speed. “ ” and “ ” show 
that the mechanical property of the sample in the longitudinal direction is 
significantly different from that in the circumferential direction (p<0.05 and 
p<0.01, respectively). 
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2.3.1.4 Mechanical properties of small diameter constructs  
PCL tubular constructs with a small diameter were prepared by 
electrospinning fibers on a cylindrical collector with a diameter of 4.96 mm 
rotating at 100 rpm (Figure 2-7). Specimens (15x3 mm) cut along the longitudinal 
and circumferential directions confirm the anisotropic mechanical behavior of the 
electrospun materials. In longitudinal direction, an elastic modulus of 11.82 ± 0.55 
MPa and an ultimate strength of 7.25 ± 0.71 MPa were obtained; in the 
circumferential direction, the elastic modulus and ultimate strength were 4.04 ± 
1.17 MPa and 3.55 ± 0.54 MPa, respectively. Thus, the mechanical anisotropic 
index (longitudinal-to-circumferential ratio of elastic modulus) results equal to 
2.92. 
 
 
Figure 2-7. PCL tubular construct prepared by electrospinning.  
2.3.1.5 Effect of collector shape   
In order to test the assumption that the anisotropic mechanical properties 
are related to the geometrical shape of the collector, we have designed a series of 
collectors which are characterized by different width-to-length aspect ratios 
(Figure 2-8). It was found that nets electrospun on a slender rectangular collector 
with higher width-to-length ratio present higher modulus and strength along the 
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length compared to those electrospun on a collector with lower width-to-length 
ratio. For example, for a width-to-length aspect ratio of 6, a mechanical 
anisotropic index of 2.27 was found. 
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Figure 2-8. Effect of collector shape on the mechanical property of PCL 
electrospun material. Elastic modulus along the two principal directions of the 
electrospun nets is reported as function of the length/width ratio of the collector. 
2.3.2  Multilayered PCL-fibroin scaffold produced by a double 
electrospinning process 
2.3.2.1 Chemical and thermal characterizations of the structure 
PCL and silk-fibroin have been electrospun on a cylindrical collector 
rotating at a constant velocity to form a composite scaffold. With the new double-
electrospinning apparatus described above, a multi-layered electrospun structure 
is formed and consists of an ultrathin layer of fibroin nanofibers, an interlayer of 
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mixed nanofibers of fibroin and PCL, and a thick layer of PCL nanofibers. FT-IR 
analyses of the two opposite surfaces confirm that the layers are completely 
different in the composition (Figure 2-9). The ATR FT-IR spectra show the 
presence of pure PCL on one side (called PCL side) and fibroin on the other side 
(called fibroin side). Additionally, the shoulder at 1730 cm
-1
 in the FT-IR spectrum 
of the fibroin side revealed a limited presence of PCL.  
 
 
Figure 2-9. ATR FT-IR analysis of the scaffold shows completely different 
compositions on the two surfaces. PCL side shows the characteristic spectrum of 
PCL, and fibroin side shows the characteristic spectrum of prevalent β-sheet 
fibroin and a small contamination of PCL due to the limited thickness of the fibroin 
layer. 
Figure 2-10 compares the DSC curve of a PCL-fibroin multilayered material 
with that of a pure electrospun PCL material. In the DSC analysis, the presence of 
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fibroin is revealed by a small endothermic peak around 280 °C, which is 
corresponding to thermal degradation of silk-fibroin. It is known from previous 
results that the degradation peak area for a pure electrospun fibroin material is in 
the range of 230-250 J/g. Thus, using the area of the small peak shown in the 
composite scaffold (around 10-12 J/g), the overall content of fibroin inside the 
multilayered scaffold can be estimated to be around 5% in weight. The degrees of 
crystallinity of PCL for PCL and PCL/fibroin samples are equal to 40.4 % and 37.5 
%, respectively. 
 
 
Figure 2-10. DSC thermographs for PCL/fibroin multilayered material, pure PCL 
and pure Fibroin. The small endothermic peak at 280 °C, which is common to 
fibroin and PCL/fibroin multilayered material, is attributed to the thermal 
degradation of silk fibroin.  
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2.3.2.2 Anisotropic mechanical properties of the multilayered structure 
The mechanical properties of nanofibrous multilayered PCL-fibroin 
scaffolds have been studied and evaluated in comparison to the mechanical 
properties of pure PCL scaffolds prepared in the same conditions (Figure 2-11a). 
No significant differences in elastic modulus or in ultimate strength (data not 
shown) are found between multilayered PCL-fibroin scaffolds and pure PCL 
scaffolds in both circumferential and longitudinal directions. This is found on the 
samples collected at a low rotation speed (150 rpm) and on those collected at a 
high rotation speed (1500 rpm).  
Therefore, fibroin does not significantly contribute to the mechanical 
property of the multilayered composite scaffold. This is also shown by 
representative stress-strain curves for multilayered PCL-fibroin material and pure 
PCL electrospun material using specimens cut in the circumferential direction 
(Figure 2-11b). These curves also show that the mechanical property of fibroin 
electrospun material is dependent on the humidity; it is much stiffer and stronger 
in a dry condition than it is in a hydrated condition. 
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Figure 2-11. a) Elastic modulus of multilayered PCL-fibroin materials and pure 
PCL materials. The material fabrication used a cylindrical collector rotating at a 
low speed (150 rpm) and a high speed (1500 rpm). All the tests were performed on 
the circumferential direction “C” and the longitudinal direction “L” of the 
samples. No significant differences in elastic modulus were found (p>0.05). b) 
Representative stress-strain curves of hydrated fibroin, dry fibroin, PCL, and PCL-
fibroin electrospun nets. The material fabrication used a cylindrical collector 
rotating at a high speed (1500 rpm). All the tests were performed on the 
circumferential direction of the tubular scaffolds.  
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2.3.2.3 Endothelial cell characterization 
Endothelial cell culture test was performed on flat electrospun constructs 
using primary arterial endothelial cells (Figure 2-12).  
 
 
Figure 2-12. SEM images of bovine pulmonary artery endothelial cells seeded on 
the fibroin side of the multilayered structure (4 days in culture). 
A low concentrated cell suspension was seeded on the two different 
surfaces of the multilayered electrospun structure. Cell morphology and adhesion 
site were examined after 4 days of culture. Endothelial cells seeded on the fibroin 
side resulted in a highly spread morphology, protruding cytoplasmic 
interconnections between the cells along a larger number of electrospun fibers. 
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2.4 Discussions 
The present study has reported the development of electrospinning 
processes of silk-fibroin, PCL and PCL-fibroin multilayer scaffolds for engineered 
vascular construct. Using a single-spinneret electrospinning system with a flat 
collector, we have optimized electrospinning parameters to obtain defect-free, 
uniform nanofibers from pure PCL and pure silk-fibroin, respectively. In particular, 
the effects of applied voltage, protein concentration, feed rate and environmental 
humidity on the fibroin fiber diameter are demonstrated. Using a rotating 
cylindrical collector, anisotropic mechanical behaviors of these pure nanofiber 
materials are obtained and the anisotropy is found to be dependent on the 
rotation speed of the collector. In addition, we have developed a new double-
electrospinning system, and have achieved a promising combination of 
mechanical property and biological property with a biohybrid nanofibrous scaffold 
made from PCL and silk-fibroin.    
2.4.1  Electrospinning of silk fibroin 
A major difference in fibroin electrospinning and characterization 
presented here from previous studies [131,132] is that we have taken the 
environmental relative humidity (RH) and the hydration state of a fibroin sample 
into consideration. We have shown that the diameter of fibers electrospun at 45% 
RH were about half of that at 70% RH (Figure 2-3d). It is likely because water 
molecules reduce the electric charge density on the developing fibers, thus 
reducing the driving force for fiber elongation and diameter reduction. Also, a 
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single fiber can be stretched more in a dry environment because the viscosity 
remains low for a longer time, an effect equivalent to extending the distance from 
the needle, while a fiber in a more humid environment becomes solid faster and 
experiences a lower degree of stretching. In addition, we have demonstrated the 
difference in mechanical properties between dry and hydrated fibroin nets (Figure 
2-11b). It is found that hydration highly reduces stiffness and strength of the 
electrospun material. Because the scaffold is often used in the hydrated state, the 
majority of mechanical characterizations performed here are based on hydrated 
samples. The ultimate tensile strengths reported in this study are comparable to 
the values reported by Soffer et al. [133] who electrospun hydrated fibroin nets 
from a PEO/fibroin water solution, but the elastic modulus reported here are 
much higher, ranging from 5.32 to 12.11 MPa. The difference is likely attributed to 
a much higher testing rate (3 mm/min compared to 0.2 mm/min) and the 
preconditioning cycles used in the present study. 
2.4.2  Effect of the rotation speed and the collector shape on 
anisotropic mechanical properties 
The present study have shown that varying rotation speed leads to 
changes in the material mechanical anisotropy index which is defined as the ratio 
of the mechanical property in the longitudinal direction to that in the 
circumferential direction. With the rotation speed varying from 0 to 2000 rpm, 
anisotropy indices of elastic modulus range from 1.7 to 0.35 for PCL material, and 
anisotropy indices range from 1.2 to 0.70 for fibroin material. PCL shows more 
gradual changes in the anisotropy index with the rotation speed, and a wider 
range of anisotropy indices is achievable with PCL. In addition, no significant 
differences are found between pure PCL nets and multilayered PCL-fibroin nets 
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both at 150 rpm and at 500 rpm. This suggests that mechanical properties of a 
PCL-fibroin bi-layered system  are similar to those of a pure PCL electrospun 
material. This could be due to the small amount of fibroin (~5% in weight) in the 
composite construct according to the DSC analysis results. The dependence of the 
mechanical anisotropy index on the rotational speed could be explained by the 
relationship between fiber alignment and rotational speed, according to previous 
studies which showed that a rotational collector tended to align the fibers along 
the circumferential direction at higher rotation speeds [134]. The nanofiber 
alignment in the circumferential direction happens when the tangential velocity at 
the collector surface exceeds the velocity at which the nanofibers approach the 
collector, particularly when the rotation speed becomes higher. Additionally, 
many studies have shown a strong correlation between mechanical properties 
and fiber alignment in non-woven electrospun materials [135–137]; progressive 
alignment of the fibers in one direction improves elastic modulus and tensile 
strength of the material in the same direction.  
It is also noticed in this study that at 0 rpm and at lower rotation speeds, 
both PCL and fibroin materials show higher modulus and strength in the 
longitudinal direction than in the circumferential direction. Because there is no 
mandrel rotation, it may involve the effect of collector shape. In order to test the 
assumption that the anisotropic mechanical properties are related to the 
geometrical shape of the collector, we have designed a series of collectors which 
are characterized by different width-to-length aspect ratios (Figure 2-8). It was 
found that nets electrospun on a slender rectangular collector with higher width-
to-length ratio present higher modulus and strength along the length compared 
to those electrospun on a collector with lower width-to-length ratio. The 
distortion of the electric field in the air gap might induce the alignment of fibers 
along the prevalent geometrical direction and thus higher mechanical properties 
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along that direction (See Figure 2-13). The collector shape effect on the 
mechanical anisotropic index is also important at lower rotation speeds when the 
effect of mandrel rotation is negligible. The inversion point, where the anisotropic 
index is equivalent to 1, suggests the balance between the collector shape effect 
and the rotation speed effect. It is about 1200rpm for PCL and 150rpm for fibroin.  
 
 
Figure 2-13. Effect of the shape of the collector. A distortion of the electric field 
in the air gap might induce a preferential alignment of nanofibers along the 
prevalent geometrical dimension of the collector 
At low rotation speed of the mandrel the material in the longitudinal 
direction is stronger and stiffer than in circumferential direction. This property is 
desired for vascular grafts. Therefore, we also produced constructs with a smaller 
diameter (4.76 mm) at a low rotation speed of 100 RPM. After mechanically 
testing the construct in longitudinal and in circumferential directions we found 
that the anisotropic behaviour was also demonstrated by small diameter 
constructs. In particular, elastic modulus and ultimate strength in the longitudinal 
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direction are higher than the respective values in the circumferential direction. 
The longitudinal-to-circumferential ratio was 2.92. 
2.4.3 Double electrospinning system 
Double electrospinning combines the advantageous properties of two 
types of materials, but more importantly, it better integrates their nanofibers 
compared to a simple overlapping of nanofibers. We have shown that the 
multilayered structure resulted from double electrospinning improves biological 
properties of PCL as endothelial adhesion potential on the scaffold surface 
increases with a natural cell-conducive polymer (fibroin), while it retains superior 
mechanical properties of the synthetic slow degradable polymer (PCL). 
Furthermore, as shown in Figure 9b, the stress-strain behaviors of fibroin and PCL 
are quite different, which result in completely different behaviors during 
deformation. As no strong adhesion exists at the PCL and fibroin interface, a 
simple overlapping of a PCL layer and a fibroin layer leads to delamination of the 
construct during deformation. Therefore, the fundamental importance of the 
double electrospinning system resides in the possibility to produce a mixed fiber 
interlayer. The intermixed region acts like an active interphase that transmits 
interfacial forces and avoids delamination. Different from the other recently 
developed double electrospinning system by Baker et al. [137], the system 
established in the present study designs two charge needles, from which the 
polymers solutions are ejected, to move concurrently along the rotating mandrel, 
thus resulting in a more effective mixing of the different materials. In addition, 
there are no charged shields placed perpendicularly to the mandrel, thus 
preventing any modifications of the electric field in the region between the charge 
spinnerets and the collector.  
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2.4.4  Application of the scaffolds in tissue engineering 
Mechanical property and surface biological property are both important 
for vascular scaffolding materials. To reproduce anisotropic mechanical property 
of arteries, engineered vascular scaffolds need sufficient radial compliance and 
relatively higher longitudinal stiffness (anisotropy index > 1). Thus electrospinning 
processes at lower rotation speeds of the mandrel are likely useful to produce 
these anisotropic scaffolds, and changing the mandrel rotation speed makes the 
anisotropy tunable, particularly with PCL bulk materials. Using a multilayer 
structure with bulk PCL and limited amount of fibroin on the surface, we can 
obtain not only an optimized combination of anisotropic mechanical property, but 
also surface properties for cells. Compared to PCL, a fibroin-based matrix better 
supports endothelial cell growth due to the favorable biological properties of the 
silk protein. Besides the composition, the net morphology is also important for 
the formation of effective endothelial layer. Other studies also demonstrated that 
three-dimensional silk-fibroin nets derived from the cocoons of the silk worm, 
Bombyx mori, support the attachment, spread and growth of a variety of human 
cell types of diverse tissue origins [138]; in particular, it has been reported that 
the regenerated silk-fibroin maintains normal cell phenotypes and functions of 
primary human macro- and micro-vascular endothelial cells as well as endothelial 
cell lines [138], and has anti-thrombogenic potential [124]. 
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2.5 Conclusions 
We have demonstrated a double-electrospinning technique to produce a 
robust tubular scaffold with well-integrated nanofibrous structure, anisotropic 
mechanical behaviour and endothelial-conducive surface, for vascular tissue 
engineering. A thick bulk PCL mesh of nanofibers, an intermediate intermixed 
fibrous layer, and a thin layer of silk-fibroin nanofibers have been combined to 
form a multilayered structure which is stable against mechanical delamination. 
The structure can be stiffer in the longitudinal direction and more compliant in 
the circumferential direction, and reach up to 2.5 in the longitudinal-to-
circumferential ratio in this study. The combination of the collector shape and the 
collector rotation allows us to produce a tubular structure with tunable 
anisotropic mechanical properties. The phenomenon has been extensively 
demonstrated in the case of electrospinning on a 20 mm mandrel, while can be 
generally applied. In fact, samples obtained with a 4.96 mm mandrel rotating at 
100 rpm confirm the anisotropic behavior reaching a longitudinal-to-
circumferential ratio higher than 2.9. In addition to vascular scaffolds, the system 
and technique developed in this study will be important for many other tissue 
engineering applications as well. 
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3 BIOMOLECULE GRADIENT IN 
MICROPATTERNED FIBROUS SCAFFOLD 
FOR SPATIOTEMPORAL RELEASE 
 
Abstract 
 
Delivery of drugs, growth factors or other biomolecules dramatically 
increases the scaffold ability to direct and sustain cell attachment, migration, 
proliferation and, ultimately, cell activity both in vitro and in vivo applications. 
Moreover, spatial confinement, temporal control and specificity of drug 
presentation are pivotal factors in directing cell behaviour and tissue repair and 
remodelling. 
Using a modified double-electrospinning system, we have demonstrated 
heterogeneous nanofibrous scaffolds composed of degradable polymers poly(ε-
caprolactone) (PCL) and poly(lactide-co-glycolide) acid (PLGA) characterized by 
compositional and biochemical gradients along the scaffold thickness. We have 
revealed the different behaviours of acid terminated PLGA (PLGAac) and ester 
terminated PLGA (PLGAes) during degradation in an isotonic phosphate solution.   
By means of fluorescent molecules and fluorescently-labeled albumins 
encapsulated in the nanofibers, we have successfully visualized the concentration 
profile of the scaffold constituents. Spatially-confined delivery was demonstrated 
for a variety of micropatterned PCL-PLGAac scaffold with a novel side-by-side 
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release test. These electrospun composite graded scaffolds have shown 
programmable delivery of the model molecules to one specific surface of the 
device with efficiency of separation as high as 95%. In addition, we obtained 
simultaneous and sequential release of two different model proteins on the two 
surfaces of the newly engineered, composite electrospun scaffolds, and we 
showed that release kinetics can be influenced by changing the initial pattern of 
drug distribution and the composition of the scaffold. We believed that scaffold 
preparation and release micropatterns presented in this work may represent the 
platform for the development of novel multifunctional matrices able to control 
and direct the process of tissue regeneration. 
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3.1 Introduction 
Growing evidence has shown that tissue morphogenesis is coordinated by 
the spatial arrangement and temporal duration of multiple molecules in the 
three-dimensional (3D) extracellular matrix [93,94]. This has stimulated recent 
advances in the design of a new generation of biomaterials, which aim to mimic 
the spatio-temporal regulatory mechanisms of molecules for tissue regeneration 
or other therapeutic purposes [92,105,108]. To incorporate biomolecules into 
biomaterials and sustain the biomolecule release in vitro or in vivo, methods, such 
as adsorption and covalent binding [83,84], encapsulation [85,86], and addition 
during scaffold formation [87], have been developed. To deliver biomolecules in a 
more specific or spatiotemporally-controlled manner, recent developments in the 
area have demonstrated the advantages of micro- and nano-structured devices 
[70,100,101] and material scaffolds [102–104]. For tissue engineering and 
regenerative medicine, the need of precisely regulating regenerative molecule 
microenvironments is ever increasing. The majority of newly-developed molecule-
impregnated scaffolds, however, are only capable of achieving sustained or 
temporally-controlled molecule release. Few techniques are available to engineer 
3D scaffolds that define spatial organization of molecules or spatially-controlled 
release. The spatial control over release is critical to coordinate cell behaviors for 
tissue pattern formation [92,102]. Also, because the functions of many 
biomolecules such as proteins are cell- and tissue- specific, selective release of 
molecules that target specific cell types or tissue formation without influencing 
the activity of other cell populations or tissue functions is important to establish 
both in vitro physiological tissue models and in vivo tissue regeneration [105–
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107]. Currently, techniques of 2D on-chip patterning or 3D segregation of 
molecule delivery materials are available to spatially confine biomolecules [108–
110]. However, to meet various physiological needs of tissue regeneration, a 3D 
scaffold should not only present a multitude of regenerative biomolecules in a 
sustained manner at defined locations, but also be capable of precisely 
programming spatiotemporal control to meet physiological needs as well as 
satisfying other tissue-specific requirements such as mechanical properties. This is 
a challenging task, given the fact that it is difficult to simultaneously build multiple 
functional features into one scaffolding material.  
Electrospinning of biomaterials has been increasingly used to fabricate 
tissue engineering scaffolds in the last decade, because they offer adequate 
mechanical property for implantation [65], and nanostructure guidance to cell 
adhesion and proliferation [53,54]. Electrospun biomaterials, consisting of 
nanofibers that mimic the structure of the native extracellular matrix, provide a 
wide range of mechanical and chemical properties via fiber composition, 
diameter, distribution and porosity [45,47,49,70]. Recently, various methods using 
electrospun fibers to encapsulate and deliver molecules have been established 
[46]. This could dramatically increase the scaffold ability to regulate various cell 
activities. Due to inherently high surface area of electrospun materials, these 
constructs allow high molecule loading and efficient release in situ. However, the 
developed techniques have been limited to tune molecule release kinetics. As far 
as we know, no electrospun constructs with capability of spatially-defined or 
spatiotemporally-controlled delivery of biomolecules have been demonstrated 
before. 
We have previously developed double-electrospinning technique to 
fabricate interpenetrating networks of nanofibers from different polymers [43]. 
We also demonstrated the use of diverse nanofibers in a tailored proportion to 
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engineer the surfaces or anisotropic mechanical properties of tissue scaffolds. By 
furthering the techniques to program micropatterns of molecule-impregnated 
nanofibers, the present study aims to demonstrate composite, electrospun 
biomaterials that are capable of selectively releasing molecules in spatially- and 
temporally- controlled manner. Herein, heterogeneous nanofibers composed of 
degradable polymers poly(ε-caprolactone) (PCL) and poly(lactide-co-glycolide) 
acid (PLGA), have been used to form scaffolds with compositional and biochemical 
gradients along the scaffold thickness. Using PLGA nanofibers to encapsulate 
small molecules or proteins, we have characterized compositional and 
morphological changes as well as degradation behaviours of these composite 
scaffolds for up to 50 days in vitro.  
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3.2 Materials and Methods 
3.2.1 Materials 
LACTEL
®
 50:50 poly(d,l lactide-co-glycolide) acid with a carboxylate end 
group and intrinsic viscosity of 0.67 dL/g, hereinafter referred to as PLGAac, was 
purchased from DURECT Corp. (Pelham, AL). PURASORB
®
 50:50 poly(d,l lactide-co-
glycolide) acid with an ester end group and intrinsic viscosity of 0.32-0.48 dL/g, 
hereinafter referred to as PLGAes, was obtained from Purac Biomaterials 
(Lincolnshire, IL). PCL with molecule weight of 80 kDa, chloroform (CF), N,N-
dimethylformamide (DMF), methylene chloride (MC), methanol (MetOH),  
1,1,3,3,3-hexaflouro-2-propanol (HFIP),  sodium phosphate (NaH2PO4), sodium 
phosphate dibasic (Na2HPO4) and sodium azide were all purchased from Sigma 
Aldrich (St. Louis, MO). Polymers were used as received. Solvents were of 
analytical grade and used without any further purification. Isotonic phosphate 
buffer solution was prepared by mixing a 0.13 M solution of NaH2PO4  with 0.002% 
sodium azide and a 0.13 M solution of  Na2HPO4 with 0.002% sodium azide, and 
then adjusting pH and osmolarity to 7.4 and 290-300 mosmol/L, respectively. 
Sodium azide was used to prevent bacterial contamination. 
Fluorescent dyes, rhodamine 123 (Rh123) with green emission, 
rhodamine-B (RhB) with red emission, coumarin with blue emission, as well as 
fluorescently-labelled proteins, fluorescein isothiocyanate conjugate bovine 
serum albumin (AlbF) with green emission and tetra-methyl-rhodamine 
isothiocyanate conjugate bovine serum albumin (AlbT) with red emission were all 
obtained from Sigma Aldrich. The molecular weight, chemical formula, 
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excitation/emission wavelength and usage in this study of fluorescent dyes and 
fluorescently-labelled albumins are summarized in Table 3-1. 
 
Dyes Molar 
Mass 
[g/mol] 
Chemical formula Exc/Em 
 
[nm] 
Use 
Rhodamine 
123 
(Rh123) 
≈760 
 
485/535 Release 
and 
Imaging 
Rhodamine-B 
(RhB) 
479.02 
 
560/590 Imaging 
Coumarin 146.14 
 
360/450 Imaging 
Albumin-
Fluorescein 
isothiocyanate 
(Alb F) 
66000/ 
389.4 
7 to 12 moles of FITC per 
mole of albumin 
485/535 Release 
Albumin-Tetra-
methylrhod. 
isothiocyanate 
(Alb T) 
66000/ 
364.2 
About 1 mole of TRITC per 
mole of albumin 
560/590 Release 
Table 3-1. Fluorescent dyes, fluorescent-labeled albumins properties and 
their uses 
3.2.2 Preparation of electrospinning solutions 
PCL was dissolved in 75/25 CF/DMF at a concentration of 10% (wt). For 
both PLGAac and PLGAes, the pre-spinning polymer solutions were prepared by 
dissolving the polymer in the mixture of HFIP and DI water with a ratio of 7:1 (vol) 
with a final concentration of 17% (wt). To visualize the compositional gradients 
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across the thickness of electrospun scaffolds and to characterize the molecule 
release profiles, fluorescent dyes or fluorescently-labelled albumins were added 
to pre-spinning solutions. DI water was used to dissolve fluorescent dyes. A 
solution of Rh123 or RhB with a concentration of 1 mg/ml was prepared with DI 
water, and then mixed with HFIP (7:1). Subsequently, the mixture was used to 
dissolve PLGAac and PLGAes. A PCL/coumarin pre-spinning solution was obtained 
by dissolving the polymer at a concentration of 8% (wt) in a ternary solvent 
mixture of MC:DMF:MetOH with a ratio of 5:3:2 (vol), where MetOH served as the 
carrier for coumarin. This was done by first dissolving 10 mg of coumarin in 300µl 
of DI water to obtain the stock solution, and subsequently adding MetOH to the 
stock solution to obtain a 5 mg/ml solution of coumarin, and finally preparing the 
pre-spinning solution with the ternary solvent mixture. To prepare PLGAac 
nanofibers for in vitro release of fluorescent-labelled albumins, 5 mg of AlbF or 
AlbT was dissolved in 90 µl of DI water. Then, 630 µl of HFIP was added to the 
solution, forming a mixture to dissolve 220 mg of PLGAac, resulting in a 17% (wt) 
polymer solution. The overall content of albumin was 2.3% with respect to the 
mass of the dry polymer. During the entire process, the dye-containing solutions 
were always shielded from light to preserve the activity of fluorescent species. 
3.2.3 Double-electrospinning process 
The electrospun composite with the compositional gradient of distinct 
materials across the composite thickness was prepared through programming the 
sequential and/or simultaneous electrospinning processes of PCL and PLGA on a 
rotating mandrel collector, using a modified double-electrospinning system 
previously described by us [43]. Briefly, a layer of PCL nanofibers, an intermixed 
layer of PCL and PLGAac (or PLGAes) nanofibers, and a layer of PLGA electrospun 
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fibers were deposited in sequence on the grounded cylindrical aluminum 
collector. The design of the compositional patterns along the thickness of the 
scaffold was achieved by controlling 3D movements of a collector, in coordination 
with spinning processes separately programmed. The cylindrical collector, with 8 
mm in diameter, rotated at a constant velocity by a brushless rotating electric 
motor (BLF230C-A, Oriental Motor, U.S.A. CORP., Torrance, CA). Each solution was 
individually stored in a 5 ml syringe. The syringe was connected to a blunt-ended 
needle that served as a charged spinneret. Each spinneret placed at the opposite 
side of the rotating collector, were perpendicularly oriented with respect to the 
principal axis of the collector, and connected to a separate high voltage power 
supply (ES30P-10W, Gamma High Voltage Research Inc, Ormond Beach, FL). Both 
spinnerets moved in concert over an 18 cm path with a speed of 5m/s along the 
collector mandrel which was under the control of a linear motorized stage 
(EZS3D025-C, Oriental Motor). The feed rate of each solution varied 
independently via separate syringe pumps (NE-300, New Era Pump Systems, 
Farmingdale, NY) during the course of deposition. The electrospinning flow rates 
that allowed the formation of defect-free nanofibers were determined 
beforehand for each solution, and used to define the maximum flow rates, which 
were 0.6ml/hr for PLGA fibers and 1.1ml/hr for PCL fibers. The collector geometry, 
the concentration of polymer solutions, and apparent density of pure PCL and 
PLGA electrospun nets were used to establish a correlation between the feed rate 
and the deposition rate of each polymer per unit of surface area. Detailed 
information of the solution compositions and electrospinning parameters is listed 
in Table 3-2.  
 
The electrospinning process was performed at room temperature in open 
atmosphere with a relative humidity of 20-25%. The overall thickness of the 
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electrospun nets was measured using a micrometer screw gauge. The design 
thickness of PCL-PLGA materials was 150 µm; samples with actual thickness 
outside of the range 135-165 µm were discarded. When fluorescent molecules 
were used, the entire apparatus was shielded from light to preserve the dyes. 
Electrospun samples were stored in a dessicator and kept in the dark.  
 
Poly-
mer 
Dye Solvent  
mixture 
Pol. 
conc. 
[% wt] 
Dye 
content [%] 
wtdye/wtpol. 
Volt. 
 
[kV] 
WD 
 
[cm] 
Feed 
rate 
[ml/h] 
PLGAac 
PLGAes 
/ 
HFIP/water 
7/1 vol. 
17 / 26 20 
0.15-
0.6 
PLGAac 
PLGAes 
Rh123 
RhB 
HFIP/water 
7/1 vol. 
17 ≈ 0.012 24 20 
0.15-
0.6 
PLGAac 
AlbF 
AlbT 
HFIP/water 
7/1 vol. 
17 2.23 22 20 
0.15-
0.6 
        
PCL / 
CF/DMF 
3/1 vol. 
10 / 26 24 0.3-1.1 
PCL 
Couma
-rin 
MC/DMF/MetOH 
5/3/2 vol. 
8 ≈ 0.05 20 20 0.3-1.1 
Table 3-2. Characteristics of polymer/dye solutions and electrospinning 
parameters 
3.2.4 Characterization of nanofiber morphology 
The morphology of the electrospun fibers was observed using a JSM-
6480LV scanning electron microscope (SEM) (JEOL Ltd., Tokyo, Japan) at 5.0 kV. 
Samples were sputter-coated with gold prior to analysis. 
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3.2.5 Characterization of compositional micropattern 
Scaffolds loaded with fluorescent dyes were embedded in cryo-optimum-
cutting-temperature compound (Andwin Scientific, Schaumburg, Germany) or in 
paraffin for histology. A series of 15 µm-thick sections were obtained with a 
cryostat or rotary microtome for confocal imaging. The cross-sections of the 
nanofiber scaffolds loaded with fluorescent species were examined under a Zeiss 
LASER Scanning 510 confocal microscope equipped with AR, HE/Ne and diode 
laser sources (Carl Zeiss Inc, Jena, Germany). The images were used to assess the 
dye distribution in the nanofibers and along the thickness of the nets. 
Compositional profiles of scaffolds were determined by measuring the color 
intensity of dyes in the confocal images, using ImageJ software 
(http://rsbweb.nih.gov/ij/). Fluorescent profiles were obtained by averaging at 
least 6 profiles acquired from 3 different samples. 
3.2.6 Thermal analysis 
The thermal analyses were performed using a differential scanning 
calorimeter (DSC) (DSC 204 F1 Phoenix®, Aurora, IL, USA) under flushing nitrogen 
(100 ml/min). Each sample was first heated from -110°C to 120°C with an 
incremental rate of 10 °C/min and held at each temperature for 3 min. The 
sample was then slowly cooled to −110°C with liquid nitrogen at a cooling rate of 
5 °C/min and reheated for a second scan to 120°C at a rate of 10°C/min. For the 
PCL-PLGA composites, the glass transition of PLGAac and PLGAes were measured 
from the first heating scans. The transformation was clearly visible and was 
accompanied by an appreciable enthalpic relaxation effect due to the aging of the 
polymer. Therefore, the onset point and inflection point were both reported. In 
the second heating scan, the glass transitions of PLGA were not visible, due to the 
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melting peak of PCL. The peak temperature of the melting transition of PCL was 
recorded and melting peaks of PCL in pure PCL sample and PCL-PLGA samples 
were quantitatively determined by integration. The crystallinity degree of PCL 
(αPCL) was determined by comparing the melting enthalpy of PCL (ΔHPCL) for PCL 
nanofibers with the theoretical value of a sample with 100% crystalline PCL 
(ΔH100%), which equals to 139.4 J/g [139]. Thus, αPCL = 100*(ΔHPCL / ΔH100%). The 
melting enthalpy was determined by calculating the area of the endothermic 
melting peak of PCL. Under the assumption that melting enthalpy of PCL remained 
constant in PCL-PLGA samples, αPCL was used to determine the fraction of PCL 
nanofibers. 
3.2.7 Hydrolytic degradation analysis  
Hydrolytic degradation analyses were performed on electrospun scaffolds 
at 37 °C in phosphate buffer solution (pH = 7.4) under constant mild agitation up 
to a maximum of 6 weeks. For each electrospun net, specimens were immersed in 
5 ml of phosphate buffer solution in separate test tubes. Triplicate samples for 
each experimental condition were withdrawn at a predetermined time, carefully 
washed in DI water and dried under vacuum in a dessicator for 48 hours. Then, 
the samples were weighed on an analytical balance.  
Using the gravimetric method, weight loss of each sample was then 
determined and averaged. Corresponding changes of nanofiber morphology were 
monitored using SEM micrographs. Molecular weights of PCL, PLGAac and PLGAes 
were determined by gel permeation chromatography (GPC) (GPCmaxTM, 
Viscotek, Houston, TX, USA) with a differential refractive index (RI) detector 
(Viscotek 3580), and a set of Viscotek viscogel columns with THF as the eluent at 
30 °C. The analytical GPC was calibrated using monodisperse polystyrene 
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standards. Molecular weights of the as-spun scaffolds and those after each 
degradation time were measured. The GPC curves of the materials presented a bi-
modal distribution. The overlapped peaks were thus deconvoluted into two 
separate asymmetric peaks with the least-squares method and assigned to PCL 
and PLGAac (or PLGAes). The peak-fitting parameters were conditioned using the 
peak parameters of the parent materials. The molecular weights corresponding to 
individual deconvoluted peaks were also determined.  
3.2.8 Release profile characterizations 
For molecule release characterizations, the circular samples with 24 mm 
in diameter were cut from PCL-PLGAac and PCL-PLGAes scaffolds loaded with 
fluorescent dye or fluorescently-labelled albumin. For each experimental 
condition, 3 samples were used for analyses. Samples were placed in a custom-
made diffusion chamber in which each surface of the electrospun scaffold faced a 
different reservoir chamber filled with 1ml of buffer solution. The two reservoirs 
used SecureSeal hybridization chambers (Grace Biolabs, Bend, OR) to seal the 
surface. Each reservoir had small holes for sampling and changing solutions. The 
holes were covered with silicone sealing tap during experiments to prevent 
evaporation. Thus, the molecule movements between the reservoirs could only be 
through the pores of the electrospun materials. 
 The release tests were performed at 37 °C. Samples of buffer solutions in 
both reservoirs were collected every day during the first 16 days, and 
subsequently once a week. After samples were taken, the reservoir chambers 
were rapidly rinsed with DI water and refilled with fresh phosphate buffer at 37°C. 
Samples of 200 µl in triplicates were analyzed in 96-well microplates with a Victor 
2 microplate reader (PerkinElmer, Santa Clara, CA) to quantify the amount of 
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Rh123, AlbF and AlbT released daily. The concentration and net amount of 
released Rh123, AlbF and AlbT were determined using the respective calibration 
curves (Table 3-3). The geometry and porosity of the molecule-releasing scaffolds 
kept constant for all the experimental samples. As various fluorophores were 
simultaneously released by some samples, the possibility of the overlap of the 
fluorophore emission spectra was examined; no evidences of any undesired 
overlap were found. An efficiency of separation (S) was introduced to quantify the 
capability of confining molecule release to one specific side of the scaffolds. The 
efficiency of separation of a particular molecule between Side A and Side B 
(Smolecule_A-B) was defined as the percentage of molecules released on Side A over 
the total amount of molecules released on Sides A and B for the whole duration of 
the test. 
 
Rh123   x < 45000               y = 4.248*10^7 x + 1014             R2 = 0.987 
Alb F     x < 20000               y = 639.9 x + 366.9                     R2 = 0.998 
Alb F  20001 < x < 60000    y = -2.432 x2 + 687.7 x + 327.4  R2 = 0.999 
Alb T  x < 20000                  y = 457.4 x + 389.3                     R2 = 0.996 
Table 3-3. Calibration curves for Rh123, AlbF and AlbT with the respective 
coefficient of determination. “x” is to the measured fluorescence intensity and “y” 
is the concentration of the molecule in solution expressed in µg/ml. The net mass 
released can be calculated taking into account the known capacity of the release 
chamber. 
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3.3  Results 
3.3.1 PCL/PLGA scaffolds with micropatterned nanofibers 
demonstrated custom-designed compositional gradients 
Using the double-electrospinning apparatus with capability of precisely 
programming the 3D position of different nanofibers, we have formed 
electrospun multi-component structures showing designed micropatterns. Figure 
3-1 illustrates a structure which consists of a 25 µm-thick PCL nanofiber layer, a 
100 µm interlayer with mixed nanofibers of PCL and PLGA, and a 25 µm PLGA 
nanofiber layer. The design shows a pattern of pure PCL and PLGA on the opposite 
sides of the surfaces, and an intermediate region in which the PLGA content varies 
gradually between 0 and 100% along with a reversed change of PCL content.  
This compositional gradient across the material thickness was achieved by 
progressively decreasing the feed rate of PCL to 0 while simultaneously increasing 
the feed rate of PLGA to the maximum value. The pattern was designed to 
produce scaffolds with equal amount of PCL and PLGA in weight. 
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Figure 3-1. Schematic illustration of the cross-section of a PCL-PLGA electrospun 
scaffold with internal compositional gradient. The fraction of PCL nanofibers 
(shown in blue) decreases along the thickness of the material from 1 on the left 
side (PCL side) to 0 on the right side (PLGA side), while the PLGA fraction (shown 
in red) increases along the thickness of the scaffold from 0 to 1. 
To assess the actual composition of scaffolds, DSC analysis was used. 
Results demonstrated that the material composition closely matched the design. 
The comparison between the endothermic melting enthalpies of PCL in the 
scaffolds and the melting enthalpies of pure electrospun PCL, was used to 
determine the actual amount of PCL and the PCL/PLGA ratio in the scaffolds 
(Table 3-4). PCL nanofibers showed crystallization enthalpy of 55.9 J/g during 
cooling and melting enthalpy of -58.5 J/g in the second scan. As the melting 
enthalpy of 100% crystalline PCL is 139.5 J/g, the resulting crystallinity of 
electrospun PCL nanofibers was 42%. Also, results from the crystallization and 
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melting enthalpies of PCL-PLGAes and PCL-PLGAac scaffolds revealed that the 
actual PCL content was around 55% in both cases. Therefore, the actual PLGA 
contents were around 45%.  
 
Sample 
PCL 
Tm 
(II scan) 
[°C] 
∆HPCL melting 
(II scan) 
[J/g] 
PCL content 
 
[%wt] 
PCL 
nanofibers 60.0 -58.5 100.0 
PCL-PLGAes 61.3 -31.9 54.5 
PCL-PLGAac 59.1 -32.2 55.0 
 
  
 
 
Tc 
 
(cooling) 
[°C] 
∆HPCL crystal. 
(cooling) 
[J/g] 
PCL content 
 
[%wt] 
PCL 
nanofibers 27.1 55.9 100.0 
PCL-PLGAes 27.9 29.7 53.1 
PCL-PLGAac 26.7 30.5 54.6 
 
Sample 
PLGA 
PLGA content 
 
(from melting) 
[%wt] 
PLGA content 
 
(from crystal.) 
[%wt] 
Tg 
(I scan, 
Onset) 
[°C]  
Tg 
(I scan, 
Inflection) 
[°C]  
PCL-PLGAes 45.4 46.9 35.2 38.5 
PCL-PLGAac 45.0 45.4 37.8 39.7 
Table 3-4. Thermal properties of PCL and PLC-PLGA electrospun materials. 
Also, the glass transition temperatures of PLGAac and PLGAes, 
determined from the inflection point in the first DSC scan curves of PCL-PLGA 
scaffolds, were 39.7 and 38.5 °C, respectively. We also noticed that the glass-
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rubber transition for PLGAes (onset point) started at 35.2 °C, below the working 
temperature of 37°C. The transition zone for PLGAac started at 37.8 °C, just above 
the working temperature. 
 
Confocal images of the cross-sections of molecule-impregnated nanofiber 
materials further demonstrated that the compositional gradients of composites 
matched the designed nanofiber micropatterns (Figure 3-2). Herein, PCL 
nanofibers were loaded with a blue fluorophore coumarin, while PLGAac 
nanofibers were loaded with red fluorophore RhB and/or green fluorophore 
Rh123. Figure 2 demonstrated the molecule pattern in a two-component scaffold 
and a three-component scaffold.  
Figure 3-2a showed the confocal image of a PCL-PLGAac material, in which 
PCL and PLGAac were loaded with blue and red fluorophores, respectively. The 
gradual increase in the red color intensity from the left to the right side of the 
image demonstrates the increase of PLGAac content across the material 
thickness, whereas the attenuation of blue intensity shows the reduction of the 
PCL fraction in the same region. Also, no red signals were found close to the 
surface on the PCL side, and no blue signals close to the surface on the PLGAac 
side. This reflects the pure polymer design in these regions. However, due to the 
saturation of fluorescent signals, the fluorescent profiles in the high intensity 
range could not be accurately assessed.  
Figure 3-2b illustrated the design of a three-component scaffold, where 
PLGAac nanofibers were used to impregnate two molecules in the respective 
regions: green Rh123 in the inner region and red RhB in the outer region of the 
scaffold. Similar to the pattern observed in the two-component scaffold, the 
fluorescent intensity profiles in the confocal image reproduced the designed 
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micropattern across the scaffold thickness with accuracy except in the high 
intensity range.  
 
 
Figure 3-2. Design illustrations and confocal images of the gradient 
micropatterns over the thickness of PCL-PLGAac scaffolds. In the design 
illustrations (a, d) and confocal images (b, e), blue color shows PCL nanofibers 
loaded with fluorophore coumarin, red shows PLGAac nanofibers loaded with 
RhB, and green shows PLGAac nanofibers loaded with Rh123. The color intensity 
profiles (c, f), quantitatively determined from the confocal images, demonstrate 
the changes in the signal intensity of each fluorophore molecule across the 
sample thickness. Results demonstrate good agreement between the design 
patterns and the actual concentration profiles of the molecules or fibers.  
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3.3.2 Hydrolytic analyses of PCL-PLGA scaffolds demonstrated the 
different degradation behaviors and morphological changes 
of PLGAac and PLGAes 
To compare the hydrolytic degradation behaviors of PCL-PLGAac and PCL-
PLGAes scaffolds, samples were analyzed with the gravimetric method for weight 
loss, GPC for changes in the polymer molar weight distribution, and SEM for the 
nanofiber morphology. The results demonstrated significant differences between 
PLGAac and PLGAes during the 6-week hydrolytic degradation process. SEM 
micrographs in Figure 3-3 and Figure 3-4 demonstrate the evolution of PCL-
PLGAac and PCL-PLGAes scaffolds during degradation. Figure 3-3a and Figure 3-3b 
shows that the morphology and network of PLGAac nanofibers remained virtually 
unchanged after 1 week of buffer exposure. During this time period, the average 
fiber diameter increased about 25%, from 0.62 ± 0.27 µm to 0.78 ± 0.28 µm. After 
3 weeks, PLGAac nanofibers exhibited more significant increase in diameter with 
an average diameter of up to few microns, and the fiber network was 
characterized by soldering-like attachments at the junctions (Figure 3-3c).  
From the SEM images, it was noticed that by week 3, the fibers on the 
sample surface had partially lost their cylindrical and smooth morphology. Also, 
the PCL nanofibers started to emerge in the SEM images; they were underneath 
the PLGA fibers, exhibiting unaffected cylindrical and smooth morphology. 
Overall, the deformed and swollen PLGAac nanofibers seemed to be collapsed 
onto, and wrapped around, the more stable PCL fibers after 3 weeks of 
degradation. After 5 weeks, the fibrous structure of PLGAac almost disappeared, 
and a film of PLGAac covered the web of PCL nanofibers which were unscathed 
after degradation (Figure 3-3).  
From a macroscopic view, it was found that the PCL-PLGAac scaffolds 
remained dimensionally stable and flat for the entire experimental period.  
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PCL
PLGAac
10um
a – PLGAac nanofibers as spun b – week 1
d – week 5c – week 3  
 
Figure 3-3. Representative SEM micrographs of the PCL-PLGAac nanofibrous 
scaffold with an internal compositional gradient. Images were taken from the 
PLGA side. (a) Morphology of PLGAac nanofibers as spun. (b-d) Changes in the 
nanofiber morphology after 1 week (b), 3 weeks (c), 5 weeks (d) of degradation 
in phosphate buffer solution at 37°C. The unchanged PCL nanofibers underneath 
the PLGAac layer were found after 5 weeks of degradation (d). Scale bar shows 
10µm. Scale bar shows 10 µm. 
Compared to PLGAac, the morphology of PLGAes nanofibers altered much 
faster (Figure 3-4). After only 1-day exposure to buffer, the electrospun PLGAes 
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nanofiber network started to collapse with extensive soldering-like attachments 
at the junctions (Figure 3-4b). 
 
10um
10um
10um
f - week 4e - week 2 g - week 6
c – day 3b – day 1 d – week 1
a – PLGAes nanofibers as spun
 
Figure 3-4. Representative SEM micrographs of the PCL-PLGAes nanofibrous 
scaffold with an internal compositional gradient. Images were taken from the 
PLGA side. (a). Morphology of PLGAes nanofibers as spun. (b-f) Changes in the 
PLGAes nanofiber morphology after 1 day (b), 3 days (c), 1 week (d), 2 weeks (e), 
4 weeks (f) and 6 weeks (g) of degradation in phosphate buffer solution at 37°C. 
The unchanged PCL nanofibers underneath the PLGAes layer were found in all 
these images (b-d). Scale bar shows 10µm. 
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Within one day, the average fiber diameter increased nearly 80%, from 
0.50 ± 0.17 µm to 0.88 ± 0.10 µm. After 3 days, no fiber-like morphology remained 
in the PLGAes layer. The layer turned into a membrane with an array of small 
circular pores (Figure 3-4c) whose diameter continued to decrease in the first 
week (Figure 3-4d). At the end of the second week, the PLGAes layer was entirely 
re-structured and became a solid substrate without pores lying on the bed of PCL 
nanofibers. 
Figure 3-4e demonstrated the structure of PCL fibers lying under a 
fractured portion of the PLGAes layer. From then on, the surface of PLGAes layer 
appeared to be continuously eroded by the buffer, and after 6 weeks, a significant 
amount of material still remained on the surface (Figure 4f-g). From a 
macroscopic view, it was found that the PCL-PLGAes scaffolds shrunk and bent 
toward the PLGAes side, which might be due to the loss of PLGAes pores reducing 
the volume of the PLGAes material. Similar to PCL-PLGAac, in the PCL-PLGAes 
composites, the morphology and network structure of the nanofibers on the PCL 
side remained unchanged during the degradation process. 
 
To gain further understanding of the hydrolytic degradation processes of 
the composite scaffolds, we characterized changes in overall weight and 
molecular weight of different PCL-PLGA scaffolds. Using GPC curves of the 
component polymers (Figure 3-5), we first determined the weight-average 
molecular weight (Mw), number-average molecular weight (Mn) and 
polydispersity (pdi) of pure PCL, PLGAac and PLGAes materials.  
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3 3.5 4 4.5 5 5.5 6 6.5
Log [MW]
PCL
PLGA ac
PLGA es
 
Polymer Mw 
[kDa] 
Mn 
[kDa] 
pdi 
PCL 137 78 1.8 
PLGAac 43 26 1.6 
PLGAes 36 22 1.7 
 
Figure 3-5. GPC curves and molecule weight analyses of pure PCL, PLGAac, 
PLGAes materials.  The weight-average molecular weight (MW), number-average 
molecular weight (Mn) and polydispersity (pdi) are reported. 
Figure 3-6 demonstrated the differences between PCL-PLGAac and PCL-
PLGAes scaffolds in GPC curves, molecular weight changes and weight loss during 
hydrolytic degradation. The GPC curves exhibited a bimodal distribution. The peak 
at higher molecular weight was assigned to PCL, whereas the peaks at lower 
molecular weights were assigned to PLGA. GPC results from both PCL-PLGAac and 
PCL-PLGAes materials (Figure 3-6a-b) showed that the PLGA peak gradually 
decreased and shifted towards lower molecular weights, while the PCL peak 
remained unaffected during the hydrolytic degradation. Using deconvolution 
analysis of GPC curves, the contributions of PCL and PLGA, the PLGA content in 
the scaffold and the number average molecular weight of the polymer were 
determined.  
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Figure 3-6. GPC analyses of PCL-PLGAac and PCL-PLGAes scaffolds as spun and 
after the hydrolytic degradation tests. (a - b) GPC curves of PCL-PLGAac and 
PCL_PLGAes; (c - d) Changes in number average molecular weight and 
remaining PLGA content determined by the deconvolution of the GPC curves; (e -
f) Overall remaining mass percentage of the scaffolds determined by the 
gravimetric method and measurement of the total area under the GPC curves. 
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As shown in Figure 3-6c, the molecular weight of PLGAac slightly 
decreased between week 2 and week 3 before getting steady at 21kDa. The 
PLGAac content in the scaffold steadily dropped to approximately 22% of the 
original amount after 6 weeks. Compared to PCL-PLGAac, the molecular weight of 
PLGA in PCL-PLGAes scaffolds dropped more progressively from 22 to 9 kDa 
during the experimental period (Figure 3-6d). The PLGAes content decreased 
accordingly. However, when compared to PCL-PLGAac, there was a higher amount 
of PLGA content present in PCL-PLGAes scaffolds after 6 weeks, approximately 
40% of the original amount of polymers. Therefore, compared to PLGAac, PLGAes 
degraded more slowly, but underwent chemical breakdown during degradation, 
showing immediate reduction in molecule weight and more rapid loss of 
nanofiber morphology. The weight loss curves for the PCL-PLGAac and PCL-
PLGAes scaffolds were presented in Figure 3-6e and Figure 3-6f, respectively. The 
remaining mass of the scaffolds was determined by the gravimetric method and 
by measuring the overall area under the GPC curve; both results in similar curves 
of weight loss.  
3.3.3 Spatially-controlled release of small molecules from PCL-
PLGAac and PCL-PLGAes scaffolds 
To assess the capacity of PCL-PLGAac and PCL-PLGAes materials for 
spatially controlled release of active molecules, we first performed release 
experiments using Rh123. PCL and PLGA/Rh123 solutions were electrospun to 
prepare scaffolds following the pattern described in Figure 3-1. Release studies 
were carried out in custom-made diffusion chambers illustrated in Figure 3-7. The 
two sealed reservoirs filled with phosphate buffer solution were placed on the 
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opposite sides of the electrospun scaffolds. The PCL side of the scaffold was set to 
face the buffer reservoir chamber on the “A” side; the Rh123-impregnated PLGA 
side was placed in contact with the buffer reservoir on the “B” side.  
 
 
 
Figure 3-7. Schematic illustration of the custom-made diffusion chambers with 
independently sealed reservoirs facing the two surfaces of the electrospun 
samples.  
Daily measurement results of the Rh123 dye concentrations in both 
reservoirs for the first 9 days are shown in Figure 3-7.  
Figure 3-8a demonstrated that the majority of the encapsulated 
fluorescent molecules were released from the PLGAac side. Thus, the electrospun 
PCL-PLGAac scaffolds demonstrated the capability of confining sustained molecule 
release to one side of the scaffolds.  
The separation efficiency of Rh123 between the two surfaces (SRh123_B-A) of 
the PCL-PLGAac scaffolds was 81 ± 5 % during 16-day release experiment. On the 
contrary, PCL-PLGAes samples displayed a mixed release behavior. 
A          B 
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Figure 3-8. Double-sided release test on PCL-PLGAac and PCL-PLGAes with 
Rh123 impregnated in the PLGA fibers. (a) Release of Rh123 from the two 
surfaces of PCL-PLGAac scaffolds. (b) Release of Rh123 from the two surfaces of 
PCL-PLGAes  scaffolds. The release was determined by measuring the 
fluorophore concentration in the chamber reservoirs. Herein, “Side B” indicates 
the fluorophore-loaded PLGA surface and “Side A” indicates the PCL surface.  
 
Figure 3-8b showed that more molecules were released from the PCL 
side, when compared to PCL-PLGAac. In addition, after day 3, the molecule 
concentration measured on the PCL side exceeded that on the PLGAes side. This 
resulted in an overall separation efficiency of around 50%; thus, no separation of 
Rh123 between the two surfaces of the PCL-PLGAac scaffolds was found.  
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Therefore, the PCL-PLGAac scaffold was chosen for the release of 
biomolecules; though interesting, PCL-PLGAes scaffolds were not further used to 
study spatially-controlled protein release. 
3.3.4 Spatially-controlled protein release from PCL-PLGAac 
scaffolds 
A variety of micropatterned composite scaffolds made up of PCL 
nanofibers and protein-impregnated PLGAac nanofibers were designed to 
demonstrate the use of nanofiber micropattern for spatially-controlled, sustained 
releases of single or dual molecules. PLGAac nanofibers loaded with fluorescently-
labeled albumins were prepared by one-phase, solution electrospinning. Albumin 
was dissolved directly in the polymeric solution prior to electrospinning and 
appeared to be homogeneously distributed in the PLGAac nanofibers (Figure 3-9). 
50 µm50 µm
 
Figure 3-9. Optical and confocal images of PLGA nanofibers prepared by one-
phase, solution electrospinning. Fluorecently-labeled, AlbF was dissolved directly 
in the polymeric solution and was homogeneously distributed along the 
nanofibers. 
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3.3.4.1 Spatially-controlled sustained release of one molecule 
Figure 3-10 demonstrates the cumulative release of AlbT from the PCL-
PLGAac electrospun scaffolds. The scaffolds were prepared according to the 
micropattern presented in Figure 2. AlbT was encapsulated in the PLGAac 
nanofibers. The scaffolds were characterized by a nanofiber gradient and thus 
AlbT gradient. Results showed that sustained release of AlbT was highly confined 
to the PLGAac side of the scaffolds (Side B), and the release of AlbT from the PCL 
surface (Side A) was limited. The separation efficiency for AlbT between side B 
and side A of PCL-PLGAac scaffolds was 90 ± 4%, higher than the efficiency for 
small molecules (i.e. fluorophores). Results also showed that approximately 88% 
of the total amount of entrapped AlbT was released during the 50-day 
experiment.  
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Figure 3-10. Cumulative release of AlbT from the two surfaces of PCL-PLGAac 
composite scaffolds. The scaffolds were prepared following the compositional 
pattern presented inTable 3-1. AlbT was encapsulated in PLGAac and it was 
released mainly from the PLGAac-rich side.  “Side A” refers to the PCL-rich side, 
whereas “Side B” refers to the AlbT-loaded PLGAac side. 
87 
  
 
 
 
 
This estimation was made using an overall PLGAac content in the scaffold 
equal to 48%, as obtained from DSC analysis of this specific AlbT-loaded PCL-
PLGAac scaffold. Approximately 20% of the total loaded proteins were released in 
the first 24 hours, 80% were released in 9 days. After day 9, the low-slope release 
curve indicated a small amount of sustained release at a constant rate (about 1% 
per week). In addition, it was found that the release rates on the two sides of the 
scaffold were similar after day 9.  
3.3.4.2 Controlled releases of dual molecules to one side 
Using electrospun scaffolds with a similar compositional micropattern as 
shown in Figure 2d, we also demonstrated the concurrent release of two proteins 
from the same side of the PCL-PLGAac composite scaffolds. Instead of dye-
impregnated nanofibers, as illustrated in Figure 3-11a, PLGAac nanofibers in the 
inner part of the scaffolds were loaded with AlbF (green), while those in the outer 
region were loaded with AlbT (red). Results of cumulative release curves (Figure 
3-11b and Figure 3-11c) showed that both AlbT and AlbF were preferentially 
released from one side of the scaffolds with high efficiency.  
The separation efficiencies of AlbT and AlbF were 91 ± 4% and 87 ± 5%, 
respectively. To compare the release kinetics of AlbT and AlbF during the first 10 
days, the cumulative release on Side B was normalized with respect to the 
respective total amount of delivered proteins (Figure 3-12). The curves suggested 
that AlbF initially was released at a slower rate when compared to AlbT which was 
located closer to the surface, but the differences were not statistically significant.  
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Figure 3-11. Dual-drug release from one surface of the scaffold. (a) Illustration 
of the compositional pattern of nanofibers. (b) Cumulative release curve of AlbT. 
(c) Cumulative release curve of AlbF. 
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Figure 3-12. Dual-drug release from one surface of the scaffold. Comparison of 
AlbF and AlbT release during the first 10 days. 
3.3.4.3 Controlled releases of dual molecules to the opposite sides 
The compositional gradient micropattern was further used as building-
blocks of a more complex scaffold design for bi-directional release-control 
purposes. As illustrated in Figure 3-13, the new pattern was generated by 
duplicating gradient patterns on both sides symmetric with respect to PCL.  
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Figure 3-13. Dual-drug release from the opposite surfaces of the PLGAac-PCL-
PLGAac scaffold. Illustration of the compositional pattern of nanofibers.. 
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Herein, PLGAac was used to encapsulate either AlbF or AlbT. The designed 
pattern consisted of a 25 µm-thick layers of PLGAac electrospun nanofibers 
loaded with different fluorophore-tagged molecules on both surfaces, a 50 µm 
layer of PCL nanofibers in the core of the scaffold, and two PCL-PLGAac inter-
layers characterized by a similar compositional gradient pattern. As a result, a 
precisely-controlled distribution of two biomolecules was generated across the 
scaffold thickness. Results from molecule release showed that AlbF and AlbT were 
selectively released from the opposite sides of the PLGAac-PCL-PLGAac composite 
scaffolds. The cumulative release curves for AlbF and AlbT are shown in Figure 
3-14a and Figure 3-14b, respectively. 
 
AlbF was predominantly delivered to the reservoir on Side A, while AlbT 
was released to that on Side B. The separation efficiency of AlbF between Side A 
and Side B (SAlbF_A-B) was equal to 0.91 ± 0.04, while the separation efficiency of 
AlbT between Side B and Side A (SAlbT_B-A) was equal to 0.92 ± 0.03. 
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Figure 3-14. Dual-drug release from the opposite surfaces of the PLGAac-PCL-
PLGAac scaffold. (a) Cumulative release curves of AlbT. (b) Cumulative release 
curves of AlbF. Release of green-emitting AlbF was mainly confined to side A, 
whereas release of red-emitting AlbT is mainly confined to side B. 
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3.4  Discussion 
This study has developed and characterized a hierarchically-structured 
biomaterial platform, in which tunable nanofiber micropatterns are designed to 
control spatio-temporal release of molecules. Herein, the molecule release from 
the materials was illustrated with electrospun scaffolds whose micropattern over 
the thickness was characterized by complementary density gradients of diverse 
molecule-impregnated fibers. The scaffolds consist of PLGA fibers, an “active” 
component that encapsulates and releases model molecules, and PCL fibers, a 
“passive” component that provides mechanical integrity of the structure and 
sequesters molecule release. Various compositional patterns were designed and 
imaged with confocal microscopy which demonstrated good correlations between 
the designed and actual patterns. Additionally, we have revealed the differences 
of PLGAac (acid terminated PLGA) and PLGAes (ester terminated PLGA) during 
degradation, by showing that PLGAac is more stable and PLGAac nanofibers more 
gradually increase the diameter during hydrolytic degradation. Thus, spatially-
confined release was demonstrated with PCL-PLGAac scaffolds but not PCL-
PLGAes scaffolds. Using the precise graded composition and the interplay 
between PCL and PLGAac, we showed that the hierarchically-structured 
composite was capable of sustaining selective release of small molecules or larger 
proteins on one side of the scaffold.  
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3.4.1 Selection of PLGA material for controlled release 
PLGA is a biodegradable polymer that has been used in a wide range of 
medical implants, tissue engineering products and drug delivery devices, because 
of its slow degradation, good biocompatibility and mechanical property [50–52]. 
Also, both PLGAac and PLGAes are often used for preparing degradable scaffolds 
or controlled release materials; however, no studies have examined the influence 
of their chemistry difference on their capability of encapsulating and releasing 
molecules. Different from previous studies, this study is the first to compare the 
use of low-molecular-weight PLGAac and PLGAes nanofibers for controlled 
release.  
There were large differences between the two PLGA materials in 
physiochemical properties and nanofiber morphology alterations during 
degradation. Our results suggested that these differences could be attributed to 
the polymer state transition as determined from the DSC thermo-analysis. PLGAes 
nanofibers changed dramatically since the beginning of degradation, lost fibrous 
features, and turned into a dense, continuous polymeric film in a week. 
Conversely, PLGAac nanofibers showed delayed morphological changes to much 
later stages of degradation. The rapid morphological evolution of PLGAes 
nanofibers can be explained by the fact that the onset point of the glass transition 
transformation for PLGAes (35.2°C) was lower than the experimental temperature 
(37°C). Although the glass transition temperature of PLGAes as measured from 
the inflection point of the DSC curve was 38.5°C, vast regions of PLGAes 
nanofibers undergo glass-rubber transitions at 37°C. Due to the phase transition, 
highly mobile polymer chains in the rubbery state allow polymer relaxation and 
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water uptake. Acting as the plasticiser, the water molecules could contribute to 
further reduction of the glass transition temperature of PLGAes. PLGAes also 
underwent chemical breakdown during degradation, showing immediate 
reduction in molecule weight. Increased mobility of polymer chains caused 
nanofibers to start soldering together at their junctions and then coalesce to form 
a continuous film. In contrast, PLGAac whose glass transition onset point was at 
37.8°C, resulted in more stable nanofiber morphology. The glass-rubber transition 
likely was deferred, preventing water uptake. The PLGAac fibrous structure thus 
retained for a longer time, showing open, interconnected pores during 
degradation.  
The structural characteristics likely contributed to different behaviours of 
PCL-PLGAes and PCL-PLGAac in controlling release of molecules impregnated in 
the PLGA fibers, as shown in the results. The early formation of continuous, non-
porous PLGAes layer might reduce the diffusion of biomolecules toward the PLGA 
surface, resulting in no confined release of Rh123 from PCL-PLGAes scaffolds after 
day 2, while PCL-PLGAac scaffolds maintained sustained, spatially-controlled 
molecule release over a 6-week long period. Therefore, molecule release from the 
nanofiber composite scaffold is largely determined by the degradation behaviours 
and morphological changes of PLGA fibers.  
3.4.2 Sustained, spatially-confined molecule release  
Release of fluorescently-labeled albumin from PCL-PLGAac composite 
scaffolds were monitored up to 50 days in our study. Our prolonged release study 
demonstrated fast release in the first 9 days and limited amount of sustained 
release over the rest of the experimental period. In particular, the release profile 
of albumin showed modest burst release (~20% of total amount) on the first day.  
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The initial burst release and subsequent fast release during the first few 
days could be attributed to: (a) the nanofiber gradient pattern, in which higher 
density of molecule-impregnated fibers is closer to the surface for earlier release, 
and (b) the molecule distribution in the nanofiber. As suggested by previous 
studies, direct dissolution of molecules in the pre-spinning organic solution, as 
used in this study, could result in a non-uniform distribution of molecules with a 
large portion segregated at the nanofiber surface [140]. Therefore, modifications 
of temporal release kinetics might be approached by altering either the fiber 
pattern or the molecule encapsulation in the nanofiber. Encapsulation techniques 
other than one-phase blending might result in different release kinetics [141], 
[142]. Different from the molecule diffusion in the initial stage, the prolonged 
slow release in the later stage of the assay in this study may be attributed to the 
polymer degradation behaviour.  
In addition to sustained release, our release profiles of single small 
molecules or larger proteins as well as multiple proteins all demonstrated high 
separation efficiency of molecule release on the side with higher molecule 
concentration. Diffusion to the side with lower or zero concentration of molecules 
was minimal. The distribution of molecule-impregnated PLGAac nanofibers was 
thus effectively translated to sequestration of molecule release. The 
compositional gradient across the scaffold thickness confined molecule release in 
the proximity of a surface of the scaffold, thus leading to a spatially-defined 
preferential release. In addition, our results suggested that the rate of water 
penetration in the scaffold may strongly influence release profiles and 
distribution. However, further explorations are required for a better 
understanding of the water penetration/drug transport coupled phenomena.  
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3.4.3 Release mechanisms 
The most important mechanisms governing molecule release from 
polymeric scaffolds are diffusion, degradation and erosion of the polymer matrix 
[143], [144], [145]. To understand the underlying mechanisms, several 
mathematical models of mass transport have been developed. In this study, 
because PLGAac nanofibers exhibited modest swelling, the polymer molecular 
weight remained unchanged and the weight loss was small during the first week, 
diffusion was likely the leading mechanism of molecule release from PLGAac 
nanofibers during this period of time. A simple semi-empirical model proposed by 
Ritger and Peppas in 1986 describes drug release behavior from polymer by taking 
into account both Fickian and non-Fickian diffusion mechanisms, and is 
mathematically written as 
 
                 
ntM kt
M
∞
=                                                                        (Eq 1) 
 
where Mt is the mass of drug released at time t, M∞ is the mass of drug 
released as time approaches infinity, k is a constant that incorporates 
characteristics of the polymer and the drug, and n is the diffusional exponent, 
which reflects the transport mechanism. Using Eq 1 to model our experimental 
data, we found this model was valid for the first 60% of the fractional release. 
Electrospun nanofibers can be modeled as a random array of mono-dispersed 
cylinders with diameters much smaller than their lengths. According to Ritger and 
Peppas, one-dimensional radial release from a cylinder, under perfect sink 
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conditions, can be described with pure Fickian diffusion using Eq 1 (n = 0.45). For 
n = 1, drug release is independent of time (zero-order release); for 0.45 < n < 1, 
drug release follows a non-Fickian anomalous transport mechanism. In this study, 
we showed that loaded molecules were released unevenly from the two surfaces 
of the scaffold. Approximately 90% of the total drug released in 50 days was 
delivered to one side of the scaffold.  
The release from the other surface was close to zero in the first week of 
the experiment and could be neglected. By fitting the first 60% of the release 
profile of AlbT from side B of PCL-PLGAac scaffolds (Figure 8), we obtained n equal 
to 0.59 ± 0.07, with a high correlation coefficient (r
2
 = 0.983). The curves were 
normalized with respect to the total amount of loaded drug. Because diffusion is 
largely dependent on the water permeation through pore-to-pore movement in 
the non-uniform scaffold, release of molecules impregnated in PLGA fibers may be 
activated at different time points according to the location in the scaffold. In 
addition, due to the high surface-to-volume ratio of electrospun materials, the 
molecule distribution in the nanofibers may significantly influence the release. 
Herein, the use of one-phase molecule dissolution yielded a large amount of 
molecules on the surface of nanofibers [140], which was likely released during the 
first day and thus could be separately modeled. Excluding the first day data 
resulted in a much lower “n”, 0.46 ± 0.04, with a higher r
2
, 0.998. The value of the 
diffusional exponent “n” was close to the theoretical value of 0.45. In light of the 
modeling results, we can divide the release profiles in three regions, based on the 
widely-used release mechanism. In the first day of the experiment, a modest burst 
release of about 20% of the total loaded molecules was obtained due to the 
molecules segregated near the nanofiber surface. Between day 2 and day 8, the 
scaffold released additional 60% of the loaded molecules by Fickian diffusion. 
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After day 9, the steady release of AlbT with a constant rate was found, which 
could resulted from PLGAac degradation and nanofiber swelling.  
3.4.4 Potential applications for regenerative scaffolds 
A new generation of scaffolding materials for tissue engineering and 
regenerative medicine seeks to combine the material scaffolding function such as 
structural guidance and mechanical support with the regenerative function such 
as molecule release to guide cell dynamics and organization [92]. We thus 
demonstrate a promising scaffolding biomaterial using programmable nanofiber 
structure to meet various mechanical and biological needs [43] Because tissue 
regeneration is a highly regulated process involving differentiation and spatial 
organization of multiple cell types in 3D, sustained release of cell-specific 
molecules in a spatially-defined arrangement, as demonstrated here, could 
spatially guide cells and their commitment to regeneration.  
Uniform presentation of a regenerative molecule may not satisfy 
regeneration needs in many situations [146], because over-expression of a 
regenerative molecule at a wrong place or a wrong time may lead to abnormal or 
diseased tissues. For example, PDGF is an important growth factor stimulating 
vascular SMC ingrowth and proliferation to build vascular medial layer, but it is 
also a major contributor to vascular intima dysfunction leading to intima 
hyperplasia and stenosis. Also, in some circumstances, biomaterials need to 
interface different tissues to stimulate regeneration [147]. 
Though we have demonstrated the potential of micropatterned nanofiber 
composite scaffolds using model fluorescent-labelled molecules or proteins, the 
material platform developed here can be applied to a wide range of applications, 
including therapeutic implants, tissue engineering, and drug delivery. In these 
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applications, spatial confinement and temporal control of various molecules are 
pivotal to the improvement of therapeutic efficacy and the reduction of 
biomolecule toxicity or side effects. Additionally, the gradient pattern structure 
could be further used as a building-block to design more complex molecule-fiber 
structures for spatially-defined, sequential release of multiple biomolecules. To 
achieve more complex structures or designs, one can take advantage of the 
programmable nanomaterial fabrication developed here, which involves separate 
control over the fabrication of different nanofibers and their positions in 3D. 
Because the bioactivity of proteins is a critical issue in the controlled release, 
future studies should involve the use of more environment-sensitive molecules. 
Electrospinning of molecule-impregnated nanofibers using a simple solution-
based method as demonstrated here, has been used to release bioactive growth 
factors [39]. Also, other molecule encapsulation methods have been developed 
for electrospun materials to retain protein bioactivity [46], [141], [142], which 
might be used in conjunction with the techniques developed here in the future.  
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3.5 Conclusion  
We have developed and characterized micropatterned nanofiber 
composites made from biodegradable materials. This is the first demonstration of 
using nanofiber patterns in 3D biomaterials to achieve sustained, 
spatiotemporally-controlled release of multiple molecules or proteins. The 
hierarchically-structure composite may be used to define 3D dynamic 
microenvironments and likely find broader applications in tissue engineering and 
therapeutic device. 
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4 PROGRAMMABLE DUAL-RELEASE 
PROFILES OF MODEL PROTEINS FROM 
ELECTROSPUN GRADED MATERIALS 
 
4.1 Introduction 
Nanofibrous scaffolds have demonstrated excellent potential for guiding 
the formation of new tissues in many tissue engineering fields [148–150]. In 
recent years, the regenerative potential of scaffolding materials has dramatically 
improved by encapsulation and release of proper biochemical signals in a 
controlled manner. Therefore, there is a great interest in developing scaffolds 
with the capability of selectively exposing cells and tissues to an assortment of 
active molecules with controlled dosage, timing and duration. Effective interplay 
between scaffolding materials and controlled release strategies is critical. In 
general, scaffold functions of can be extended to the delivery of signaling 
molecules either by using drug releasing scaffold or by incorporating drug delivery 
devices into the scaffold itself [151,152].  
Bulk- and surface-eroding polymeric devices can serve as programmable 
drug delivery systems to generate pulsatile release of one protein or sequential 
release of multiple biomolecules. Effective multipulse drug delivery system has 
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been demonstrated using materials based on resorbable polyesters [153,154], 
polyanhydride-based laminates [155] and crosslinked hydrogels [156]. Chen and 
Mooney [157] developed PLGA scaffolds for spatially confined delivery and 
sequential release of VEGF and PDGF; Suciati et al. demonstrated the release of 
different bioactive molecules by sintering alternative layers of drug-loaded PLA 
microparticles plasticized with PEG and unloaded microparticles [158]. 
Alternatively, PLGA microparticles have been used to obtain delayed release after 
an initial lag-time [92]. In addition, several drug delivery materials have been 
recently developed for dual GF delivery. Burdick et al. demonstrated dual release 
of GFs for neural regeneration by encapsulating PLGA microspheres loaded with 
NT-3 in a PLA-PEG-PLA hydrogel with free CNTF [159]. Instead, porous scaffolds 
were shown that promoted neo-vascularization as a result of the release of 
known pro-angiogenic GFs, such as VEGF and PDGF [160]. 
In the previous chapter, we designed and established a material platform 
with electrospun composite scaffolds consisting of PCL and PLGA nanofibers with 
the ability to selectively deliver model biomolecules to one side of the scaffold. A 
precise gradient of composition through the scaffold thickness was created, which 
allowed one to tailor the initial distribution of small molecules and fluorescent-
labeled proteins inside the device. We demonstrated that encapsulated molecules 
were released from one side of the scaffold with high efficiency of separation. We 
demonstrated that the composite structure could serve as a building-block to 
generate complex multilayered devices for controlled release of multiple 
biomolecules. This chapter thus further illustrates how different patterns and 
kinetics of release of two separate biomolecules can be achieved just by 
combining two of the basic elements. We also seek to better understand the 
mechanism of the controlled release by providing the evidence about the critical 
role of PCL nanofibers in limiting water permeation in the scaffold for modulating 
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the release pattern.  This is then applied to guide the design of new composite 
scaffolds with the capability of control the timing and the kinetics of molecule 
release.
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4.2 Experimental part 
4.2.1 Materials and preparation of multi-component, electrospun 
scaffolds 
As described in the previous chapter, Poly(d,l lactide-co-glycolide) acid 
(PLGA) with a 50:50 ratio of lactide/glicolide and carboxylate end-group from 
LACTEL
®
, was selected as the carrier for fluorescein isothiocyanate conjugate 
bovine serum albumin (AlbF, green emission) and Tetra-methyl-rhodamine 
isothiocyanate conjugate bovine serum albumin (AlbT, red emission). Poly-ε-
caprolactone (PCL, 80 kDa) from Sigma Aldrich (St Louis, MO) and PLGA solutions 
with ALbF and AlbT were electrospun with a double electrospinning apparatus to 
obtain scaffolds with gradients of composition though their thickness. Electrospun 
nanofibers of pure PLGA were also prepared from PLGA solution without loaded 
molecules. Rhodamine B (RhB) was used as a fluorescent marker to study water 
penetration through electrospun scaffolds. Details about fluorescent molecules, 
solution preparations for electrospinning and parameters for the electrospinning 
process are provided in the previous chapter (refer to sections 3.1, 3.2 and 3.3 of 
Chapter 3). Electrospinning conditions of PLGA were slightly modified to 
overcome the problem of unreliable spinning conditions at low flow rate, by 
limiting the duration of the spinning stages at the lowest rates.The electrospun 
composite materials with internal compositional gradients were prepared through 
sequential and/or simultaneous electrospinning of PCL and drug-loaded PLGA on a 
rotational mandrel collector. A previously described double-electrospinning 
system was used. In some cases, intermixed layers of PCL and PLGA were 
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integrated in the design to modify water diffusion characteristics of the scaffolds. 
In general terms, electrospun structures consisted of layers of single polymer 
nanofibers and layers of mixed nanofibers made of different polymers. Fibers in 
different layers were obtained through the continuous spinning process following 
the designed micropatterns, in order to integrate materials with variable 
composition and uneven distribution of biomolecules inside the scaffold. More 
details of the compositional profile and the biomolecule distribution along the 
thickness of the different scaffolds are given in the Results section. The double-
side molecule release was described in section 3.3 of chapter 3.  
4.2.2 Water permeation into the scaffolds 
PCL and PLGA were individually electrospun to prepare mats with an 
uniform composition. Circular samples were obtained with a 25 mm punch cutter 
from each electrospun net and were placed between 2 cylindrical chambers made 
out of PMMA to form a custom made diffusion cell. The actual thickness of all the 
samples was within 10% of the designed thickness. Each chamber, with 2.2 mm in 
diameter and 2 ml in volume, was sealed to one side of the scaffold with bi-
adhesive rubber gasket. Small holes on the side of the PMMA chambers were 
used to add or remove the liquid from the diffusion cell. The chamber on one side 
of the scaffold, or named sink reservoir here, was filled with phosphate buffer 
solution; the other chamber, or named source reservoir here, was filled with a 
concentrated solution of RhB in phosphate buffer (2 mg/ml). With predetermined 
intervals, 200 µl of solution were withdrawn from the sink reservoir and replaced 
with fresh medium. The collected medium was analyzed for RhB concentration 
with a microplate spectrophotometer. A total of 4 PCL disks and 6 PLGA disks 
were tested. The results were expressed as average ± standard deviation.
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4.3 Results and Discussions 
In this study, we designed electrospun scaffolds for controlled release of 
multiple active molecules. In the previous chapter, we demonstrated electrospun 
scaffolds with variable composition and graded micro-patterns of nanofibers 
along the thickness of the scaffold. We also demonstrated that electrospun 
scaffolds were capable of confining the release of model proteins to one side of 
the materials. Herein, we aimed to study whether the spatial patterns of 
nanofibers had the capacity of programming release kinetics. By using the basic 
patterns developed before as building blocks, we engineered the scaffolds for 
various release patterns. This was done through modifying the distribution and 
proportion of PCL and PLGA nanofibers along the thickness of the scaffold. The 
newly designed scaffolds maintained the ability to localize the delivery of each 
loaded biomolecule and demonstrated the capability of controlling the release 
kinetics.  
4.3.1 Sequential release  
Using PCL as the matrix, electrospun composite scaffolds with dual PLGA 
gradient patterns were designed for the sequential release of two proteins. The 
materials were prepared by continuous electrospinning in sequence of a 50 µm-
thick layer of PCL nanofibers, a mixed layer of PCL and AlbF-loaded PLGA 
nanofibers with varied PCL/PLGA ratios, a 25 µm-thick transitional layer of PCL 
nanofibers, and a mixed layer of PCL and AlbT-loaded PLGA nanofibers with varied 
PCL/PLGA ratios.  
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Figure 4-1 shows a schematic illustration of the pattern. The micro-
pattern was characterized by an equal amount of AlbF-loaded PLGA and AlbT-
loaded PLGA, and consequently, an equal amount of AlbF and AlbT. The overall 
composition was 55% (wt) of PCL, 22.5% (wt) of AlbF-loaded PLGA and 22.5% (wt) 
of AlbF-loaded PLGA.  
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Figure 4-1. PCL-PLGA scaffold for the sequential release of proteins. Illustration 
of the compositional pattern of nanofibers. AlbF-loaded PLGA nanofibers were 
confined in the middle of the scaffold, while AlbT-loaded PLGA nanofibers were 
close to side B. 
 
Figure 4-2a shows the cumulative release profiles of AlbF and AlbT 
released from both sides of the scaffold. It was found that both AlbF and AlbT 
were delivered preferentially to the chamber on side B. The separation 
efficiencies of AlbF and AlbT between side B and side A were 0.92 ± 0.03 and 0.85 
± 0.04, respectively. The scaffold was highly efficient in spatially confining the 
delivery of both AlbT and AlbF. The spatial confinement was more efficient for 
AlbT than for Alb F. AlbF was also released mainly on side B, although it was 
originally localized in a central region of the scaffold. Daily net release of AlbF and 
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AlbT to side B in the first 12 days were shown in Figure 4-2b. The release kinetics 
of AlbF and AlbT are different from the previous study on dual protein release in 
Chapter 3. The net release of AlbT peaked on day 1 and day 2, and the net release 
of AlbF peaked on day 5.  
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Figure 4-2. PCL-PLGA scaffold for the sequential release of protein.(a) 
Cumulative release profiles of AlbF and AlbT from the two surfaces of the 
scaffold (b) Net release profiles of AlbF and AlbT to side B during the first 12 
days 
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Furthermore, to explore the effect of the material pattern on the spatio-
temporal release kinetics, a scaffold structure of modified dual gradients for the 
sequential release was designed (Figure 4-3a).  
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Figure 4-3. PCL-PLGA scaffold with PLGA in the transitional layer of the pattern 
to modify the sequential release of proteins. (a) Illustration of the compositional 
pattern of nanofibers. PLGA and PCL nanofibers were combined in the transition 
zone between AlbF-loaded PLGA and AlbT-loaded PLGA nanofibers. (b) Net 
release profiles of AlbF and AlbT to both sides during the first 12 days 
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In the modified design, the 25 µm-thick transitional layer of PCL 
nanofibers was replaced by a layer of intermixed PCL and PLGA nanofibers 
(PCL/PLGA ratio of 50/50). Compared to Figure 1, the release profile for AlbF was 
different: the net release of AlbF to side B peaked on day 3, much earlier than the 
similar pattern without PLGA in the transitional layer (Figure 4-3b). Meanwhile, 
the ability of the scaffold to confine the release on one specific side remained 
unaffected. 
Therefore, various release kinetics of combined biomolecules could be 
achieved by modulating the nanofiber micropattern and the composition profile 
including the thickness of the PCL layer, thickness and composition of transitional 
layer. Regulating the timing and release kinetics of different molecules from 
scaffolds is critical to successful tissue regeneration. For example, there are 
different molecules influencing the process of neovascularization at different 
stages. In particular, VEGF contributes to initiate angiogenesis, while PDGF 
promotes vessel maturation in a later stage [161], [162]. For this reason, porous 
PLGA scaffolds for the sequential release of VEGF and PDGF were prepared by 
subsequently entrapping PDGF-loaded nanoparticles and integrating free VEGF 
into a scaffold by gas foaming and particulate leaching [160]. The nanofiber-based 
materials developed here may more readily program the desired molecule release 
kinetics for regeneration of mechanically strong tissues such as artery. For 
instance, it has been shown that PDGF guide the migration of smooth muscle 
cells, while transforming growth factor beta (TGF-β) is able to accelerate the 
proliferation of smooth muscle cells. 
111 
  
 
 
 
 
 
 A sequential release of PDGF and TGF-β with proper timing (Figure 4-4) 
may promote regeneration of arterial media.  
 
 
Figure 4-4. Schematic illustration of a possible pattern for the sequential release 
of PDGF and TGF-β to regenerate vascular media.  
Currently, the optimal release kinetics for tissue regeneration in vitro or in 
vivo is largely unexplored. Using scaffolds to program release kinetics as 
demonstrated here, could be instrumental to identify an optimal condition from a 
large variety of release patterns and to study the underlying molecule mechanism. 
In addition, this method could be applied to the preparation of drug delivery 
devices for pulsatile release of active molecules. 
112 
  
 
 
 
 
 
4.3.2 Dual molecule release to the opposite sides of a scaffold 
In order to demonstrate the effect of nanofiber composition on spatial 
control over biomolecule release from the scaffold, we have modified the pattern 
for dual molecule release to the opposite sides of a scaffold, which was 
demonstrated in Chapter 3. As shown in Figure 4-5a, the modified pattern 
comprised a 25 µm-thick layer of AlbF-loaded PLGA electrospun nanofibers on 
one surface of the scaffold, an inter-layer of PCL and AlbF-loaded PLGA with 
variable composition, a 50 µm-thick transitional layer of intermixed PCL and PLGA 
nanofibers in the core of the scaffold, an inter-layer of PCL and AlbT-loaded PLGA 
with variable composition, and 25 µm-thick layers of AlbT-loaded PLGA 
electrospun nanofibers close to the other surface. The micro-pattern was 
characterized by an equal amount of AlbF-loaded PLGA and AlbT-loaded PLGA, 
and consequently, an equal amount of AlbF and AlbT. The material composition 
was 35% (wt) of PCL, 25% (wt) of AlbF-loaded PLGA, 25% (wt) of AlbF-loaded PLGA 
and 15% (wt) of PLGA. Overall, the scaffold consisted of 65% of PLGA nanofibers 
and 35% of PCL nanofibers. 
The cumulative release curves for both AlbF and AlbT were shown in 
Figure 4-5b and Figure 4-5c, respectively. The separation efficiency of AlbF 
between side A and side B (SAlbF_A-B) was 0.82 ± 0.04, while the separation 
efficiency of AlbT between side B and side A (SAlbT_B-A) was 0.81 ± 0.05.  
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Figure 4-5. PCL-PLGA scaffold with PLGA in the transitional layer of the pattern 
to modify the spatially-controlled release of proteins. (a) Illustration of the 
compositional pattern of nanofibers. PLGA and PCL nanofibers were combined in 
the transition zone between AlbF-loaded PLGA and AlbT-loaded PLGA 
nanofibers. (b) Cumulative release profiles of AlbF to both sides of the scaffold; 
(c) Cumulative release profiles of AlbT to both sides of the scaffold. 
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As shown in the previous chapter (Chapter 3, Section 3.4), when the 
transitional region consisted of only PCL nanofibers, the separation efficiencies of 
AlbF and AlbT (SAlbF_A-B and SAlbT_B-A) were 0.91 ± 0.04 and 0.92 ± 0.03, respectively. 
Here, we showed the scaffold pattern with the presence of a considerable amount 
of PLGA nanofibers in the transitional layer retained the ability to confine the 
protein release to one side, but the separation efficiency was significantly 
reduced. This molecule-releasing scaffold may be used in the applications where 
coordination of different molecule activities is needed. In the last 10 years, 
electrospun scaffolds have been explored for a number of applications such as 
wound dressing materials, anti-adhesion membranes, vascular and cardiac 
patches, vascular grafts, neural conduits and repair of osteochondral defects. In 
these applications, the materials often interact with different cells, tissues and 
even organs. As illustrated in Figure 4-6, scaffolds that selectively provide proper 
biochemical cues to different cell populations on two surfaces of the scaffolds 
may help simultaneous and coordinated regeneration of tissues. In the case of 
vascular tissue engineering.  
Figure 4-6. Schematic illustration of a possible pattern for the separate release 
of VEGF and TGF-β on different sides of a vascular graft to regenerate artery. 
The delivery of each growth factor is spatially confined to one of the opposite 
surfaces of the scaffold to meet the specific requirements of different cell 
populations. 
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For example, a scaffold releasing VEGF and TGF-β respectively to the two 
surfaces might simultaneously promote the formation of an endothelial layer on 
one side while inducing the proliferation of smooth muscle cells on the other side. 
4.3.3 Delayed release of AlbF and AlbT from opposite sides  
To further modulate the release patterns for delayed protein release, 
another pattern with two symmetric compositional gradients inside the scaffold 
was designed and characterized (Figure 4-7).  
 
Side 
A 
0 50 100 150 200
0.0
0.5
1.0
PLGA PLGA/AlbT
PCL
PL
G
A
 
fra
c
tio
n
Thickness [µm]
PLGA/AlbF
 
Side 
B 
Figure 4-7. Modified PCL-PLGA scaffold with inverse gradient for dual molecule 
release from opposite sides of the scaffold and in vitro release profiles of AlbF 
and AlbT from the two surfaces of the scaffold. Schematic representation of a 
PCL-PLGA graded scaffold with two reversed gradients. The content of albumin-
loaded PLGA nanofibers was 0 near the surfaces and maximum in the internal 
part of the scaffold. PLGA and PCL nanofibers were combined in the transition 
region between AlbF-loaded and AlbT-loaded PLGA nanofibers  
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In this design, the fraction of albumin-loaded PLGA nanofibers was higher 
in the internal region of the construct, rather than near the surfaces. Starting from 
side A, the molecule delivery scaffold consisted of a 20 µm-thick layer of PCL 
nanofibers, an interlayer of mixed PCL and AlbF-loaded PLGA nanofibers with 
PLGA content varying from 0 to 0.8, a 50 µm-thick transitional layer of intermixed 
PCL and PLGA nanofibers, a interlayer of mixed PCL and AlbT-loaded PLGA 
nanofibers with PLGA content gradually varying from 0.8 to 0, and a second 20 
µm-thick layer of PCL nanofibers on Side B. The scaffold contained equal amount 
of AlbF-loaded PLGA and AlbT-loaded PLGA. As a result, the scaffold was 
composed of approximately 40% (wt) of PCL, 22.5% of AlbF-loaded PLGA, 22.5% of 
AlbF-loaded PLGA and 15% of PLGA. Overall, the scaffold consisted of 65% of 
PLGA nanofibers and 35% of PCL nanofibers.  
The cumulative release curves for AlbF and AlbT are shown in Figure 4-8a 
and Figure 4-8b, respectively. With this configuration, the scaffold maintained the 
ability to localize the release of each drug on one surface,  but the separation 
efficiency was dramatically reduced: SAlbF_A-B and SAlbT_B-A was reduced to 0.66 ± 
0.05 and 0.63 ± 0.05, respectively. Also, it resulted in a different release pattern: a 
near-zero order release was obtained instead of a power law behavior. Compared 
to the release profiles shown before, the initial burst release on the first day 
dramatically diminished. The stage of fast release due to diffusion was also 
delayed and kept over a longer period.  
In general, we have demonstrated the capability of modifying the release 
kinetics with programmable the pattern and/or the fiber composition. 
Unfortunately, modulating temporal kinetics may reduce the spatially 
confinement of the molecule delivery to one side. However, this might be mainly 
due to the presence of PLGA nanofibers in the transitional layer along with PCL 
fibers. For the applications that require a high separation efficiency of a molecule 
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to one side, a pattern without PLGA nanofibers in the transitional region is 
suggested.  
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Figure 4-8. Modified PCL-PLGA scaffold with inverse gradient for dual molecule 
release from opposite sides of the scaffold and in vitro release profiles of AlbF 
and AlbT from the two surfaces of the scaffold. Cumulative release curves for 
AlbF (b.) and AlbT ( 
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4.3.4 Mechanisms of drug release 
In the previous chapter, we suggested that the protein release was 
divided into 3 stages: (1) the initial burst release on the first day, which resulted 
from a non-Fickian diffusion mechanism (anomalous diffusion); (2) the stage of 
fast release, which can be described by a semi-empirical equation developed by 
Rittger and Peppas using a network of mono-disperse infinite cylinders to model 
nanofibers; and (3) the final stage of steady slow release. Despite a number of 
approximations in the Rittger and Peppas equation, this approach has been widely 
used in order to describe the release behavior of electrospun nanofibers. 
However, the understanding of the molecular diffusion through the scaffold was 
still limited. The role of PCL nanofibers and the water diffusion or permeation into 
the scaffold remained unclear.  In this chapter, we thus designed and 
characterized several different scaffolds to better understand the regulatory 
mechanisms of release through nanofiber patterns. By comparing all the release 
profiles, we could reach the following conclusions:  
First, the integration of PLGA nanofibers and PCL nanofibers in the 
transitional regions of the scaffold resulted in a reduced capability of the scaffold 
to spatially confine the molecule delivery (Figure 4-5 and Figure 4-7). In other 
words, the diffusion of biomolecules, limited by PCL nanofibers, was expedited 
with the presence of PLGA nanofibers. In the case of sequential release, the 
movement of AlbF toward side B was faster in the presence of PLGA in the 
transitional region. 
Second, when the fluorophore-labeled albumin is located close to the 
surface of the scaffold, a relatively faster release is obtained with a larger portion 
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released in the first days (Figure 4-6). If albumin-loaded PLGA nanofibers are 
covered by a layer of PCL fibers, delayed release is found (Figure 4-1b, Figure 4-3b, 
Figure 4-7).  
Third, the thickness of the PCL layers is important. For example, as shown 
in Figure 4-1, a 50 µm-thick layer of PCL nanofibers almost completely prevents 
AlbF from releasing to side A, while a 25 µm-thick transitional layer of PCL 
nanofibers only delays the molecule diffusion toward side A. 
 
In summary, the role of PCL nanofibers that play in the pattern-controlled 
spatiotemporal  release is likely to prevent molecule diffusion, while PLGA 
nanofibers seems to favor the transfer of biomolecules. To study this hypothesis, 
we compared the water diffusion through PLGA nanofibers and PCL nanofibers 
(Figure 4-9). Macroscopically, we found that within less than two days, the 
appearance of a 150 µm-thick layer of PLGA nanofibers turned from white to 
completely translucent, a sign of complete water uptake. Also, small molecules 
dissolved in the water can freely move from one side of the material to the other. 
On the contrary, in the case of PCL nanofibrous materials, no small molecules 
(RhB) were detected for almost 2 days in the sink reservoir, showing that there 
was no molecule movement between the opposite chambers. After 6 days, the 
concentration still increased slowly. Macroscopically, the material retained its 
white color. Therefore, the results suggested that water diffusion through a thin 
layer of PCL nanofibers was difficult. This is probably due to the hydrophobicity of 
PCL nanofibers, which hinder the movement of water molecules. 
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Figure 4-9. Water permeation into PLGA and PCL electrospun scaffolds. 
Because the molecule diffusion or release through the nanofibrous 
scaffold was via the water permeation, to fully describe the release behavior of 
the composite electrospun scaffolds, both the molecule diffusion from the 
nanofibers and the water movement through the scaffold have to be taken into 
account.  
With a finite velocity of water uptake, the molecule diffusion and 
dissolution are activated at different time points in different scaffold regions. The 
diffusion pathways of the molecules toward the surface of the device are limited 
by the presence of air-filled pores. 
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4.3.5 Modeling drug release 
A full understanding of the material performances could help to guide the 
design of programmable molecule delivery systems with desired release profiles. 
This will only be possible with the development or identification of a 
mathematical model that properly describe the release. This is a challenging task. 
Herein, we propose a possible modeling approach using a basic gradient pattern 
(Figure 4-10). 
 
 
Figure 4-10. Design pattern for composite scaffold with compositional and 
biochemical internal gradient  
The diffusion coefficient for water (Dwater) is required to describe the 
water movement in the scaffold. According to our experimental results, the 
diffusion coefficient of water in PLGA nanofibers (Dwater-PLGA) defines the higher 
end of Dwater, while the diffusion coefficient of water in PCL nanofibers (Dwater-PCL) 
defines the lower end of Dwater. Dwater-PLGA and Dwater-PCL can be determined from 
diffusion studies or derived from thermodynamic principles. As the micropattern 
is characterized by a gradient structure with varied PCL/PLGA ratios, Dwater varies 
with the composition in the intermixed layers of nanofibers. Thus, a linear 
relationship between Dwater with the PCL/PLGA ratio or the position x over the 
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scaffold thickness is expected. The rate of water uptake in the scaffold (w) at a 
specific time point can be determined with Eq.1.  
 
( )waterw d dwD xt dx dx
∂  
=  ∂  
                          Eq. 1 
 
In alternative, we could also determine with the relationship with the 
percolation theory. The amount of encapsulated molecules in the scaffolds and 
the amount of mobile molecules at each time point may be quantified with Eq. 2 
and Eq. 3, where K is a constant that depends on the molecule and the material. 
Eq. 2 describes the variation of encapsulated molecules in the scaffold, while Eq. 3 
describes the rate of molecule release.  
 
fix
fixK wt
ρ ρ∂ = − ⋅
∂
          Eq. 2 
( ),mob fix d dwK w D x wt dx dx
ρ ρ∂  = ⋅ +  ∂  
    Eq. 3 
 
In summary, the dependence of the diffusion coefficient (D(x,w)) on the 
material composition point by point (x) and on the water content (w) has been 
used to describe the molecule diffusion in the scaffold. The diffusion problem can 
be solved with boundary conditions that depend on the specific compositional 
pattern and D(x,0) = 0, at t = 0. To our knowledge, there is no analytical solution 
for this problem, and thus a numerical solution should be expected.  
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4.4 Conclusions 
Taking advantage of multi-functional scaffolds produced by a double 
electrospinning, we demonstrated programmable drug delivery devices able to 
deliver different active molecules in a controlled fashion. We obtained 
simultaneous and sequential release of two different model proteins on the two 
surfaces of a newly engineered, composite electrospun scaffolds, and we showed 
that release kinetics can be influenced by changing the initial pattern of drug 
distribution and the composition of the scaffold. We believed that scaffold 
preparation and release micropatterns presented in this work may represent the 
platform for the development of novel multifunctional matrices able to control 
and direct the process of tissue regeneration. 
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5 SOLUTION AND EMULSION 
ELECTROSPINNING FOR VASCULAR 
ENDOTHELIAL GROWTH FACTOR 
ENCAPSULATION AND RELEASE  
 
5.1 Introduction  
In the previous chapters we presented a number of electrospun scaffolds 
with a potential as specialized drug delivery systems. We designed and prepared 
by electrospinning nanofibers mats characterized by a novel compositional and 
biochemical micropattern for encapsulation and release of biomolecules. By 
taking advantage of a smart distribution of encapsulated species and differential 
water penetration rates throughout the scaffold, we demonstrated spatially- and 
temporally-programmable delivery of model biomolecules, such as fluorescent 
dyes and fluorescently-labeled proteins. Previously in this thesis work, we used 
one-phase, solution electrospinning process to encapsulate model molecules in 
the nanofiber scaffolds; however, our findings can be extended to any 
encapsulation methods and any drug-carrier polymers. The usage of different 
polymer/drug systems will result in different release rates and profiles of the 
specific loaded molecules, but the overall release scheme, involving locally-
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confined and temporally-programmable deliveries, will be respected. In fact, the 
release profile of a particular drug depends just on the specific mechanism of 
release from nanofibers, while the overall release pattern depends essentially on 
the peculiar compositional pattern and the initial drug distribution that we 
designed.  
Growth factors (GF) are proteins specific for cell-to cell and cell-extra 
cellular matrix communication. During tissue morphogenesis GFs influence 
cellular behavior, tissue formation and organization. Growth factors are stored in 
the extra cellular matrix in insoluble, inactive forms via specific binding with 
glycosaminoglycans like heparins. Upon specific activation GFs are readily 
released in the intercellular fluid, where they can express their biological activity. 
Confinement of inactivated GFs within the ECM is an amazingly efficient solution 
for rapid, extracellular signal transduction. Concentration and spatial distribution 
in the extracellular environment are key factors for GFs efficacy. In particular, it 
has been shown that gradients in the concentration of free GFs can direct cell 
adhesion and migration, differentiation of multipotent cells and organization of 
cells into complex structure [163,164]. 
Vascular endothelial growth factor (VEGF) is a potent mitogen for micro- 
and macro-vascular endothelial cells and it is considered to be one of the most 
critical aspects in vascular formation and regeneration, particularly regulating the 
function of endothelium. Dosage of these biomolecules must be carefully 
regulated in a quantitative, spatial, and temporal manner in order to control 
cellular behaviors. Efficiently engineered VEGF delivery systems are required to 
minimize drug loss, degradation and denaturation, to assure a release within the 
concentration range in which the maximum benefit is provided. As VEGF has a 
short half-life in the body, a smart drug delivery system have to maximize the 
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medicament availability in the most required zone and limit the release in the 
near-by region [165].  
In one-phase, solution electrospinning biomolecules are directly mixed 
within the polymer solution, and  the mixed solution is electrospun to fabricate 
drug-loaded nanofibers. Researchers have used solution electrospinning to 
incorporate various types of proteins and genes in nanofiber scaffolds, including 
bovine serum albumin (BSA) [166], lysozyme [167] and growth factors [49]. 
Although solution electrospinning is relatively easy to perform, a possible issue 
with activity loss of incorporated biomolecules can arise. This is a quite severe 
problem for proteins, because they may lose their bioactivity due to 
conformational changes in the organic solution. For this reason, emulsion 
electrospinning has been proposed as an alternative technique for the 
preparation of drug-loaded nanofiber materials. Emulsion electrospinning is 
relatively novel and simple method of encapsulating biomolecules in biomaterials 
and has attracted increasing interest in the recent years [142,168]. It was also 
pointed out that nanofibers prepared by emulsion electrospinning could protect 
the structural integrity and bioactivity of encapsulated protein [166,168].  
In this part of the work we used both one-phase solution electrospinning 
and emulsion electrospinning to encapsulate VEGF in nanofiber scaffolds and we 
monitored VEGF release with a short-term in vitro release experiment. In 
addition, by using fluorescent molecules, we showed how the specific 
encapsulation method strongly influences drug distribution inside the nanofibers.  
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5.2 Experimental part 
5.2.1 Materials 
LACTEL® 50:50 poly(d,l lactide-co-glycolide) acid with a carboxylate end 
group and intrinsic viscosity of 0.67 dL/g, hereinafter referred to as PLGA, was 
purchased from DURECT Corp. (Pelham, AL, USA).  
RESOMER® R207S poly(d,l lactide) acid with inherent viscosity of 1.3 - 1.7 
dL/g, hereinafter referred to as PdlLA, was obtained from Pharma Polymers 
(Darmstadt, Germany) 
Poly(ε-caprolactone) (PCL) with molecule weight of 80 kDa, chloroform 
(CF), N,N-dimethylformamide (DMF), methylene chloride (MC), 1,1,3,3,3-
hexaflouro-2-propanol (HFIP), as well as emulsifiers, Span
TM
 80 and Tween
TM
 80 
were all purchased from Sigma Aldrich (St. Louis, MO, USA).  
Bovine serum albumin (BSA), fluorescein isothiocyanate conjugate bovine 
serum albumin (AlbF) with green emission and vascular endothelial growth factor 
human recombinant (VEGF) were also obtained from Sigma Aldrich (St. Louis, MO, 
USA).  
Quantikine® Human VEGF ELISA kit was purchased from R&D Systems 
(Minneapolis, MN, USA) and used for the quantitative determination of VEGF 
content in the release medium, kit following the manufacturer's protocol. 
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5.2.2 Preparation of pre-spinning solutions and electrospinning 
Protein-loaded electrospun PLGA and PdlLA nanofibers were prepared by 
conventional solution electrospinning. Flourescently-labeled albumin AlbF was 
encapsulated in PLGA and PdlLA nanofibers for visualization of the distribution of 
the loaded biomolecules. A solution of AlbF in DI water with a concentration of 5 
mg/ml was prepared and then mixed with HFIP in a 1:7 volumetric proportion. 
The HFIP:DI water mixture with AlbF was used to dissolve PLGA with a final 
concentration of 17% (wt) and PLGA nanofibers loaded with AlbF were prepared 
from a homogeneous, one-phase solution by solution electrospinning. Nanofiber 
mats prepared with this technique were indicated hereinafter as PLGAsol_AlbF. 
Electrospinning parameters for all the electrospun nanofibers prepared by 
solution electrospinning are listed inTable 5-1. 
The HFIP:DI water mixture with AlbF was also used to dissolve PdlLA to a 
final concentration of 10% (wt) and PdlLA nanofibers loaded with AlbF were 
prepared by solution electrospinning (hereinafter indentified as PdlLAsol_AlbF). 
Thin layers of PLGA and PdlLA electrospun nanofibers loaded with AlbF were 
deposited on glass slides for confocal observation.  
Lyophilized VEGF was reconstituted with DI water at a concentration of 
0.1 mg/ml to prepare the VEGF batch solution. By dilution of the VEGF batch 
solution in DI water and addition of BSA powder, a 17 µg/ml VEGF solution in DI 
water with 5% BSA was obtained, and then mixed with HFIP in a 1:7 volumetric 
proportion. This mixture was used to dissolve PLGA to a final concentration of 
17% (wt) and VEGF-embedded PLGA nanofiber nets were produced by solution 
electrospinning (hereinafter PLGAsol_VEGF-BSA). 
Similarly, by dilution of the VEGF batch solution in DI water and addition 
of BSA powder, a 10 µg/ml VEGF solution in DIwater with 5% BSA was obtained, 
and then mixed with HFIP in a 1:7 volumetric proportion. This new mixture was 
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used to dissolve PdlLA to a final concentration of 10% (wt) and VEGF-embedded 
PdlLA nanofiber nets were produced by solution electrospinning (hereinafter 
PdlLAsol_VEGF-BSA). In addition, PCL was dissolved in 75/25 CL/DMF at a 
concentration of 10% (wt).  
 
Mat Samples 
Prepared 
Solvent 
system 
Polymer 
conc. 
[% wt] 
Voltage 
 
[kV] 
Work 
Distance 
[cm] 
Feed 
rate 
[ml/h] 
       
PLGA 
PLGAsol_AlbF 
HFIP/water
7/1 vol. 
17 24 22 0.65 
PLGAem_AlbF 
CL-water-
emulsifier* 
10 24 18 0.5 
PLGAsol_VEGF-BSA 
HFIP/water
7/1 vol. 
17 18 22 0.65 
PLGAem_VEGF-BSA 
CL-water-
emulsifier* 
10 18 20 0.5 
       
PdlLA 
PdlLAsol_AlbF 
HFIP/water
7/1 vol. 
17 24 22 0.9 
PdlLAem_AlbF 
CL-water-
emulsifier* 
10 24 18 0.8 
PdlLAsol_VEGF-BSA 
HFIP/water
7/1 vol. 
17 18 22 0.9 
PdlLAem_VEGF-BSA 
PCL-PdlLA_VEGF-BSA 
CL-water-
emulsifier* 
10 18 18 0.2-0.8 
       
PCL 
PCL-PdlLA_VEGF-
BSA 
CF/DMF 
3/1 vol. 
10 26 24 0.3-1.1 
Table 5-1. Electrospinning parameters for the nanofiber mats prepared by 
solution and emulsion electrospinning (* Emulsion consisting of CL-water phase-
emulsifier mixture with a 100-5-2 volumetric ratio). 
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5.2.3 Preparation of the pre-spinning W/O emulsions and 
electrospinning 
Protein-loaded electrospun PLGA and PdlLA nanofibers were also 
prepared by electrospinning of a water-in-oil (W/O) emulsions. Electrospinning 
parameters for electrospun nanofibers prepared by emulsion electrospinning are 
also listed in Table 5 – 1. 
A combination of Span80 and Tween80 (9 to 1 in volume) was used as 
emulsifier to stabilize the emulsions. The volume of the aqueous phase and the 
volume of emulsifier  were set to 1/20 and 1/50 of the volume of the organic 
solution, respectively. First, the organic phase and the emulsifier were 
homogenized  in a glass vial with a magnetic stirrer, then the aqueous solution 
was added drop-by-drop under constant stirring. A magnetic stirring bar rotating 
at 1000 rpm was used for the emulsification process. A secondary stage of 
emulsification via ultrasonification was also considered. 
Flourescently-labeled albumin, AlbF was encapsulated in PLGA and PdlLA 
nanofibers prepared by emulsion electrospinning for the visualization of the 
protein distribution. A 2 mg/ml solution of AlbF in DI water was emulsified with a 
17% (wt) PLGA solution in CL. AlbF-loaded PLGA nanofibers prepared by emulsion 
electrospinning are hereinafter indicated as PLGAem_AlbF.  
A 2 mg/ml solution of AlbF in DI water was also emulsified with a 11% 
(wt). AlbF-loaded PdlLA nanofibers prepared by emulsion electrospinning are 
hereinafter indicated as PdlLAem_AlbF.  
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W/O emulsions containing AlbF were examined with a confocal 
microscope to assess the distribution of the AlbF-marked dispersed phase (water 
phase) inside the continuous phase (polymeric organic solution). 
In addition, a 17 µg/ml VEGF solution in DIwater with 5% BSA was 
emulsified with a 17% (wt) PLGA solutions in CL. Similarly, a 10 µg/ml VEGF 
solution in DIwater with 5% BSA was emulsified with a 11% (wt) PdlLA solutions in 
CL. VEGF-loaded PLGA and PdlLA nanofiber materials produced by emulsion 
electrospinning of the previously prepared emulsions are hereinafter indicated as 
PLGAem_VEGF-BSA and PdlLAem_VEGF-BSA.  
5.2.4 PCL-PLGA and PCL-PdlLA graded scaffolds for spatially-
confined release of VEGF 
PCL-PLGA and PCL-PdlLA composite scaffolds with a compositional and 
biochemical gradient along their thickness were also prepared (hereinafter PCL-
PLGA_VEGF-BSA and PCL-PdlLA_VEGF-BSA, respectively). VEGF-loaded PdlLA and 
VEGF-loaded PLGA nanofibers were electrospun by emulsion electrospinning of 
the corresponding emulsion prepared as indicated above. 
A schematic representation of a composite scaffold is reported in Figure 
5-1. The scaffold was obtained following the design of the basic drug-delivering 
element already described and tested in Chapter 3. Please, refer to Chapter 3 for 
a detailed description of the micropattern, scaffold composition, the drug 
distribution and preparation procedures.  
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Figure 5-1. Schematic illustration of the cross-section of PCL-PdlLA_VEGF-BSA 
electrospun scaffold with internal compositional and biochemical gradient. 
5.2.5 Nanofibers characterization 
Nanofibers loaded with AlbF were examined as spun with a confocal 
microscope to assess the distribution of encapsulated molecules. The morphology 
of the electrospun fibers was observed using scanning electron Microscopy SEM. 
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5.2.6 In vitro release of VEGF 
Phosphate buffer solution pH 7.4 used as release medium was prepared 
as indicated in Chapter 3, with the addition of 0.1% BSA.   
VEGF-loaded PLGA and PdlLA nanofiber materials prepared by solution 
and emulsion electrospinning (PLGAsol_VEGF-BSA, PdlLAsol_VEGF-BSA, 
PLGAem_VEGF-BSA and PdlLAem_VEGF-BSA) were immersed in the BSA-enriched 
release medium to assess in vitro release of VEGF. Three pre-cut specimens, 
approximately 20 mg in weight, were obtained from PLGA and PdlLA mats 
prepared either by solution or by emulsion electrospinning. Each specimen was 
placed in a separate test tube, covered with 2 ml of 0.1% BSA phosphate buffer 
solution and placed at 37°C for 7 days, under mild agitation. For the PCL-PdlLA 
composite scaffolds (PCL-PdlLA_VEGF-BSA) the in vitro release test was 
performed using the diffusion cell and methodologies for side-by-side release 
tests previously described in Chapter 3. Using this release system, it was possible 
to discriminate between VEGF delivered to Side A and VEGF delivered to side B.  
Each day the supernatant was removed, the samples were briefly rinsed 
in DI water, and fresh release medium was added. Extracted samples were stored 
at -80°C, prior examination. VEGF content in the release medium was determined 
for elutions with the Quantikine® Human VEGF ELISA kit, following manufacturer’s 
specifications. To reduce the number of analyzed samples, elutions extracted 
from the three repetitions of each data point were mixed together prior 
examination; for this reason, the reported values represent the average value of 
the release and no error bars are provided.  
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5.3 Results and Discussions 
5.3.1 Preparation of stable W/O emulsions and electrospinning 
A number of water solutions were mixed with either PLGA or PdlLA 
solutions in chloroform and stable emulsions was obtained under agitation. The 
aqueous solution was added into the oily phase drop-by-drop to ensure the 
atomization of the aqueous phase. A mixture of Span80 and Tween80 was added 
into the polymer solution prior to emulsification as a surfactant to lower the 
surface tension of the oily phase. Tween 80 belongs to a class of food additives 
also known as polysorbates, while Span 80 (Sorbitan monooleate) is a sorbitan 
ester widely used in food products and oral pharmaceuticals. Tween 80 and Span 
80 are generally regarded as non-toxic and non-irritating. According to the 
hydrophile-lipophile balance  system (HLB), surfactants with HLB values between 
4 and 6 are suitable for making W/O emulsions. Therefore, a mixture of SPAN80 
and Tween80 (9 parts of Span80 and 1 part of Tween80) with a resulting HLB 
value of 5 was used as emulsifier to prepare the W/O emulsions. 
In the preliminary stage of the work, the concentration of the organic, 
polymeric solutions, the volume of aqueous phase and emulsifier and the 
emulsification conditions were considered. The organic phase and the emulsifier 
were homogenized  in a glass vial with a magnetic stirrer, then the aqueous 
solution was added drop-by-drop under constant stirring. A magnetic stirring bar 
rotating at 1000 rpm was used for the emulsification process; a secondary stage 
of emulsification with ultrasonification was also considered. Preliminary 
electrospinning experiments were performed in order to evaluate the impact of 
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the different parameters on the electrospinning process. A optical microscopy was 
used to monitor the overall quality of the electrospun nets. Concentration and 
composition of the PLGA and PdlLA solutions resulted to be the particularly 
important for the formation of nanofibers during the electrospinning process. 
Stable emulsions were obtained by adding to the organic polymer solutions 
volumes of emulsifier ranging from 1/50 to 1/25 of the volume of the polymeric 
solutions. The volume of watery-phase with AlbF was successfully varied between 
1/20 and 1/10 of the volume of the organic solutions. From the preliminary 
electrospinning experiments it was clear that larger amounts of water phase 
made the electrospinning process less effective and discontinuous. Generally, the 
presence of the emulsifier had a benign effect on the quality of the fibers and the 
overall process, but this effect was not related to the actual amount of emulsifier 
in the tested range. So, the volume of watery-phase and emulsifier were fixed at 
1/20 and 1/50 of the oily-phase volume, respectively. PLGA and PdlLA were 
dissolved in CL at a concentration of 17% and 11%, respectively. Those values 
represented the best compromise between emulsion stability and quality of the 
electrospinning process for the present system of emulsifiers and solvents.     
As far as the emulsification process itself, confocal micrographs were used 
to determine dimension and distribution of the dispersed phase after each stage 
of emulsification. 
Figure 5-2a shows a confocal image of a W/O emulsion of a water solution 
of AlbF in a 17% PLGA in CL; the emulsion was obtained by stirring the two 
solutions at 1000 rpm for 10 min on a conventional magnetic stirrer. 
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    c. 
Figure 5-2. W/O emulsions consisting a 2 mg/ml water solution of ALbF 
dispersed in a 17% (wt) solution of PLGA in CL prepared with different 
emulsification methods. a.) W/O emulsion homogenized with a magnetic stirrer 
with magnetic bar rotating at 1000 rpm for 10 min; b.) W/O emulsion subjected 
to sonication for 1 min after stirring; c.) Diameter of the disperse phase as a 
result of different emulsification methods. 
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Except in the short initial transient during the formation of the emulsion, 
the time of stirring was found not to be a significant factor in the emulsification 
process. As reported in the graph in Figure 5-2c, at front of a the time of stirring 
increased from 10 min to 1 hour, no significative changes in the diameter and 
distribution of the water phase were found (from 5.6 ± 2.9 to 5.0 ± 2.9 µm). On 
the contrary, a similar emulsion was sonicated for 1 minute after 1 hour of stirring 
(see Figure 5-2b), resulting in a significative decrease of the water drops 
dimension to 2.4 ± 1.4 µm. However, all the emulsions remained stable for several 
hours after the emulsification, and we chose to avoid the sonication to preserve 
both the loaded biomolecules and the molecular weight of the polymers. A similar 
behavior was found when 11% PdlLA in CL was used as organic phase. 
Figure 5-3 demonstrates the distribution of loaded molecules in 
electrospun nanofibers prepared from W/O emulsions. A W/O emulsion 
consisting a water solution of ALbF dispersed in a 17% (wt) solution of PLGA in CL 
was electrospun on a glass slide. The resulting nanofibers were imaged with the 
confocal microscopy.  
AlbF was not homogeneously dispersed in the electrospun nanofibers; on 
the contrary, the entrapped biomolecules were confined in islands and rounded 
clusters along the nanofibers. It was not trivial to determine the dimension of 
those clusters, but we estimated that they ranged between 100 and 300 nm. It is 
interesting to recall that the dimension of the dispersed phase in the emulsion 
ranged between 1 and 8 µm. We think that large shear stresses and mechanical 
compression in the Taylor cone and in the linear region of the electrospinning 
induce an extended breakdown of the disperse phase, resulting in drastic 
reduction of the dimension of the drops. Evaporation of the solvent during the 
fiber formation may also contribute to the formation of the nanoclusters of the 
encapsulated molecules.  
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Figure 5-3. Confocal images of a W/O emulsion of AlbF in and the corresponding 
electrospun nanofibers. a.) W/O emulsion consisting a 2mg/ml water solution of 
ALbF dispersed in a 17% (wt) solution of PLGA in CL (water phase/organic 
phase ratio equal to 1/20); b.) AlbF distribution in AlbF-loaded PLGA nanofibers 
obtained by electrospinning of the emulsion; c.) Schematic illustration of the 
microdroplets breakdown in the region of the Taylor cone and the formation of 
fluorescent nanoclusters along the nanofibers during electrospinning  
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5.3.2 Preparation of AlbF-loaded nanofibers by solution and 
emulsion electrospinning 
In Figure 5-4, AlbF-embedded nanofiber meshes prepared by solution 
electrospinning and emulsion electrospinning are compared. Nanofibers in Figure 
5-4.a and Figure 5-4c were prepared by solution electrospinning of a one-phase, 
homogeneous pre-spinning solutions; nanofibers in Figure 5-4b and Figure 5-4d 
were prepared by emulsion electrospinning of a biphasic W/O emulsion.  
In the case of solution electrospinning the loaded AlbF was 
homogeneously dispersed into the nanofibers. On the contrary - as previously  
discussed - entrapped AlbF was confined in isolated nanoclusters along the fibers 
in the case of emulsion electrospinning. This is particularly evident in the PdlLA 
nanofibers prepared by emulsion electrospinning (PdlLAem_AlbF), where AlbF 
clusters are aligned with great regularity along the fibers (Figure 5-4c). Emulsion 
electrospinning of PdlLA originated highly reproducible defect-free nanofibers and 
a high-quality electrospinning process. 
Instead, as it is possible to see in Figure 5-4b, PLGA nanofibers prepared 
by emulsion electrospinning (PLGAem_AlbF) presented several microscopic 
defects. It is worth to emphasize here that, regardless all our efforts, it was not 
possible to prepare PLGA W/O emulsions with optimal electrospinning properties. 
Discontinuity in the electrospinning jet, instability of the Taylor cone, high 
viscosity of the emulsion and fast solvent evaporation resulted in the formation of 
polymeric agglomerates at the tip of the needle. 
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Solution Electrospinning Emulsion Electrospinning 
100um
 
a. PLGAsol_AlbF 
100um
 
b. PLGAem_AlbF 
100um
 
c. PdlLAsol_AlbF 
100um
 
d. PdlLAem_AlbF 
Figure 5-4. Confocal images of PLGA and PdlLA nanofibers embedded with AlbF 
either prepared by one-phase, solution electrospinning (a.-c.) or by emulsion 
electrospinning (b.-d.). 
The process was also highly discontinuous; excellent fibers were obtained 
at times, but macroscopic and microscopic droplets, large fibers and aggregates 
were also deposited onto the collector (see also Figure 5-5). At times, no 
electrospinning was obtained at all. We think that, due to its low molecular 
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weight, PLGA in solution has a limited ability to withstand shear stresses during 
the formation of the fiber resulting in a instability of the polymer jet. In presence 
of a disperse phase, the polymer may not be able to overcome the increased 
viscosity of the emulsion. We also tried to use alternative solvents or mixtures of 
solvents (toluene and xylene between others) for the preparation of the PLGA 
organic solution. Regardless a large number of alternative formulations, no 
evident improvement of the process was found.  
 
 
Figure 5-5. PLGAem_AlbF nanofibers with macroscopic solidified polymer drops, 
large fibers and aggregates (Scale bar 50µm). 
SEM micrographs in Figure 5-6 display the morphology of the different 
Alb-loaded electrospun nets. Cylindrical, smooth nanofibers were observed in all 
cases. Spindle-like defects and irregular diameters were found for PLGA 
nanofibers. It is interesting to compare confocal images and SEM micrographs for 
samples prepared by emulsion electrospinning (for instance compare Figure 5-4d 
and Figure 5-6d). Although encapsulated AlbF had a non-homogenous distribution 
and it was confined in clusters, nanofibers did not present any evident bulges or 
irregularities on the exterior.  
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Solution Electrospinning Emulsion Electrospinning 
 
a. PLGAsol_AlbF 
 
b. PLGAem_AlbF 
 
c. PdlLAsol_AlbF 
 
d. PdlLAem_AlbF 
Figure 5-6. SEM micrographs of PLGA and PdlLA nanofibers loaded with AlbF. a.) 
PLGAsol_AlbF nanofibers  were prepared by directly dissolving AlbF along with 
PLGA into a HFIP/water (7 to 1 vol.) solution; b.) PLGAem_AlbF nanofibers  were 
obtained from a W/O emulsion of a AlbF aqueous solution into 17% (wt) PLGA 
in chloroform; c.) PdlLAsol_AlbF nanofibers  were prepared by directly dissolving 
AlbF along with PdlLA into a HFIP/water (7 to 1 vol.) solution; d.) PdlLAem_AlbF 
nanofibers  were obtained from a W/O emulsion of a AlbF aqueous solution into 
11% (wt) PdlLA in chloroform 
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5.3.3 VEGF-loaded nanofibers prepared by solution and emulsion 
electrospinning 
In this study, electrospun nanofiber materials were prepared in which BSA 
was encapsulated along with VEGF. BSA is added as a protectant to the VEGF to 
prevent protein degradation and inactivation under extremely hostile 
environments, such a dissolution and dispersion in organic solvents during 
scaffold fabrication and protein encapsulation. In some manufacturing processes, 
the addition of albumin aided in protecting growth factors from denaturation in 
organic solvents [169],[170]. Other results suggested that BSA has the potential of 
stabilizing other protein or peptide drugs [171]. In addition, Valmikinathan et al. 
demonstrated that BSA helps in overcoming the most common drawbacks 
associated with hydrophobic polymers such as reduced loading efficiency, long 
degradation periods, and burst release [172].  
 
All nanofibers loaded with VEGF and BSA exhibited a defect-free 
morphology (Figure 5-7) regardless the preparation method. Most likely, the 
presence of BSA increased the electrical conductivity of the solution, making the 
process of fiber drawing more efficient. However, very much like in the case of 
ALb, the electrospinning process of PLGA emulsions with VEGF and BSA presented 
several challenges. No large aggregates were observed, but the surface of the 
scaffold was interspersed with macroscopic and microscopic round defects 
originated by solvent-rich polymer droplets deposited over the time. Those 
defects are particularly harmful because of the residual solvent that could re-
dissolve the nanofibers, and create discontinuities and even holes in the material.  
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Solution Electrospinning Emulsion Electrospinning 
 
a. PLGAsol_VEGF-BSA 
 
b. PLGAem_VEGF-BSA 
 
c. PdlLAsol_VEGF-BSA 
 
d. PdlLAem_VEGF-BSA 
Figure 5-7. SEM micrographs of PLGA and PdlLA nanofibers loaded with VEGF 
and BSA. a.) PLGAsol_VEGF-BSA nanofibers  were prepared by directly dissolving 
VEGF and BSA along with PLGA into a HFIP/water (7 to 1 vol.) solution; b.) 
PLGAem_VEGF-BSA nanofibers  were obtained from a W/O emulsion of an 
aqueous solution of  VEGF and BSA into 17% (wt) PLGA in chloroform; c.) 
PdlLAsol_VEGF-BSA nanofibers  were prepared by directly dissolving VEGF and 
BSA along with PdlLA into a HFIP/water (7 to 1 vol.) solution; d.) 
PdlLAem_VEGF-BSA nanofibers  were obtained from a W/O emulsion where an 
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aqueous solution of  VEGF and BSA was dispersed into 11% (wt) PdlLA in 
chloroform 
5.3.4 In vitro VEGF release from PLGA and PdlLA nanofiber mats 
prepared by solution and emulsion electrospinning   
VEGF-loaded PLGA and PdlLA nanofiber materials prepared by solution 
and emulsion electrospinning were immersed in a phosphate buffer solution with 
0.1% BSA to assess in vitro release of VEGF. Very dilute protein solutions more 
prone to inactivation and loss as a result of low-level binding to the storage vessel. 
Therefore, it is common practice to add proteins, such as bovine serum albumin 
(BSA) as carrier or filler to protect against such degradation and loss.  
Buffer solution with released VEGF was completely removed every 24 
hours and replace with fresh medium. Samples extracted at day 1, 2 and 4 were 
analyzed using Quantikine® VEGF ELISA kit to determine the amount of release 
VEGF. Results are summarized in Figure 5-8. For all the experiments, we found 
release profile with a strong burst at day 1, an intermediate amount of release at 
day 2 and very limited release at day 4.  
The data suggest that, both in case PLGA and in case of PdlLA, samples 
prepared by emulsion electrospinning had a smaller amount of release at day 1 
and a slightly more sustained release in the following days when compared with 
samples prepared by solution electrospinning. However, as no error bars are 
available, we cannot provide a conclusive result. In general term, the drug 
distribution along the fiber could explain a more gradual release in the case of 
samples prepared by emulsion electrospinning. As it results from confocal images, 
the clusters of encapsulated molecules in nanofibers prepared from emulsions 
appear to be located toward the center of the fibers (Figure 5-4b-d).  
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Figure 5-8. VEGF released in days 1, 2, and 4 from PLGA (a.) and PdlLA (b.) 
nanofibrous scaffolds. VEGF-loaded nanofibers were prepared either by directly 
dissolving VEGF or by emulsifying an aqueous solution of VEGF the polymeric 
solution. The content of active-VEGF in the release medium was determined by 
enzyme-linked immunosorbent assay (ELISA). The reported values represent the 
average of three separate release samples. (Release area 3.14cm2) 
As a consequence, a limited amount of drug is available on the surface or 
near the surface of the nanofibers for immediate release. On the other side, 
148 
  
 
 
 
 
encapsulated molecules have a more uniform distribution in nanofibers obtained 
from solutions (Figure 5-4a-c). Thus, a larger share of molecules on the surface 
could result in a larger immediate (burst) release.  
PCL-PLGA_VEGF-BSA and PCL-PdlLA_VEGF-BSA composite scaffolds with a 
compositional and biochemical gradient along their thickness for spatially-
confined release of VEGF to a specific surface of the scaffold were prepared 
according to the scheme in Figure 5-1. We used side-by-side release chambers 
presented in Chapter 3 to separate VEGF delivered to the opposite sides of the 
composite scaffolds. Release data for the PCL-PdlLA composite scaffolds are 
presented in Figure 5-9.  
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Figure 5-9. Average amount of VEGF released daily from the opposite surfaces of 
a PCL-PdlLA composite scaffold. VEGF and BSA were encapsulated in the PdlLA 
nanofibers by emulsion electrospinning and released in 0.1% BSA release 
medium. Active-VEGF content in the release medium was determined by ELISA. 
The reported values represent the average of three separate release tests. 
(Release area 3.14 cm2)   
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The vast majority of the detected VEGF was release on side B, while very 
little amount of VEGF was found in the chamber on Side A. Again, as in the side-
by-side experiments presented in the previous chapters, composite scaffolds with 
internal gradients demonstrated the ability to confine with high efficiency the 
release of loaded molecules to a specific surface of the  scaffold. In this case, the 
efficiency of separation was higher than 93%. Unfortunately, no results were 
obtained with PCL-PLGA_VEGF-BSA composite scaffolds. Macroscopic defects and 
poor overall quality of PLGA nanofibers obtained from emulsion spoiled the side-
by-side release test. 
 
In all the release experiments presented in this chapter, the amount of 
VEGF detected in the release media as soon as at day 4 was very limited. This 
result is in contrast with the findings that we presented in the previous chapters 
where an appreciable release of encapsulated molecules was demonstrated for 10 
or more days. The reasons of this discrepancy are not clear. We think that the 
main reason is related to the detection technique itself. It is worth pointing out 
that ELISA kit can detect only active forms of the tested molecules. In fact, ELISA is 
designed to test protein activity based on the ligand (analyte)-protein 
interactions. The protein activity in the body is based on a ligand-specific 
recognition. If the binding site is denatured, the interaction does not occur, 
and unbound proteins are washed away. In principle, detected VEGF 
contents presented in Figure 5-8 and Figure 5-9 are different from the total 
amount of released VEGF (active and inactive). In fact, the fraction of 
inactive molecules is not taken into account. If one could quantify the total 
amount of VEGF in the release media, regardless its ligand-specific activity, 
it would be possible to provide more complete results. Bicinchoninic acid 
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(BCA) assay, micro BCA assay and Bradford Reagent have been tentatively 
used in the effort to determine the total content of VEGF. Unfortunately, a 
quantification of the total amount of VEGF in the release medium was not 
trivial. In fact, the extremely low levels of VEGF (tens of nanograms per ml), 
the preponderant and virtually unknown release of BSA from nanofibers, 
along with the presence of BSA in the release medium, made conventional 
protein quantification techniques ineffectual.  
In relation to the release from PCL-PdlLA_VEGF-BSA composite 
scaffolds, we can estimate that the amount of VEGF detected in the release 
media accounted for about the 25% of the total VEGF encapsulated in the 
nanofibers. This means that about 75% of the loaded VEGF either was still 
in the fibers or was wasted cue to inactivation or denaturation. With data 
obtained here we cannot produce definitive results. For this reason, 
additional experimentation is necessary to determine the real efficiency of 
VEGF encapsulation, the complete release kinetics of VEGF and the 
VEGF/BSA ratio that maximize the release of functional proteins.  
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5.4 Conclusions 
In this chapter we will show a preliminary study for the encapsulation and 
the controlled-release of medically relevant biomolecules. We successfully 
encapsulated vascular endothelial growth factor (VEGF) in poly(lactide-co-
glycolide) acid and poly(d,l-lactide) acid nanofibers by using both conventional 
solution electrospinning and emulsion electrospinning process. In the first case, 
VEGF was directly mixed into the polymeric solution; in the second case, a 
aqueous VEGF solution was emulsified within the organic polymeric solution. 
Release experiments demonstrated the delivery of functional biomolecules for at 
least 4 days, although the efficiency of the process and overall release kinetics are 
still partially unknown. In the present chapter, we also confirmed that composite 
scaffolds with a compositional and biochemical gradient have the ability to 
confine the release of VEGF to a specific region of the  scaffold. In addition, by 
using fluorescently-labeled molecules, we showed that encapsulated molecules 
are evenly distributed in nanofibers prepared by one-phase solution 
electrospinning, while they are arranged in discrete periodic domains along 
nanofibers prepared by emulsion electrospinning. 
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6 FINAL REMARKS 
 
In this research work, a multicomponent scaffold for Vascular Tissue 
Engineering was designed, produced and characterized. The objective of this 
thesis was to prepare and characterize a tubular scaffold with adequate 
mechanical property, improved biocompatible surface for endothelial cell 
recognition and selective biomolecule release ability.  
In the first part of this thesis, we have demonstrated a double-
electrospinning technique to produce a robust tubular scaffold with well-
integrated nanofibrous structure, anisotropic mechanical behaviour and 
endothelial-conducive surface. The advantage of this approach resides in the 
combination of superior biological properties of a natural polymer (silk fibroin) 
with higher mechanical stability and performance of a synthetic degradable 
polyester (PCL). A thick bulk PCL mesh of nanofibers, an intermediate intermixed 
fibrous layer, and a thin layer of silk-fibroin nanofibers have been combined to 
form a multilayered structure which is stable against mechanical delamination. 
Using a rotating cylindrical collector, anisotropic mechanical behavior of these 
electrospun structures was obtained and the anisotropy is found to be dependent 
on the rotation speed of the collector. It was previously known that a rotating 
collector allowed to produce a tubular structure with anisotropic mechanical 
properties; however, we recognized for the first time that the combination of the 
collector shape and the collector rotation allows to obtain tunable mechanical 
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properties. In particular, previous studies failed to recognize partial alignment of 
nanofibers along the longitudinal direction with slender collectors rotating at low 
speed, which in turn results in higher mechanical properties in the longitudinal 
direction with respect to circumferential direction. In fact, at lower rotation 
speeds the structure was stiffer in the longitudinal direction and more compliant 
in the circumferential direction, reaching up to 2.5 in the longitudinal-to-
circumferential ratio in this study. In this context, fibroin fibers acted as an 
“active” cell-conductive component that could actively dialogue with endothelial 
cells, and PCL fibers acted as a “passive” component that control mechanical and 
deformational behaviour of the scaffold.  
In the attempt to promote the “passive” PCL component of the scaffold to 
a more “active” role, we designed a graded electrospun structure able to 
sequester and deliver active biomolecules, while providing structural and 
mechanical integrity. In this view, we prepared a variety of tunable nanofiber 
micropatterns to control spatio-temporal release of one or multiple molecules. In 
fact, selective release of molecules that target specific cell types or tissue 
formation without influencing the activity of other cell populations or tissue 
functions is important to establish both in vitro physiological tissue models and in 
vivo tissue regeneration. Therefore, spatial and temporal control over release is 
critical to coordinate cell behaviors for healthy tissue formation. Herein, 
heterogeneous nanofibers scaffolds of PCL and PLGA with compositional and 
biochemical gradients along the scaffold thickness have been designed. Using 
PLGA nanofibers to encapsulate small molecules or proteins, we have 
characterized compositional and morphological changes as well as degradation 
behaviours of these composite scaffolds for up to 50 days in vitro. Using the 
precise graded composition and the interplay between PCL and PLGA, we showed 
that the hierarchically-structured composite was capable of sustaining selective 
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delivery of small molecules or larger proteins as well as multiple proteins to one 
specific side of the scaffold with efficiency of separation as high as 93%. We 
demonstrated that encapsulated molecules were released from one side of the 
scaffold with high efficiency of separation.  
Moreover, various release profiles of combined biomolecules could be 
achieved by modulating the nanofibers micropattern. Thus, we obtained 
simultaneous and sequential release of two different model proteins on the two 
surfaces of a newly engineered graded scaffolds, and we showed that timing and 
the kinetics of molecule release can be influenced by changing the initial pattern 
of drug distribution and the composition of the scaffold.  
We believed that scaffold preparation and release micropatterns 
presented in this work may represent the platform for the development of novel 
mechanically-competent scaffolds and multifunctional matrices able to actively 
control and direct the process of vascular tissue regeneration. However, the 
materials developed in this study can have also a broader impact in several fields 
of Tissue Engineering, where transitional components and active interfacial 
scaffolds with programmable and spatially controlled drug delivery ability are 
required. 

157 
  
 
 
 
 
 
REFERENCES 
 
1.  Ratcliffe A. Tissue engineering of vascular grafts. Matrix Biology. 
2000;19(4):353–7.  
2.  Martini FNJ. Fundamentals of Anatomy & Physiology. 8th ed. New York, 
NY: Benjamin-Cummings Pub Co; 2008.  
3.  Tu JV, Pashos CL, Naylor CD, Chen E, Normand SL, Newhouse JP, et al. Use 
of cardiac procedures and outcomes in elderly patients with myocardial 
infarction in the United States and Canada. The New England journal of 
medicine. 1997;336(21):1500–5.  
4.  World Health Organization. Cardiovascular Diseases Fact Sheet. 2009.  
5.  Tan, Wei; Bonani, Walter; Madhavan K. Nanofibrous Materials for 
Vascular Tissue Engineering and Regeneration. In: Popat K, editor. 
Nanotechnology in Tissue Engineering and Regenerative Medicine. CRC 
Press; 2011. p. 1–26. 
6.  Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM. Current 
status of prosthetic bypass grafts: a review. J Biomed Mater Res. 
2005;74B:570–81.  
7.  Kakisis JD, Liapis CD, Breuer C, Sumpio BE. Artificial blood vessel: the Holy 
Grail of peripheral vascular surgery. J Vasc Surg. 2005;41:349–54.  
8.  Zilla P, Bezuidenhout D, Human P. Prosthetic vascular grafts: Wrong 
models, wrong questions and no healing. Biomaterials. 
2007;28(34):5009–27.  
9.  Herring M, Baughman S, Glover J, Kesler K, Jesseph J, Campbell J, et al. 
Endothelial seeding of Dacron and polytetrafluoroethylene grafts: the 
cellular events of healing. Surgery. 1984;96(4):745–55.  
158 
  
 
 
 
 
10.  Zhang Z, Wang Z, Liu S, Kodama M. Pore size, tissue ingrowth, and 
endothelialization of small diameter microporous polyurethane vascular 
prostheses. Biomaterials. 2003;25:177–87.  
11.  Sauvage L, Berger K, Wood S, Nakagawa Y, Mansfield P. An external 
velour surface for porous arterial prostheses. Surgery. 1971;70(6):940–53.  
12.  Gupta BS, Kasyanov VA. Biomechanics of human common carotid artery 
and design of novel hybrid textile compliant vascular grafts. J Biomed 
Mater Res. 1997;34:341–9.  
13.  Taylor PR, Wolfe JH, Tyrrell MR, Mansfield AO, Nicolaides AN, Houston RE. 
Graft stenosis: justification for 1-year surveillance. Br J Surg. 
1990;77(10):1125–8.  
14.  Stewart SF, Lyman DJ. Effects of a vascular graft/natural artery 
compliance mismatch on pulsatile flow. J Biomech. 1992;25:297–310.  
15.  Sarkar S, Schmitz-Rixen T, Hamilton G, Seifalian AM. Achieving the ideal 
properties for vascular bypass grafts using a tissue engineered approach: 
a review. Med Biol Eng Comput. 2007;45:327–36.  
16.  Mitchell SL, Niklason LE. Requirements for growing tissue-engineered 
vascular grafts. Cardiovascular Pathology. 2003;12:59–64.  
17.  Brewster LP, Bufallino D, Ucuzian A, Greisler HP. Growing a living blood 
vessel: Insights for the second hundred years. Biomaterials. 
2007;28(34):5028–32.  
18.  Langer R, Vacanti JP. Tissue Engineering. Science. 1993;260(5110):920–6.  
19.  Lavik E, Langer R. Tissue engineering: current state and perspectives. 
Applied Microbiology and Biotechnology. 2004;65(1):1–8.  
20.  Lee KY, Peters MC, Anderson KW, Mooney DJ. Controlled growth factor 
release from synthetic extracellular matrices. Nature. 
2000;408(6815):998–1000.  
159 
  
 
 
 
 
21.  Sahoo S, Ang LT, Goh JCH, Toh SL. Growth factor delivery through 
electrospun nanofibers in scaffolds for tissue engineering applications. 
Journal of Biomedical Materials Research Part A. 2010;93A(4):1539–50.  
22.  Weinberg C, Bell E. A blood vessel model constructed from collagen and 
cultured vascular cells. Science. 1986;231(4736):397–400.  
23.  Xue L, Greisler HP. Biomaterials in the development and future of vascular 
grafts. Journal of Vascular Surgery. 2003;37(2):472–80.  
24.  Haruguchi H, Teraoka S. Intimal hyperplasia and hemodynamic factors in 
arterial bypass and arteriovenous grafts: a review. Journal of artificial 
organs : the official journal of the Japanese Society for Artificial Organs. 
2003;6(4):227–35.  
25.  MacNeill BD, Pomerantseva I, Lowe HC, Oesterle SN, Vacanti JP. Toward a 
new blood vessel. Vascular Medicine. 2002;7(3):241–6.  
26.  Rayleigh J. On the equilibrium of liquid conducting masses charged with 
electricity. London Edinburgh Dublin Philos Mag. 1882;44:184–6.  
27.  Zeleny J. Instability of Electrified Liquid Surfaces. Physical Review. 
1917;10(1):1–6.  
28.  Dole M, Hines RL, Mack LL, Mobley RC, Ferguson LD, Alice MB. Gas Phase 
Macroions. Macromolecules. 1968;1(1):96–7.  
29.  Formhals A. US Patent 1975504. 1934; 
30.  Formhals A. US Patent 2160962. 1939; 
31.  Simons HL. US patent 3280229. 1966; 
32.  Larrondo L, St. John Manley R. Electrostatic fiber spinning from polymer 
melts. III. Electrostatic deformation of a pendant drop of polymer melt. 
Journal of Polymer Science: Polymer Physics Edition. 1981;19(6):933–40.  
33.  Reneker DH, Yarin AL. Bending instability of electrically charged liquid jets 
of polymer solutions in electrospinning. Journal of Applied Physics. 
2000;87(9).  
160 
  
 
 
 
 
34.  Deitzel JM, Kleinmeyer J, Harris D, Tan NCB. The effect of processing 
variables on the morphology of electrospun nanofibers and textiles. 
Polymer. 2001;42:261–72.  
35.  Kowalewski TA, Barral S, Blonski S. Experiments and modelling of 
electrospinning process. Bull Pol Acad Sci Tech Sci. 2005;53(4):385.  
36.  Yarin a. L, Koombhongse S, Reneker DH. Bending instability in 
electrospinning of nanofibers. Journal of Applied Physics. 
2001;89(5):3018.  
37.  Rutledge GC, Fridrikh SV. Formation of fibers by electrospinning. 
Advanced drug delivery reviews. 2007;59(14):1384–91.  
38.  Beachley V, Wen XJ. Effect of electrospinning parameters on the 
nanofiber diameter and length. Materials science & engineering. C, 
Materials for biological applications. 2009;29(3):663–8.  
39.  Sill TJ, von Recum HA. Electrospinning: applications in drug delivery and 
tissue engineering. Biomaterials. 2008;29(13):1989–2006.  
40.  Pham QP, Sharma U, Mikos AG. Electrospinning of polymeric nanofibers 
for tissue engineering applications: A review. Tissue Engineering. 
2006;12(5):1197–211.  
41.  Zhang YZ, Su B, Venugopal J, Ramakrishna S, Lim CT. Biomimetic and 
bioactive nanofibrous scaffolds from electrospun composite nanofibers. 
Int J Nanomedicine. 2007;2:623–38.  
42.  Zhang Y, Lim CT, Ramakrishna S. Recent development of polymer 
nanofibers for biomedical and biotechnological applications. Business. 
2005;6:933–46.  
43.  Bonani W, Maniglio D, Motta A, Tan W, Migliaresi C. Biohybrid nanofiber 
constructs with anisotropic biomechanical properties. Journal of 
Biomedical Materials Research Part B-Applied Biomaterials. 
2011;96B(2):276–86.  
161 
  
 
 
 
 
44.  Greiner A, Wendorff JH. Electrospinning: A fascinating method for the 
preparation of ultrathin fibres. Angewandte Chemie-International Edition. 
2007;46(30):5670–703.  
45.  Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FK. Electrospun nanofibrous 
structure: a novel scaffold for tissue engineering. J. Biomed. Mater. Res. 
B. 2002;60:613.  
46.  Chakraborty S, Liao IC, Adler A, Leong KW. Electrohydrodynamics: A facile 
technique to fabricate drug delivery systems. Advanced Drug Delivery 
Reviews. 2009;61(12):1043–54.  
47.  Chew SY, Wen J, Yim EK, Leong KW. Sustained release of proteins from 
electrospun biodegradable fibers. Biomacromolecules. 2005;6(4):2017–
24.  
48.  Goldberg M, Langer R, Jia XQ. Nanostructured materials for applications 
in drug delivery and tissue engineering. Journal of Biomaterials Science-
Polymer Edition. 2007;18(3):241–68.  
49.  Cui W, Zhou Y, Chang J. Electrospun nanofibrous materials for tissue 
engineering and drug delivery. Science and Technology of Advanced 
Materials. 2010;11(1):014108.  
50.  Bhattarai SR, Bhattarai N, Yi HK, Hwang PH, Cha DI, Kim HY. Novel 
biodegradable electrospun membrane: scaffold for tissue engineering. 
Biomaterials. 2004;25(13):2595–602.  
51.  Bini T., Gao S, Wang S, Ramakrishna S. Poly(l-lactide-co-glycolide) 
biodegradable microfibers and electrospun nanofibers for nerve tissue 
engineering: an in vitro study. Journal of Materials Science. 
2006;41(19):6453–9.  
52.  Puppi D, Piras AM, Detta N, Dinucci D, Chiellini F. Poly(lactic-co-glycolic 
acid) electrospun fibrous meshes for the controlled release of retinoic 
acid. Acta biomaterialia. 2010;6(4):1258–68.  
53.  Dong YX, Liao S, Ngiam M, Chan CK, Ramakrishna S. Degradation 
Behaviors of Electrospun Resorbable Polyester Nanofibers. Tissue 
Engineering Part B-Reviews. 2009;15(3):333–51.  
162 
  
 
 
 
 
54.  Malafaya PB, Silva GA, Reis RL. Natural-origin polymers as carriers and 
scaffolds for biomolecules and cell delivery in tissue engineering 
applications. Advanced Drug Delivery Reviews. 2007;59(4-5):207–33.  
55.  Whatley BR, Kuo J, Shuai C, Damon BJ, Wen X. Fabrication of a biomimetic 
elastic intervertebral disk scaffold using additive manufacturing. 
Biofabrication. 2011;3(1):015004.  
56.  Baker BM, Mauck RL. The effect of nanofiber alignment on the 
maturation of engineered meniscus constructs. Biomaterials. 
2007;28(11):1967–77.  
57.  Nerurkar NL, Elliott DM, Mauck RL. Mechanics of oriented electrospun 
nanofibrous scaffolds for annulus fibrosus tissue engineering. Journal of 
orthopaedic research : official publication of the Orthopaedic Research 
Society. 2007;25(8):1018–28.  
58.  Nerurkar NL, Baker BM, Sen S, Wible EE, Elliott DM, Mauck RL. 
Nanofibrous biologic laminates replicate the form and function of the 
annulus fibrosus. Nature materials. 2009;8(12):986–92.  
59.  Moffat KL, Wang I-NE, Rodeo SA, Lu HH. Orthopedic interface tissue 
engineering for the biological fixation of soft tissue grafts. Clinics in sports 
medicine. 2009;28(1):157–76.  
60.  Fujimoto KL, Tobita K, Merryman WD, Guan J, Momoi N, Stolz DB, et al. 
An elastic, biodegradable cardiac patch induces contractile smooth 
muscle and improves cardiac remodeling and function in subacute 
myocardial infarction. Journal of the American College of Cardiology. 
2007;49(23):2292–300.  
61.  Li W-J, Jiang YJ, Tuan RS. Cell-nanofiber-based cartilage tissue engineering 
using improved cell seeding, growth factor, and bioreactor technologies. 
Tissue engineering. Part A. 2008;14(5):639–48.  
62.  Yang X, Shah JD, Wang H. Nanofiber enabled layer-by-layer approach 
toward three-dimensional tissue formation. Tissue engineering. Part A. 
2009;15(4):945–56.  
163 
  
 
 
 
 
63.  Griffin J, Delgado-Rivera R, Meiners S, Uhrich KE. Salicylic acid-derived 
poly(anhydride-ester) electrospun fibers designed for regenerating the 
peripheral nervous system. Journal of biomedical materials research. Part 
A. 2011;97(3):230–42.  
64.  Slater SC, Beachley V, Hayes T, Zhang D, Welsh GI, Saleem MA, et al. An in 
vitro model of the glomerular capillary wall using electrospun collagen 
nanofibres in a bioartificial composite basement membrane. PloS one. 
2011;6(6):e20802.  
65.  Drilling S, Gaumer J, Lannutti J. Fabrication of burst pressure competent 
vascular grafts via electrospinning: effects of microstructure. Journal of 
biomedical materials research. Part A. 2009;88(4):923–34.  
66.  Karageorgiou V, Tomkins M, Fajardo R, Meinel L, Snyder B, Wade K, et al. 
Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic 
protein-2 in vitro and in vivo. Journal of biomedical materials research. 
Part A. 2006;78(2):324–34.  
67.  Mieszawska AJ, Kaplan DL. Smart biomaterials - regulating cell behavior 
through signaling molecules. BMC biology. 2010;8:59.  
68.  Hanjaya-Putra D, Bose V, Shen Y-I, Yee J, Khetan S, Fox-Talbot K, et al. 
Controlled activation of morphogenesis to generate a functional human 
microvasculature in a synthetic matrix. Blood. 2011;118(3):804–15.  
69.  Zhang X, Reagan MR, Kaplan DL. Electrospun silk biomaterial scaffolds for 
regenerative medicine. Advanced drug delivery reviews. 
2009;61(12):988–1006.  
70.  Goldberg M, Langer R, Jia XQ. Nanostructured materials for applications 
in drug delivery and tissue engineering. Journal of Biomaterials Science-
Polymer Edition. 2007;18(3):241–68.  
71.  Ionescu LC, Lee GC, Sennett BJ, Burdick JA, Mauck RL. An anisotropic 
nanofiber/microsphere composite with controlled release of 
biomolecules for fibrous tissue engineering. Biomaterials. 
2010;31(14):4113–20.  
164 
  
 
 
 
 
72.  Mironov V, Kasyanovand V, Markwald RR. Nanotechnology in vascular 
tissue engineering: from nanoscaffolding towards rapid vessel 
biofabrication. Trends in Biotechnology. 2008;26(6):338–44.  
73.  Vasita R, Katti DS. Nanofibers and their applications in tissue engineering. 
Int J Nanomedicine. 2006;1:15–30.  
74.  Smith LA, Ma PX. Nano-fibrous scaffolds for tissue engineering. Colloids 
Surf. B Biointerfaces. 2004;39:125.  
75.  Miller DC, Webster TJ, Hasirci V. Technological advances in nanoscale 
biomaterials: the future of synthetic vascular graft design. Expert Rev 
Med Devices. 2004;1:259–68.  
76.  Miller DC, Haberstroh KM, Webster TJ. PLGA nanometer surface features 
manipulate fibronectin interactions for improved vascular cell adhesion. 
Journal of Biomedical Materials Research Part A. 2007;81A(3):678–84.  
77.  Mo X. M, Xu C. Y, Kotaki M, Ramakrishna S. Electrospun P(LLA-CL) 
nanofiber: a biomimetic extracellular matrix for smooth muscle cell and 
endothelial cell proliferation. Biomaterials. 2004;25(10):1883–90.  
78.  Luong-Van E, Grondahl L, Chua KN, Leong KW, Nurcombe V, Cool SM, et 
al. Controlled release of heparin from poly(epsilon-caprolactone) 
electrospun fibers. Biomaterials. 2006;27(9):2042–50.  
79.  Matthews JA, Wnek GE, Simpson DG, Bowlin GL. Electrospinning of 
collagen nanofibers. Biomacromolecules. 2002;3:232.  
80.  Li M, Mondrinos MJ, Gandhi MR, Ko FK, Weiss AS, Lelkes PI. Electrospun 
protein fibers as matrices for tissue engineering. Biomaterials. 
2005;26(30):5999–6008.  
81.  Boland ED, Matthews JA, Pawlowski KJ, Simpson DG, Wnek GE, Bowlin GL. 
Electrospinning collagen and elastin: preliminary vascular tissue 
engineering. Front. Biosci. 2004;9:1422.  
82.  Kidoaki S, Kwon IK, Matsuda T. Mesoscopic spatial designs of nano- and 
microfiber meshes for tissue-engineering matrix and scaffold based on 
165 
  
 
 
 
 
newly devised multilayering and mixing electrospinning techniques. 
Biomaterials. 2005;26:37.  
83.  Ziegler J, Mayr-Wohlfart U, Kessler S, Breitig D, Günther K-P. Adsorption 
and release properties of growth factors from biodegradable implants. 
Journal of biomedical materials research. 2002;59(3):422–8.  
84.  Lefler A, Ghanem A. Development of bFGF-chitosan matrices and their 
interactions with human dermal fibroblast cells. Journal of biomaterials 
science. Polymer edition. 2009;20(10):1335–51.  
85.  Wei G, Jin Q, Giannobile WV, Ma PX. Nano-fibrous scaffold for controlled 
delivery of recombinant human PDGF-BB. Journal of Controlled Release. 
2006;112(1):103–10.  
86.  Hile DD, Pishko MV. Solvent-free protein encapsulation within 
biodegradable polymer foams. Drug delivery. 2004;11(5):287–93.  
87.  Guan J, Stankus JJ, Wagner WR. Biodegradable elastomeric scaffolds with 
basic fibroblast growth factor release. Journal of Controlled Release. 
2007;120(1-2):70–8.  
88.  Moore K, MacSween M, Shoichet M. Immobilized concentration gradients 
of neurotrophic factors guide neurite outgrowth of primary neurons in 
macroporous scaffolds. Tissue engineering. 2006;12(2):267–78.  
89.  Nie T, Baldwin A, Yamaguchi N, Kiick KL. Production of heparin-
functionalized hydrogels for the development of responsive and 
controlled growth factor delivery systems. Journal of Controlled Release. 
2007;122(3):287–96.  
90.  Al-Tahami K, Singh J. Smart polymer based delivery systems for peptides 
and proteins. Recent patents on drug delivery & formulation. 
2007;1(1):65–71.  
91.  Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ. Polymer 
carriers for drug delivery in tissue engineering. Advanced drug delivery 
reviews. 2007;59(4-5):187–206.  
166 
  
 
 
 
 
92.  Biondi M, Ungaro F, Quaglia F, Netti PA. Controlled drug delivery in tissue 
engineering. Advanced Drug Delivery Reviews. 2008;60(2):229–42.  
93.  Tayalia P, Mooney DJ. Controlled growth factor delivery for tissue 
engineering. Advanced materials (Deerfield Beach, Fla.). 2009;21(32-
33):3269–85.  
94.  Discher DE, Mooney DJ, Zandstra PW. Growth Factors, Matrices, and 
Forces Combine and Control Stem Cells. Science. 2009;324(5935):1673–7.  
95.  Sy JC, Davis ME. Delivering regenerative cues to the heart: cardiac drug 
delivery by microspheres and peptide nanofibers. Journal of 
cardiovascular translational research. 2010;3(5):461–8.  
96.  Liu H, Fan H, Cui Y, Chen Y, Yao K, Goh JCH. Effects of the controlled-
released basic fibroblast growth factor from chitosan-gelatin 
microspheres on human fibroblasts cultured on a chitosan-gelatin 
scaffold. Biomacromolecules. 2007;8(5):1446–55.  
97.  Deng T, Huang S, Zhou S, He L, Jin Y. Cartilage regeneration using a novel 
gelatin-chondroitin-hyaluronan hybrid scaffold containing bFGF-
impregnated microspheres. Journal of microencapsulation. 
2007;24(2):163–74.  
98.  Ghotbi Z, Haddadi A, Hamdy S, Hung RW, Samuel J, Lavasanifar A. Active 
targeting of dendritic cells with mannan-decorated PLGA nanoparticles. 
Journal of Drug Targeting. 2011;19(4):281–92.  
99.  Gandhi M, Srikar R, Yarin AL, Megaridis CM, Gemeinhart RA. Mechanistic 
examination of protein release from polymer nanofibers. Molecular 
pharmaceutics. 2009;6(2):641–7.  
100.  Ainslie KM, Kraning CM, Desai TA. Microfabrication of an asymmetric, 
multi-layered microdevice for controlled release of orally delivered 
therapeutics. Lab on a chip. 2008;8(7):1042–7.  
101.  Ainslie KM, Lowe RD, Beaudette TT, Petty L, Bachelder EM, Desai TA. 
Microfabricated devices for enhanced bioadhesive drug delivery: 
attachment to and small-molecule release through a cell monolayer 
167 
  
 
 
 
 
under flow. Small (Weinheim an der Bergstrasse, Germany). 
2009;5(24):2857–63.  
102.  Silva EA, Mooney DJ. Effects of VEGF temporal and spatial presentation 
on angiogenesis. Biomaterials. 2010;31(6):1235–41.  
103.  Hong Y, Guan J, Fujimoto KL, Hashizume R, Pelinescu AL, Wagner WR. 
Tailoring the degradation kinetics of poly(ester carbonate urethane)urea 
thermoplastic elastomers for tissue engineering scaffolds. Biomaterials. 
2010;31(15):4249–58.  
104.  Nelson DM, Baraniak PR, Ma Z, Guan J, Mason NS, Wagner WR. 
Controlled Release of IGF-1 and HGF from a Biodegradable Polyurethane 
Scaffold. Pharmaceutical Research. 2011;28(6):1282–93.  
105.  Chen F-M, Zhang M, Wu Z-F. Toward delivery of multiple growth factors in 
tissue engineering. Biomaterials. 2010;31(24):6279–308.  
106.  Sohier J, Vlugt TJH, Cabrol N, Van Blitterswijk C, de Groot K, Bezemer JM. 
Dual release of proteins from porous polymeric scaffolds. Journal of 
Controlled Release. 2006;111(1-2):95–106.  
107.  Young S, Patel ZS, Kretlow JD, Murphy MB, Mountziaris PM, Baggett LS, et 
al. Dose effect of dual delivery of vascular endothelial growth factor and 
bone morphogenetic protein-2 on bone regeneration in a rat critical-size 
defect model. Tissue engineering. Part A. 2009;15(9):2347–62.  
108.  Huebsch N, Mooney DJ. Inspiration and application in the evolution of 
biomaterials. Nature. 2009;462(7272):426–32.  
109.  Sabella S, Brunetti V, Vecchio G, Torre AD, Rinaldi R, Cingolani R, et al. 
Micro/Nanoscale Parallel Patterning of Functional Biomolecules, Organic 
Fluorophores and Colloidal Nanocrystals. Nanoscale research letters. 
2009;4(10):1222–9.  
110.  Martin TA, Herman CT, Limpoco FT, Michael MC, Potts GK, Bailey RC. 
Quantitative photochemical immobilization of biomolecules on planar 
and corrugated substrates: a versatile strategy for creating functional 
biointerfaces. ACS applied materials & interfaces. 2011;3(9):3762–71.  
168 
  
 
 
 
 
111.  Davies N, Dobner S, Bezuidenhout D, Schmidt C, Beck M, Zisch AH, et al. 
The dosage dependence of VEGF stimulation on scaffold 
neovascularisation. Biomaterials. 2008;29(26):3531–8.  
112.  Sakano S, Hasegawa Y, Murata Y, Ito T, Genda E, Iwata H, et al. Inhibitory 
effect of bFGF on endochondral heterotopic ossification. Biochemical and 
Biophysical Research Communications. 2002;293(2):680–5.  
113.  Hutmacher DW. Scaffold design and fabrication technologies for 
engineering tissues - state of the art and future perspectives. Journal of 
Biomaterials Science-Polymer Edition. 2001;12(1):107–24.  
114.  Chen GP, Ushida T, Tateishi T. Scaffold design for tissue engineering. 
Macromolecular Bioscience. 2002;2(2):67–77.  
115.  Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. 
Biomaterials. 2000;21(24):2529–43.  
116.  Conte MS. The ideal small arterial substitute: a search for the Holy Grail? 
Faseb Journal. 1998;12(1):43–5.  
117.  Yoshimoto H, Shin YM, Terai H, Vacanti JP. A biodegradable nanofiber 
scaffold by electrospinning and its potential for bone tissue engineering. 
Biomaterials. 2003;24(12):2077–82.  
118.  Mo XM, Weber HJ. Electrospinning P(LLA-CL) nanofiber: A tubular scaffold 
fabrication with circumferential alignment. Macromolecular Symposia. 
2004;217:413–6.  
119.  Xu C, Inai R, Kotaki M, Ramakrishna S. Electrospun nanofiber fabrication 
as synthetic extracellular matrix and its potential for vascular tissue 
engineering. Tiss Eng. 2004;10:1160.  
120.  Burger C, Hsiao BS, Chu B. Nanofibrous materials and their applications. 
Annual Review of Materials Research. 2006;36:333–68.  
121.  Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen JS, et al. Silk-
based biomaterials. Biomaterials. 2003;24(3):401–16.  
169 
  
 
 
 
 
122.  Unger RE, Sartoris A, Peters K, Motta A, Migliaresi C, Kunkel M, et al. 
Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts 
and the formation of microcapillary-like structures on three-dimensional 
porous biomaterials. Biomaterials. 2007;28(27):3965–76.  
123.  Kim HJ, Kim U-J, Leisk GG, Bayan C, Georgakoudi I, Kaplan DL. Bone 
regeneration on macroporous aqueous-derived silk 3-D scaffolds. 
Macromolecular Bioscience. 2007;7(5):643–55.  
124.  Zhang X, Baughman CB, Kaplan DL. In vitro evaluation of electrospun silk 
fibroin scaffolds for vascular cell growth. Biomaterials. 2008;29(14):2217–
27.  
125.  Bondar B, Fuchs S, Motta A, Migliaresi C, Kirkpatrick CJ. Functionality of 
endothelial cells on silk fibroin nets: Comparative study of micro- and 
nanometric fibre size. Biomaterials. 2008;29(5):561–72.  
126.  Hutmacher DW, Goh JCH, Teoh SH. An introduction to biodegradable 
materials for tissue engineering applications. Annals Academy of 
Medicine Singapore. 2001;30(2):183–91.  
127.  Li WJ, Danielson KG, Alexander PG, Tuan RS. Biological response of 
chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-
caprolactone) scaffolds. Journal of Biomedical Materials Research Part A. 
2003;67A(4):1105–14.  
128.  Kweon H, Yoo MK, Park IK, Kim TH, Lee HC, Lee HS, et al. A novel 
degradable polycaprolactone networks for tissue engineering. 
Biomaterials. 2003;24(5):801–8.  
129.  Valluzzi R, He SJ, Gido SP, Kaplan D. Bombyx mori silk fibroin liquid 
crystallinity and crystallization at aqueous fibroin-organic solvent 
interfaces. International Journal of Biological Macromolecules. 1999;24(2-
3):227–36.  
130.  Pham QP, Sharma U, Mikos AG. Electrospun poly(epsilon-caprolactone) 
microfiber and multilayer nanofiber/microfiber scaffolds: Characterization 
of scaffolds and measurement of cellular infiltration. Biomacromolecules. 
2006;7(10):2796–805.  
170 
  
 
 
 
 
131.  Sukigara S, Gandhi M, Ayutsede J, Micklus M, Ko F. Regeneration of 
Bombyx mori silk by electrospinning - part 1: processing parameters and 
geometric properties. Polymer. 2003;44(19):5721–7.  
132.  Sukigara S, Gandhi M, Ayutsede J, Micklus M, Ko F. Regeneration of 
Bombyx mori silk by electrospinning. Part 2. Process optimization and 
empirical modeling using response surface methodology. Polymer. 
2004;45(11):3701–8.  
133.  Soffer L, Wang X, Mang X, Kluge J, Dorfmann L, Kaplan DL, et al. Silk-based 
electrospun tubular scaffolds for tissue-engineered vascular grafts. 
Journal of Biomaterials Science-Polymer Edition. 2008;19(5):653–64.  
134.  Thomas V, Jose MV, Chowdhury S, Sullivan JF, Dean DR, Vohra YK. 
Mechano-morphological studies of aligned nanofibrous scaffolds of 
polycaprolactone fabricated by electrospinning. Journal of Biomaterials 
Science-Polymer Edition. 2006;17(9):969–84.  
135.  Li W-J, Mauck RL, Cooper JA, Yuan X, Tuan RS. Engineering controllable 
anisotropy in electrospun biodegradable nanofibrous scaffolds for 
musculoskeletal tissue engineering. Journal of Biomechanics. 
2007;40(8):1686–93.  
136.  Kenawy ER, Layman JM, Watkins JR, Bowlin GL, Matthews JA, Simpson 
DG, et al. Electrospinning of poly(ethylene-co-vinyl alcohol) fibers. 
Biomaterials. 2003;24(6):907–13.  
137.  Baker BM, Gee AO, Metter RB, Nathan AS, Marklein RA, Burdick JA, et al. 
The potential to improve cell infiltration in composite fiber-aligned 
electrospun scaffolds by the selective removal of sacrificial fibers. 
Biomaterials. 2008;29(15):2348–58.  
138.  Unger RE, Wolf M, Peters K, Motta A, Migliaresi C, Kirkpatrick CJ. Growth 
of human cells on a non-woven silk fibroin net: a potential for use in 
tissue engineering. Biomaterials. 2004;25(6):5137–46.  
139.  Crescenzi V, Manzini G, Calzolari G, Borri C. Thermodynamics of fusion of 
poly-β-propiolactone and poly-ϵ-caprolactone. comparative analysis of 
the melting of aliphatic polylactone and polyester chains. European 
Polymer Journal. 1972;8(3):449–63.  
171 
  
 
 
 
 
140.  Zhang YZ, Wang X, Feng Y, Li J, Lim CT, Ramakrishna S. Coaxial 
electrospinning of (fluorescein isothiocyanate-conjugated bovine serum 
albumin)-encapsulated poly(epsilon-caprolactone) nanofibers for 
sustained release. Biomacromolecules. 2006;7(4):1049–57.  
141.  Huang ZM, He CL, Yang AZ, Zhang YZ, Hang XJ, Yin JL, et al. Encapsulating 
drugs in biodegradable ultrafine fibers through co-axial electrospinning. 
Journal of Biomedical Materials Research Part A. 2006;77A(1):169–79.  
142.  Xu XX, Yang L, Wang X, Chen X, Liang Q, Zeng J, et al. Ultrafine medicated 
fibers electrospun from W/O emulsions. Journal of Controlled Release. 
2005;108(1):33–42.  
143.  Ritger PL, Peppas NA. A simple equation for description of solute release I. 
Fickian and non-fickian release from non-swellable devices in the form of 
slabs, spheres, cylinders or discs. Journal of Controlled Release. 
1987;5(1):23–36.  
144.  Siepmann J, Siepmann F. Mathematical modeling of drug delivery. 
International journal of pharmaceutics. 2008;364(2):328–43.  
145.  Fu Y, Kao WJ. Drug release kinetics and transport mechanisms of non-
degradable and degradable polymeric delivery systems. Expert opinion on 
drug delivery. 2010;7(4):429–44.  
146.  Chen RR, Silva EA, Yuen WW, Mooney DJ. Spatio-temporal VEGF and 
PDGF delivery patterns blood vessel formation and maturation. 
Pharmaceutical research. 2007;24(2):258–64.  
147.  Phillips JE, Burns KL, Le Doux JM, Guldberg RE, García AJ. Engineering 
graded tissue interfaces. Proceedings of the National Academy of 
Sciences of the United States of America. 2008;105(34):12170–5.  
148.  Ashammakhi N, Ndreu A, Nikkola L, Wimpenny I, Yang Y. Advancing tissue 
engineering by using electrospun nanofibers. Regenerative Medicine. 
2008;3(4):547–74.  
149.  Liao S, Li B, Ma Z, Wei H, Chan C, Ramakrishna S. Biomimetic electrospun 
nanofibers for tissue regeneration. Biomedical Materials. 2006;1(3):R45–
53.  
172 
  
 
 
 
 
150.  Dahlin RL, Kasper FK, Mikos AG. Polymeric Nanofibers in Tissue 
Engineering. Tissue Engineering Part B-Reviews. 2011;17(5):349–64.  
151.  Saltzman WM, Olbricht WL. Building drug delivery into tissue engineering. 
Nature Reviews Drug Discovery. 2002;1(3):177–86.  
152.  Tessmar JK, Goepferich AM. Matrices and scaffolds for protein delivery in 
tissue engineering. Advanced Drug Delivery Reviews. 2007;59(4-5):274–
91.  
153.  Sanchez A, Gupta RK, Alonso MJ, Siber GR, Langer R. Pulsed controlled-
release system for potential use in vaccine delivery. Journal of 
Pharmaceutical Sciences. 1996;85(6):547–52.  
154.  Grayson ACR, Choi IS, Tyler BM, Wang PP, Brem H, Cima MJ, et al. Multi-
pulse drug delivery from a resorbable polymeric microchip device. Nature 
Materials. 2003;2(11):767–72.  
155.  Liu X, Pettway GJ, McCauley LK, Ma PX. Pulsatile release of parathyroid 
hormone from an implantable delivery system. Biomaterials. 
2007;28(28):4124–31.  
156.  Franssen O, Vandervennet L, Roders P, Hennink WE. Degradable dextran 
hydrogels: controlled release of a model protein from cylinders and 
microspheres. Journal of Controlled Release. 1999;60(2-3):211–21.  
157.  Chen RR, Mooney DJ. Polymeric growth factor delivery strategies for 
tissue engineering. Pharmaceutical Research. 2003;20(8):1103–12.  
158.  Suciati T, Howard D, Barry J, Everitt NM, Shakesheff KM, Rose FRAJ. Zonal 
release of proteins within tissue engineering scaffolds. Journal of 
Materials Science-Materials in Medicine. 2006;17(11):1049–56.  
159.  Burdick JA, Mason MN, Hinman AD, Thorne K, Anseth KS. Delivery of 
osteoinductive growth factors from degradable PEG hydrogels influences 
osteoblast differentiation and mineralization. Journal of Controlled 
Release. 2002;83(1):53–63.  
160.  Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for 
dual growth factor delivery. Nature Biotechnology. 2001;19(11):1029–34.  
173 
  
 
 
 
 
161.  Jain RK. Molecular regulation of vessel maturation. Nature Medicine. 
2003;9(6):685–93.  
162.  Peirce SM, Skalak TC. Microvascular remodeling: A complex continuum 
spanning angiogenesis to arteriogenesis. Microcirculation. 2003;10(1):99–
111.  
163.  Gurdon JB, Harger P, Mitchell A, Lemaire P. Activin signalling and 
response to a morphogen gradient. Nature. 1994;371(6497):487–92.  
164.  Burgess BT, Myles JL, Dickinson RB. Quantitative analysis of adhesion-
mediated cell migration in three-dimensional gels of RGD-grafted 
collagen. Annals of biomedical engineering. 2000;28(1):110–8.  
165.  Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, et al. 
Therapeutic angiogenesis. A single intraarterial bolus of vascular 
endothelial growth factor augments revascularization in a rabbit ischemic 
hind limb model. The Journal of clinical investigation. 1994;93(2):662–70.  
166.  Yang Y, Li X, Cui W, Zhou S, Tan R, Wang C. Structural stability and release 
profiles of proteins from core-shell poly (DL-lactide) ultrafine fibers 
prepared by emulsion electrospinning. Journal of biomedical materials 
research. Part A. 2008;86(2):374–85.  
167.  Li Y, Jiang H, Zhu K. Encapsulation and controlled release of lysozyme 
from electrospun poly(epsilon-caprolactone)/poly(ethylene glycol) non-
woven membranes by formation of lysozyme-oleate complexes. Journal 
of materials science. Materials in medicine. 2008;19(2):827–32.  
168.  Li X, Su Y, Liu S, Tan L, Mo X, Ramakrishna S. Encapsulation of proteins in 
poly(L-lactide-co-caprolactone) fibers by emulsion electrospinning. 
Colloids and surfaces. B, Biointerfaces. 2010;75(2):418–24.  
169.  King TW, Patrick CW. Development and in vitro characterization of 
vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-
glycolic acid)/poly(ethylene glycol) microspheres using a solid 
encapsulation/single emulsion/solvent extraction technique. Journal of 
biomedical materials research. 2000;51(3):383–90.  
174 
  
 
 
 
 
170.  Cao X, Shoichet MS. Delivering neuroactive molecules from biodegradable 
microspheres for application in central nervous system disorders. 
Biomaterials. 1999;20(4):329–39.  
171.  Zhao H, Gagnon J, Häfeli UO. Process and formulation variables in the 
preparation of injectable and biodegradable magnetic microspheres. 
Biomagnetic research and technology. 2007;5:2.  
172.  Valmikinathan CM, Defroda S, Yu X. Polycaprolactone and Bovine Serum 
Albumin Based Nanofibers for Controlled Release of Nerve Growth Factor. 
Scanning. 2009;:1084–9.  
175 
  
 
 
 
 
ACKNOWLEDGEMENTS 
 
I would like to express my sincere thanks to Professor Migliaresi, 
Professor Wei Tan and Dr. Antonella Motta, who supervised this dissertation 
work. With constant support, encouragement, suggestions and example, they led 
me to this important achievement. 
I would also like to thank all the amazing colleagues, who accompanied 
me along this doctorate trip, offering me a material support and a warm 
friendship.  
I thank my parents, my sister and my friends ,who always supported, 
encouraged and backed me up, with understanding and love.  
Finally, I would like to send a sweet thought to Monica, who has someway 
managed to bear the weight of my swinging mood and has always taken good 
care of me, lovely, patiently and unconditionally. 
 
 
